"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOU_SENESE",2000,22,7.27272727272727,2.31818181818182,0.409090909090909,0.363636363636364,0.5,1.18604651162791,0.9,1,1,0.272727272727273,0,6,6,3,4,0.27,0.27,0.14,0.18,53.64,1.18321656517364,NA,0.181818181818182,0.863636363636364,0.304,0.167,0.242,0.171,"PIERSANTE SESTINI;LUCA PADUA;MAURIZIO ZAZZI;ALFREDO ORRICO;VINCENZO SORRENTINO;ELISABETTA RENZONI;CHRISTOPHER BUNN;MICHELE ZAPPELLA;PATRICK FOLEY;JOUSSEF HAYEK;PANAGIOTIS PANTELIDIS;GIULIETTA VENTURI;MAURO MONDELLI;CHRIS KNIGHT;GUIDO GAROSI;F. REALE;LAURA ROMANÓ;LUCIA GALLI;KEN I. WELSH;MARINUNZIA CATUCCI","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GUIDO GAROSI;LUCA PADUA;G GAROSI;N DI PAOLO;DI PAOLO N;MAURO MONDELLI;F. REALE;ALFONSO CERASE;CESARE COLOSIMO;G. MAIRA;MAURIZIO ZAZZI;GIULIETTA VENTURI;LAURA ROMANÓ;MARINUNZIA CATUCCI;PIER E. VALENSIN;PIERSANTE SESTINI;SALVATORE GROSSO;PAOLO BALESTRI;STEFANO L. SENSI;ANTONIO ACQUAVIVA","0.62;0.58;0.5;0.5;0.5;0.42;0.42;0.33;0.33;0.33;0.31;0.31;0.31;0.31;0.31;0.31;0.25;0.25;0.25;0.25","PIERSANTE SESTINI;LUCA PADUA;MAURIZIO ZAZZI;ALFREDO ORRICO;VINCENZO SORRENTINO;MICHELE ZAPPELLA;JOUSSEF HAYEK;MAURO MONDELLI;GUIDO GAROSI;F. REALE;LUCIA GALLI;PIER E. VALENSIN;ALFONSO CERASE;P ADDARI;G.L. TRIANNI;L. CAPOTONDO;E. BOCCOLI;L. DI COSMO;PAOLA PIOMBONI;E. ZEI","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","GUIDO GAROSI;LUCA PADUA;N DI PAOLO;MAURO MONDELLI;F. REALE;ALFONSO CERASE;MAURIZIO ZAZZI;PIER E. VALENSIN;PIERSANTE SESTINI;E. ZEI;A D’AGATA;S. PASSERO;FRANCESCO SICURELLI;MARCO BERNINI;FABIO REALE;G. CIACCI;ALFREDO ORRICO;VINCENZO SORRENTINO;LUCIA GALLI;P ADDARI","0.62;0.58;0.5;0.42;0.42;0.33;0.31;0.31;0.31;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.22;0.22;0.22;0.2","JOUSSEF HAYEK;MICHELE ZAPPELLA;ALFREDO ORRICO;LUCIA GALLI;VINCENZO SORRENTINO;ANTONIO FEDERICO;CHING‐WAN LAM;MARIA TERESA DOTTI;PRISCILLA M.K. POON;SUI-FAN TONG;B. BACCETTI;E. FILIMBERTI;ELENA MORETTI;ELISABETTA BALDI;GIANNI FORTI;LAURA GAMBERA;MARIO MAGGI;MONICA MURATORI;PAOLA PECCHIOLI;PAOLA PIOMBONI","289;289;274;274;274;233;233;233;233;233;186;186;186;186;186;186;186;186;186;186","JOUSSEF HAYEK;MICHELE ZAPPELLA;B. BACCETTI;ELENA MORETTI;LAURA GAMBERA;PAOLA PIOMBONI;PIERSANTE SESTINI;F. REALE;FRANCESCO SICURELLI;LUCA PADUA;MAURO MONDELLI;MAURIZIO ZAZZI;PIER E. VALENSIN;E. ZEI;FABIO REALE;G. CIACCI;S. PASSERO;A.S. MELANI;E. BOCCOLI;G.L. TRIANNI","289;289;186;186;186;186;182;143;143;143;143;113;113;70;70;70;70;59;59;59","PIERSANTE SESTINI;F. REALE;GUIDO GAROSI;JOUSSEF HAYEK;MAURIZIO ZAZZI;MICHELE ZAPPELLA;PIER E. VALENSIN;A BASILE;A BRAVI;A. BRUCI;A.S. MELANI;ALFONSO CERASE;ALFREDO ORRICO;B. BACCETTI;CARLO ALDINUCCI;E. BOCCOLI;E. ZEI;ELENA MORETTI;FABIO REALE;FRANCESCO SICURELLI","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;ECONOMICS;ENGINEERING;SOCIOLOGY","17;9;3;3;2;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;NURSING;ANESTHESIA;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;RADIOLOGY;VIROLOGY;ANDROLOGY;ASTRONOMY;BIOINFORMATICS;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;CHROMATOGRAPHY;COGNITIVE PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;ECOLOGY;ECONOMIC GROWTH;EMERGENCY MEDICINE;ENVIRONMENTAL HEALTH;EVOLUTIONARY BIOLOGY;FAMILY MEDICINE;GENERAL SURGERY;MECHANICAL ENGINEERING;NEUROSCIENCE;OPHTHALMOLOGY;OPTICS;ORGANIC CHEMISTRY;PEDIATRICS;POLYMER SCIENCE;PSYCHOTHERAPIST;SOCIAL SCIENCE;TRADITIONAL MEDICINE","10;8;7;6;5;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;DISEASE;ANTIBODY;CARPAL TUNNEL SYNDROME;DNA;EPIDEMIOLOGY;MULTIPLE SCLEROSIS;NEUROLOGY;NEUROSURGERY;PERITONEAL DIALYSIS;PUBLIC HEALTH;VIRUS;ADDICTION;ALTERNATIVE MEDICINE;ANIMAL MODEL;ANTIGEN;APOPTOSIS;BIOPSY;BLOOD CIRCULATION;BLOOD PRESSURE;BLOOD TEST;BOLUS (DIGESTION);CENTRIFUGATION;CEREBROSPINAL FLUID;CIRCADIAN RHYTHM;COEFFICIENT OF VARIATION;DAUGHTER;DONATION;DRUG RESISTANCE;DUODENUM;ELECTROPHYSIOLOGY;ENDOSCOPY;ENZYME;ETIOLOGY;EVENING;EXTRACORPOREAL;EXTRACORPOREAL CIRCULATION;FLOW CYTOMETRY;FRAGMENTATION (COMPUTING);FUNCTIONAL MAGNETIC RESONANCE IMAGING;GIRL;GLIOMA;HEART FAILURE;HELICOBACTER PYLORI;HOSPITAL DISCHARGE;INCIDENCE (GEOMETRY);INTELLECTUAL DISABILITY;INTERVENTION (COUNSELING);LOGISTIC REGRESSION;MAGNETIC RESONANCE IMAGING;MEDIAN NERVE;MEMBRANE;METHYLPREDNISOLONE;MORNING;MORTALITY RATE;MOTILITY;MULTIDISCIPLINARY APPROACH;MULTIDISCIPLINARY TEAM;MULTIVARIATE ANALYSIS;NERVE CONDUCTION;NERVE CONDUCTION VELOCITY;NEUROFIBROMATOSIS;OPTIC NERVE;OXYGENATION;OZONE;PATHOGEN;PATHOPHYSIOLOGY;PERITONITIS;POPULATION;PROSPECTIVE COHORT STUDY;PSYCHOSOCIAL;QUALITY OF LIFE (HEALTHCARE);RADIOLOGICAL WEAPON;RANITIDINE;SEMEN;SENSORY SYSTEM;SIGNAL TRANSDUCTION;SPERM;STOMACH;STROKE (ENGINE);SUBARACHNOID HEMORRHAGE;THICKENING;TRANSPLANTATION","7;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EXON;MUTATION;GENOTYPE;NEURORADIOLOGY;PHENOTYPE;RETT SYNDROME;RNA;ACUTE DISSEMINATED ENCEPHALOMYELITIS;ASTROCYTOMA;AUTOIMMUNITY;BLOOD OXYGENATION;CARPAL TUNNEL;CARPAL TUNNEL RELEASE;DNA DAMAGE;ENCEPHALOMYELITIS;ESOPHAGOGASTRODUODENOSCOPY;GUANINE NUCLEOTIDE EXCHANGE FACTOR;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HUMAN GENETICS;INTRACEREBRAL HEMORRHAGE;INTRAVENOUS IMMUNOGLOBULINS;MESSENGER RNA;MOLECULAR MIMICRY;NICOTINE ADDICTION;OPTIC CHIASMA;ORGAN DONATION;ORGAN TRANSPLANTATION;OZONE THERAPY;PLASMAPHERESIS;PLECKSTRIN HOMOLOGY DOMAIN;POLYMERASE CHAIN REACTION;PROGRAMMED CELL DEATH;PROTEASE;PSYCHOSOCIAL SUPPORT;REAL-TIME POLYMERASE CHAIN REACTION;SENSORY NERVE;SPERM MOTILITY;TUNEL ASSAY;UNIVARIATE ANALYSIS;VIRAL DISEASE;VIRAL LOAD;X CHROMOSOME","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MECP2;REVERSE TRANSCRIPTASE;SINGLE-NUCLEOTIDE POLYMORPHISM;ANTIRETROVIRAL THERAPY;DNA FRAGMENTATION;IN SITU NICK-END LABELING;LAMIVUDINE;LENTIVIRUS;MUTATION TESTING;PILOCYTIC ASTROCYTOMA;REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;RNA EXTRACTION;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;VIRAL QUASISPECIES;ZIDOVUDINE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;ITALY;MIDDLE AGED;PERITONITIS;HIV-1;AGED;DNA-BINDING PROTEINS;HIV INFECTIONS;PERITONEAL DISEASES;RETT SYNDROME;CHILD;DNA PRIMERS;MUTATION;PERITONEAL DIALYSIS;PERITONEUM;PROTEINS;RNA, VIRAL","19;13;11;10;8;8;8;6;5;5;5;5;5;4;4;4;4;4;4;4","CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;COMPREHENSIVE APPROACH TO SCHOOL HEALTH PROMOTION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;MALE REPRODUCTIVE HEALTH;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;SCIENTIFIC AND MEDICAL ASPECTS OF OZONE THERAPY","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTIBODIES;IMMUNE RESPONSES;MECP2;NEURORADIOLOGY;PERITONEAL DIALYSIS;RETT SYNDROME;TGF-ß SIGNALING;ACUTE DISSEMINATED ENCEPHALOMYELITIS;ANIMAL MODEL;ANTIRETROVIRAL THERAPY;APOPTOTIC DNA FRAGMENTATION;BARIATRIC SURGERY;BLOOD CIRCULATION;BLOOD OXYGENATION;BLOOD TEST;BOLUS (DIGESTION);CANCER THERAPY;CARPAL TUNNEL SYNDROME;COEFFICIENT OF VARIATION;DAUGHTER","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CARPAL TUNNEL;CRYPTOGENIC FIBROSING;CXC RECEPTOR;FIBROSING ALVEOLITIS;PERITONEAL SCLEROSIS;SYSTEMIC SCLEROSIS;TUNNEL SYNDROME;AARSKOGSCOTT SYNDROME;ACUTE DISSEMINATED;ANTIBLASTIC POLYCHEMOTHERAPY;ANTIGENIC MIMICRY;ANTIRETROVIRAL RESISTANCE;ARTERIOSCLEROTIC LESIONS;BARIATRIC SURGERY;BLOOD OXYGENATION;BOSTON QUESTIONNAIRE;CEREBROSPINAL FLUID;CHILD AFFECTED;CLINICAL CORRELATION;CONGESTIVE HEART;DIALYSIS-INDUCED PERITONEAL;DIFFERING TEMPORAL;DISSEMINATED ENCEPHALOMYELITIS;DNAFRAGMENTED HUMAN;DYSPLASIA AARSKOGSCOTT;ELECTROPHYSIOLOGICAL FINDINGS;EXTRACORPOREAL BLOOD;FACIOGENITAL DYSPLASIA;FAILURE PATIENTS;FGD GENE","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CXCR- GENE;FIBROSING ALVEOLITIS;DNA FRAGMENTATION;FGD GENE;FASSC PATIENTS;NFASSC PATIENTS;BLOOD PRESSURE;FUNCTIONAL SIGNIFICANCE;HYPERTENSIVE ICH;PH DOMAINS;AAS PHENOTYPE;ACID CHANGE;ALVEOLITIS CFA;ALVEOLITIS FASSC;ALVEOLITIS NFASSC;AMINO ACID;ANALYSIS REVEALED;BIALLELIC POLYMORPHISMS;BRITISH CAUCASIAN;CAUCASIAN SUBJECTS;CC HOMOZYGOTE;CHAIN REACTION;CODON CHANGE;CONSERVATIVE AMINO;CONTROL SUBJECTS;CONTROLS PATIENTS;CRYPTOGENIC FIBROSING;CXCR- CC;CXCR- GENES;CXCR- TT","6;6;5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2001,28,6.53571428571429,1.67857142857143,0.464285714285714,0.285714285714286,0.5,1.42424242424242,1.18181818181818,1,1.16666666666667,0.178571428571429,1,10,6,7,2,0.36,0.21,0.25,0.07,30.64,0.670633139858864,NA,0.178571428571429,0.714285714285714,0.412,0.33,0.286,0.329,"PAOLO GALLUZZI;MICHELE ZAPPELLA;JOUSSEF HAYEK;ALFONSO CERASE;PAOLO BALESTRI;G MORGESE;ALFREDO ORRICO;SALVATORE GROSSO;ALFONSO DE STEFANO;LORENZO GAROSI;FRANCO ROVIELLO;VELIO BOCCI;LUCA PADUA;ALESSANDRA RENIERI;LUCIA MONTI;DANIELE MARRELLI;EMMA BORRELLI;MAURO MONDELLI;ILARIA MELONI;MAURIZIO FARNETANI","5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CARLO PIERLI;GUIDO GAROSI;PAOLO GALLUZZI;N. DI PAOLO;MICHELE ZAPPELLA;JOUSSEF HAYEK;FABIO REALE;PAOLO BALESTRI;ALFONSO CERASE;NICOLA DI PAOLO;G MORGESE;LUCA PADUA;MAURO MONDELLI;ALFREDO ORRICO;VELIO BOCCI;EMMA BORRELLI;S. PASSERO;G. CIACCI;SALVATORE GROSSO;ALFONSO DE STEFANO","1.25;1;0.72;0.7;0.58;0.58;0.53;0.51;0.5;0.5;0.42;0.4;0.4;0.34;0.34;0.34;0.33;0.33;0.31;0.31","PAOLO GALLUZZI;MICHELE ZAPPELLA;JOUSSEF HAYEK;ALFONSO CERASE;ALFREDO ORRICO;LUCIA MONTI;MAURIZIO FARNETANI;CARLO PIERLI;GUIDO GAROSI;FABIO REALE;N. DI PAOLO;MAURIZIO ZAZZI;L PIPPI;GIUSEPPE SINICRÒPI;ALESSANDRO IADANZA;GIUSEPPE FANETTI;F CAPPELLETTI;S AIOLFI;M FARZAD;ALESSIA DEL PASQUA","5;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CARLO PIERLI;GUIDO GAROSI;PAOLO GALLUZZI;N. DI PAOLO;MICHELE ZAPPELLA;JOUSSEF HAYEK;FABIO REALE;ALFONSO CERASE;NICOLA DI PAOLO;ALFREDO ORRICO;MAURIZIO FARNETANI;GIUSEPPE SINICRÒPI;ALESSANDRO IADANZA;ALESSIA DEL PASQUA;LUCIA MONTI;F CAPPELLETTI;MELANI S. ANDREA;ANDREA S. MELANI;A ORSI;SESTINI PIERSANTE","1.25;1;0.72;0.7;0.58;0.58;0.53;0.5;0.5;0.34;0.31;0.25;0.25;0.25;0.24;0.2;0.2;0.2;0.2;0.2","JOUSSEF HAYEK;MICHELE ZAPPELLA;ALFONSO DE STEFANO;DANIELE MARRELLI;ENRICO PINTO;FRANCO ROVIELLO;LORENZO GAROSI;MAURIZIO FARNETANI;ALESSANDRA RENIERI;ILARIA MELONI;PAOLO GALLUZZI;LUCA PADUA;ILARIA LONGO;PAOLO BALESTRI;ALFONSO CERASE;G MORGESE;MAURO MONDELLI;SALVATORE GROSSO;LUCIA MONTI;F. REALE","193;193;172;172;172;172;172;172;164;164;162;144;135;120;98;90;90;80;79;72","JOUSSEF HAYEK;MICHELE ZAPPELLA;MAURIZIO FARNETANI;PAOLO GALLUZZI;F. REALE;LUCIA MONTI;GIUSEPPE FANETTI;FABIO REALE;L PIPPI;MAURIZIO ZAZZI;PIER E. VALENSIN;GUIDO GAROSI;ALFONSO CERASE;CARLO PIERLI;MELANI S. ANDREA;SESTINI PIERSANTE;A.S. MELANI;CATERINA CINTI;DORIANA ZANCHETTA;G DE ANGELIS","193;193;172;162;72;47;42;36;33;33;33;27;26;18;18;18;16;16;16;16","PAOLO GALLUZZI;JOUSSEF HAYEK;MICHELE ZAPPELLA;CARLO PIERLI;FABIO REALE;GUIDO GAROSI;MAURIZIO FARNETANI;A BASILE;A ORSI;A.S. MELANI;ALESSANDRO IADANZA;ALESSIA DEL PASQUA;ALFONSO CERASE;ALFREDO ORRICO;ANDREA S. MELANI;ANTONIO MANGANELLI;CATERINA CINTI;DORIANA ZANCHETTA;F CAPPELLETTI;F. REALE","5;4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;HISTORY;MATERIALS SCIENCE;MATHEMATICS;PHYSICS","25;7;3;2;1;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;ANATOMY;CARDIOLOGY;ENVIRONMENTAL HEALTH;GENETICS;ANESTHESIA;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;PEDIATRICS;DERMATOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PSYCHIATRY;ARTIFICIAL INTELLIGENCE;EMERGENCY MEDICINE;ENDOCRINOLOGY;FAMILY MEDICINE;GENEALOGY;MACROECONOMICS;MECHANICAL ENGINEERING;METALLURGY;MICROBIOLOGY;NUCLEAR MEDICINE;NURSING;OPHTHALMOLOGY;OPTICS;ORTHODONTICS;PALEONTOLOGY;PHARMACOLOGY;PHYSICAL THERAPY;STATISTICS;UROLOGY;VIROLOGY","18;10;9;6;4;4;4;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;ALTERNATIVE MEDICINE;CANCER;POPULATION;BLUNT;CARPAL TUNNEL SYNDROME;CRANIOFACIAL;DIALYSIS;HEART FAILURE;HEART SEPTAL DEFECT;HEART SEPTUM;HYPOPLASIA;MAGNETIC RESONANCE IMAGING;MEDIAN NERVE;MICROCEPHALY;MULTIVARIATE ANALYSIS;PERITONEAL DIALYSIS;PERITONEUM;SHUNT (MEDICAL);VENTRICULAR FUNCTION","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;PHENOTYPE;RETT SYNDROME;TUMOR MARKER;UNIVARIATE ANALYSIS;VOLUME OVERLOAD;ADENOCARCINOMA;AUTOSOMAL RECESSIVE INHERITANCE;BIOSTATISTICS;BLEPHAROPHIMOSIS;CARCINOEMBRYONIC ANTIGEN;CARPAL TUNNEL;CARPAL TUNNEL RELEASE;CIPROFLOXACIN;DETRUSOR MUSCLE;GENE EXPRESSION;HEART TRANSPLANTATION;INTRACEREBRAL HEMORRHAGE;MUSCARINIC ACETYLCHOLINE RECEPTOR;NEURODEVELOPMENTAL DISORDER;OSTEOARTHRITIS;OXYGENATOR;OZONE THERAPY;PANCREATIC CANCER;PERFORMANCE STATUS;PROTEASE;PSORIATIC ARTHRITIS;PSYCHOMOTOR RETARDATION;PURINERGIC RECEPTOR;RETINOBLASTOMA;SURAMIN;SYRINGOMYELIA;VIRAL LOAD;WEIGHT LOSS","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MECP2;ANTIRETROVIRAL THERAPY;CA19-9;CHIARI MALFORMATION;MISSENSE MUTATION;MUTATION TESTING;OFLOXACIN;REPRESSOR","2;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;AGED;MIDDLE AGED;ADOLESCENT;CHILD, PRESCHOOL;CARPAL TUNNEL SYNDROME;CHILD;CRANIOFACIAL ABNORMALITIES;INTELLECTUAL DISABILITY;BRAIN;ITALY;NEOPLASM RECURRENCE, LOCAL;STOMACH NEOPLASMS;DNA-BINDING PROTEINS;FOLLOW-UP STUDIES;ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE;BIOMARKERS, TUMOR","24;20;17;11;11;10;8;8;7;7;7;7;6;6;6;6;5;5;4;4","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;GASTRIC CANCER RESEARCH AND TREATMENT;MANAGEMENT OF RIB FRACTURES IN TRAUMA PATIENTS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CONGENITAL CORONARY ARTERY ANOMALIES AND THEIR MANAGEMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;FEEDING DISORDERS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS;HEDGEHOG SIGNALING IN DEVELOPMENT AND CANCER;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;MECHANICAL CIRCULATORY SUPPORT SYSTEMS;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;OCULAR CANCER RESEARCH AND TREATMENT;ORGAN TRANSPLANTATION AND REJECTION;OSTEOARTHRITIS AND CARTILAGE REPAIR;PREOPERATIVE CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER;PULMONARY DRUG DELIVERY TECHNIQUES","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GASTRIC CANCER;HEART SEPTAL DEFECT;HEART SEPTUM;MECP2;MICROCEPHALY;OXYGEN-OZONE THERAPY;OZONE THERAPY;POSTINFARCTION VENTRICULAR SEPTAL DEFECT;RETT SYNDROME;UNIVARIATE ANALYSIS;VENTRICULAR FUNCTION;VENTRICULAR RECONSTRUCTION;VOLUME OVERLOAD;WIDE AWAKE HAND SURGERY;AMBROXOL;ANGIOKERATOMA;ANIMAL MODEL;ANTIRETROVIRAL THERAPY;AUTISM;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE","2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","BLUNT CHEST;CARPAL TUNNEL;CHEST TRAUMA;CLINICAL PRACTICE;GASTRIC CANCER;PERITONEAL DIALYSIS;RETT SYNDROME;SEPTAL DEFECT;TUNNEL SYNDROME;UNUSUAL LOCALISATION;VENTRICULAR SEPTAL;ACUTE EXACERBATION;AECB CHRONICALLY;AFFECTED GLOBE;AUTOSOMAL-RECESSIVE INHERITANCE;BARAITSERREARDON SYNDROME;BIOINFORMATIC ANALYSIS;BRAIN IMAGING;BRONCHITIS AECB;CAPILLAROSCOPIC FINDINGS;CEA CA;CHRONIC BRONCHITIS;CHRONICALLY TREATED;CIRCULATION II;CLINICAL ANALYSIS;CLINICAL UTILITY;COATS DISEASE;COMPARATIVE ANALYSIS;COMPARATIVE STUDY;CONSERVED REGION","2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARPAL TUNNEL;TUNNEL SYNDROME;SIENA ITALYSEARCH;MUSCLE NERVE;DISEASES UNIVERSITY;MENTAL DISEASES;SIENA SIENA;SKIN RESPONSE;SYMPATHETIC SKIN;DOVILE SIENA;GIANNINI MD;MAURO MONDELLI;MD FABIO;MONDELLI MD;PIAN DOVILE;REALE MD;SEPTAL DEFECT;SERVICE USL;AMERICAN ACADEMY;AUTHOR MAURO;HOME NEBULIZER;NERVE FIBERS;PERITONEAL DIALYSIS;SYNDROME MUSCLE;ACTA NEUROL;ANOMALOUS CHRONIC;AUTHORBENITO VECCHIARELLI;AUTHORFABIO GIANNINI;AUTHORFABIO REALE;AUTHORTATIANA MARSILI","13;13;10;8;6;6;6;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2",4,0.14,4.75,6.25,0,0,0,1,7,0,0,7,0,0,0,0,3.5,0,0,0,0,0,0,41.25,41.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,8,244,3.33,0,0,48,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COLO-RECTAL CANCER;DIGESTIVE DISEASES","1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","COLON AND RECTAL CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2002,29,6.75862068965517,1.75862068965517,0.379310344827586,0.344827586206897,0.448275862068966,1.5,1,0.909090909090909,1,0.103448275862069,1,14,8,2,1,0.48,0.28,0.07,0.03,32.21,0.583789185032161,NA,0.344827586206897,0.862068965517241,0.364,0.329,0.288,0.375,"PAOLO GALLUZZI;G MORGESE;MICHELE ZAPPELLA;SALVATORE GROSSO;PAOLO BALESTRI;ALFONSO CERASE;ALFREDO ORRICO;LUCIA PUCCI;CARLO VENTURI;LUCIA GALLI;RAFFAELLA ZANNOLLI;CARLO FRATICELLI;ALEXIS BRICE;CHRISTOPHER GILLBERG;MARIA RÅSTAM;ANNE PHILIPPE;MARION LEBOYER;JOUSSEF HAYEK;MARÍA MARTÍNEZ;ANDREA COLLINI","6;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MICHELE ZAPPELLA;CARLO FRATICELLI;PAOLO GALLUZZI;SALVATORE GROSSO;PAOLO BALESTRI;G MORGESE;ALFONSO CERASE;ROSARIO SUTERA;DI PAOLO N;GUIDO GAROSI;F. REALE;ALFREDO ORRICO;LUCIA GALLI;CARLO VENTURI;ANDREA COLLINI;MAURO PIGNI;MARCO PASSAMONTI;MONICA ULIVELLI;S. PASSERO;M. CIONI","1.34;0.83;0.71;0.55;0.55;0.54;0.53;0.5;0.5;0.5;0.5;0.48;0.48;0.45;0.42;0.33;0.33;0.33;0.33;0.29","PAOLO GALLUZZI;MICHELE ZAPPELLA;SALVATORE GROSSO;PAOLO BALESTRI;ALFONSO CERASE;ALFREDO ORRICO;CARLO VENTURI;LUCIA GALLI;CARLO FRATICELLI;JOUSSEF HAYEK;ANDREA COLLINI;ROSA MOSTARDINI;F. REALE;ROSARIO BERARDI;L. PERGOLA;MAURIZIO ZAZZI;VINCENZO SORRENTINO;ALDO CAPOROSSI;GIOVANNI PETRINI;F CAPPELLETTI","6;5;4;4;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1","MICHELE ZAPPELLA;CARLO FRATICELLI;PAOLO GALLUZZI;SALVATORE GROSSO;PAOLO BALESTRI;ALFONSO CERASE;ROSARIO SUTERA;GUIDO GAROSI;F. REALE;ALFREDO ORRICO;LUCIA GALLI;CARLO VENTURI;ANDREA COLLINI;ROSA MOSTARDINI;ROSARIO BERARDI;ALDO CAPOROSSI;CLAUDIO DE FELICE;JOUSSEF HAYEK;GIOVANNI PETRINI;F CAPPELLETTI","1.34;0.83;0.71;0.55;0.55;0.53;0.5;0.5;0.5;0.48;0.48;0.45;0.42;0.25;0.25;0.25;0.25;0.24;0.2;0.2","PAOLO GALLUZZI;G MORGESE;CLAUDIO DE FELICE;GIUSEPPE LATINI;PAOLA VACCA;ROBERT J. KOPOTIC;ALFREDO ORRICO;LUCIA GALLI;F. REALE;MICHELE ZAPPELLA;LUCIA PUCCI;PAOLO BALESTRI;SALVATORE GROSSO;CARLO VENTURI;SÍMONE ROSSI;MONICA ULIVELLI;S. PASSERO;ANDREA S. MELANI;DHIMITRAQ ARGJIRI;ILIR PEPOSHI","189;145;140;140;140;140;113;113;111;110;92;90;90;89;88;82;82;80;80;80","PAOLO GALLUZZI;CLAUDIO DE FELICE;ALFREDO ORRICO;F. REALE;LUCIA GALLI;MICHELE ZAPPELLA;ANDREA S. MELANI;ALFONSO CERASE;CARLO VENTURI;MAURIZIO ZAZZI;VINCENZO SORRENTINO;GUIDO GAROSI;E. GAGGIOTTI;F CAPPELLETTI;GIOVANNI PETRINI;G. VATTI;ALDO CAPOROSSI;ANDREA COLLINI;A. CASASCO;PAOLO BALESTRI","189;140;113;111;84;81;80;69;60;59;50;34;30;30;30;29;24;23;16;16","PAOLO GALLUZZI;MICHELE ZAPPELLA;ALFONSO CERASE;ALFREDO ORRICO;ANDREA COLLINI;CARLO VENTURI;F. REALE;LUCIA GALLI;A. CASASCO;ALDO CAPOROSSI;ANDREA S. MELANI;CAETANO GALVÃO PETRINI;CLAUDIO DE FELICE;E. GAGGIOTTI;F CAPPELLETTI;G. VATTI;GIOVANNI PETRINI;GUIDO GAROSI;JOUSSEF HAYEK;L FORZINI","6;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;ECONOMICS;CHEMISTRY;ENGINEERING;MATHEMATICS;PHYSICS;SOCIOLOGY","25;11;5;2;2;1;1;1;1;1","PATHOLOGY;SURGERY;PSYCHIATRY;GENETICS;INTERNAL MEDICINE;RADIOLOGY;PEDIATRICS;ANATOMY;ANESTHESIA;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE;MACROECONOMICS;NEUROSCIENCE;OPHTHALMOLOGY;AUDIOLOGY;BIOCHEMISTRY;BIOINFORMATICS;CARDIOLOGY;DEMOGRAPHY;DERMATOLOGY;DEVELOPMENTAL PSYCHOLOGY;ELECTRICAL ENGINEERING;EMERGENCY MEDICINE;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;FOOD SCIENCE;GASTROENTEROLOGY;GENERAL SURGERY;MOLECULAR BIOLOGY;OPTICS;PHYSICAL THERAPY;PROGRAMMING LANGUAGE;SOCIAL PSYCHOLOGY;STATISTICS;VIROLOGY;WORLD WIDE WEB","11;11;10;9;7;6;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;AUTISM;MAGNETIC RESONANCE IMAGING;ATAXIA;COMPLICATION;DEPRESSION (ECONOMICS);DISEASE;HYDROCEPHALUS;NEUROLOGY;PREGNANCY;SEVERITY OF ILLNESS;VERTEBRAL ARTERY;ABNORMALITY;ADENOMA;ADVERSE EFFECT;ALEXITHYMIA;ANEURYSM;ANGIOGRAPHY;ANTIFUNGAL;ARTERIOVENOUS FISTULA;BIOPSY;CALCIFICATION;CANCER;CARPAL TUNNEL SYNDROME;CATHETER;CERVICAL SPINE;CERVICAL VERTEBRAE;CHEMOTHERAPY;CHILD AND ADOLESCENT PSYCHIATRY;CHORDOMA;CLINICAL SIGNIFICANCE;COGNITION;COMA (OPTICS);COMBINATION THERAPY;COMPUTED TOMOGRAPHY;CROSS-SECTIONAL STUDY;DEGENERATION (MEDICAL);DETECTOR;DISSECTION (MEDICAL);DYSGENESIS;DYSPLASIA;DYSTONIA;EATING DISORDERS;ECTODERMAL DYSPLASIA;ELECTROENCEPHALOGRAPHY;EMBOLIZATION;ENZYME;EPILEPSY;ETIOLOGY;EXTRACORPOREAL;EXTRACORPOREAL MEMBRANE OXYGENATION;FASCIITIS;FERMENTATION;FISTULA;FUNCTIONAL MAGNETIC RESONANCE IMAGING;GLASGOW COMA SCALE;HEMODIALYSIS;HISTOLOGY;HORNER SYNDROME;HYPOPLASIA;INDEX (TYPOGRAPHY);INTERVENTION (COUNSELING);INTERVENTIONAL RADIOLOGY;INTRACELLULAR;INTRAOCULAR LENS;LOBE;MALIGNANT HYPERTHERMIA;MEDIAN NERVE;MEGALENCEPHALY;METHOTREXATE;MICROCEPHALY;MUCORMYCOSIS;MYCOSIS;MYOCLONUS;MYOPATHY;NAUSEA;NEUROSURGERY;NUCLEOSIDE;OXYGENATION;PANCREAS;PARAGANGLIOMA;PATHOLOGICAL;PERFUSION;PERITONEAL DIALYSIS;PERITONEUM;PERITONITIS;PERSONALITY;PNEUMOTHORAX;POPULATION;PRESENTATION (OBSTETRICS);RADIOLOGICAL WEAPON;RANDOMIZED CONTROLLED TRIAL;REPRODUCIBILITY;RETINAL;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TICS;TONGUE;TORTICOLLIS;TOURETTE SYNDROME;TRAIT;TRISOMY;TUBEROUS SCLEROSIS;VEIN;VIRUS;VISUAL ACUITY;VOMITING;WRIST","8;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELE;CANDIDATE GENE;CHROMOSOME;GENETIC LINKAGE;NEURORADIOLOGY;PHENOTYPE;ADENOCARCINOMA;AMPHOTERICIN B;ANOREXIA NERVOSA;BIPOLAR DISORDER;BLOOD OXYGENATION;CARPAL TUNNEL;CARPAL TUNNEL RELEASE;CENTRAL VENOUS CATHETER;CEREBELLAR DEGENERATION;CEREBRAL ANGIOGRAPHY;CERVICAL ARTERY;CLINICAL NEUROPHYSIOLOGY;COMPUTED TOMOGRAPHIC;CORTICAL DYSPLASIA;DEGENERATIVE DISEASE;DIALYSIS CATHETER;DYSMETRIA;EXON;FETUS;GENE DUPLICATION;GENOTYPE;HEMODIALYSIS CATHETER;HEMOTHORAX;HEPATITIS B VIRUS;HYPOXANTHINE;ILLNESS SEVERITY;INTRAOCULAR LENSES;MAGNETIC RESONANCE ANGIOGRAPHY;MAINTENANCE THERAPY;MUCINOUS CYSTADENOCARCINOMA;MUCINOUS TUMOR;MUSCLE BIOPSY;MUTANT;MUTATION;NAD+ KINASE;NUCLEOSIDE ANALOGUE;NUCLEOTIDE;PARKINSON'S DISEASE;PHACOEMULSIFICATION;PULSE (MUSIC);PURINE;RETINAL DEGENERATION;RETINITIS PIGMENTOSA;RHIZOPUS;RHIZOPUS ORYZAE;RNA;RYANODINE RECEPTOR;SMOKING PREVALENCE;SPASMODIC TORTICOLLIS;SPINOCEREBELLAR ATAXIA;SUBCLAVIAN VEIN;TEMPORAL LOBE;TOBACCO USE;VERTEBRAL ARTERY DISSECTION;VIRAL DISEASE;WHITE MATTER","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HAPLOTYPE;KARYOTYPE;ADENINE PHOSPHORIBOSYLTRANSFERASE;CONGENITAL MYOPATHY;CYSTADENOCARCINOMA;DYSKINESIA;HEMIMEGALENCEPHALY;HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE;LAMIVUDINE;NUCLEOTIDE SALVAGE;POINT MUTATION;POLYHYDRAMNIOS;PROBAND;REVERSE TRANSCRIPTASE;RYR1;SIDA;ZIDOVUDINE;ZYGOMYCOSIS","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;MAGNETIC RESONANCE IMAGING;MUTATION;AGED;AUTISTIC DISORDER;BRAIN;CEREBELLUM;INTELLECTUAL DISABILITY;ABNORMALITIES, MULTIPLE;ADULT;CHILD;CHILD, PRESCHOOL;ADENOMA;AGED, 80 AND OVER;CEREBRAL HEMORRHAGE;CYSTADENOCARCINOMA, MUCINOUS;HIV-1","26;17;16;9;8;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4","AUTISM SPECTRUM DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;CATARACT SURGERY TECHNIQUES AND COMPLICATIONS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;COMPREHENSIVE APPROACH TO SCHOOL HEALTH PROMOTION;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EMERGING ANIMAL PATHOGENS AND DISEASES;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;INTEROCEPTION AND SOMATIC SYMPTOMS;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;NON-CONTACT PHYSIOLOGICAL MONITORING TECHNOLOGY;NUCLEOTIDE METABOLISM AND ENZYME REGULATION;PANCREATIC CANCER RESEARCH AND TREATMENT;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AUTISM;CANDIDATE GENE;DEPRESSION (ECONOMICS);GENETIC LINKAGE;LINKAGE DISEQUILIBRIUM;NEURONAL DEGENERATION;NEURORADIOLOGY;TRANSMISSION DISEQUILIBRIUM TEST;ABACAVIR;ABNORMALITY;ADENINE PHOSPHORIBOSYLTRANSFERASE;ALEXITHYMIA;ANOREXIA NERVOSA;BLOOD OXYGENATION;CENTRAL CORE DISEASE;CENTRAL VENOUS CATHETER;CENTRAL VENOUS CATHETERIZATION;CEREBELLAR DEGENERATION;CERVICAL ARTERY;CHORDOMA","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANDIDATE GENES;TEN CANDIDATE;ACRYLIC INTRAOCULAR;ACRYSOF MABA;AR ACRYLIC;ARTERY ANEURYSM;ATAXIA TYPE;AUTISTIC BEHAVIOUR;AUTONOMIC FAILURE;BLOOD OXYGENATION;BROAD NUCLEOSIDEANALOGUE;C-TERMINAL REGION;CARPAL TUNNEL;CEREBELLAR DEGENERATION;CERVICAL SPINE;CHRONIC MEDICAL;CLINICAL SEVERITY;COIL EMBOLIZATION;COLLISION TUMOR;COMORBID CHRONIC;COMPLETE TRISOMY;DE NOVO;DIGITAL ANOMALIES;DISSECTING VERTEBRAL;DYSMATURATIONAL DISORDER;DYSPLASIA SYNDROME;EARLY-ONSET TOURETTE;ECTODERMAL DYSPLASIA;ENDOVASCULAR TREATMENT;EPIDEMIOLOGICAL STUDY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SEVERITY SCALE;CARPAL TUNNEL;CLINICAL SEVERITY;TUNNEL SYNDROME;CAUSATIVE FACTORS;CLINICAL STATUS;IMAGING FEATURES;IN-HOSPITAL MORTALITY;NUCLEOSIDE RT;ABACAVIR SITE-DIRECTED;ACID SUBSTITUTIONS;ACTA NEUROL;ADVERSE EVENTS;AGE DURATION;AGE RESULTS;AMINO ACID;ANALYSED CLINICAL;ANGIOGRAPHY REVEALED;APPLIED PROSPECTIVELY;ARTERIAL HYPERTENSION;ASSESS PREDICTORS;ASSIGNING SEVERITY;BLACKWELL MUNKSGAARD;BOSTON CARPAL;BQ MATERIAL;BQ SCORES;BRAIN SCAN;BROAD IMPLICATIONS;CLINICAL WORSENING;CLOTTING DISORDER","4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",7,0.24,4.5,2,0,0,0,0,1.25,0,1,2,0,0,0,0,2.5,0,0,0,0,0,0,40.5,40.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2003,32,6.8125,2.375,0.5,0.3125,0.5,1.40740740740741,1.14285714285714,1.25,1.14285714285714,0.3125,1,22,5,3,2,0.69,0.16,0.09,0.06,32.94,0.622308818858198,NA,0.15625,0.8125,0.44,0.302,0.19,0.302,"ALFONSO CERASE;PAOLO GALLUZZI;CLAUDIO DE FELICE;GABRIELE CENTINI;L. ROSIGNOLI;A. KENANIDIS;SALVATORE GROSSO;G MORGESE;FELICE PETRAGLIA;SANDRA BRACCO;ALFREDO ORRICO;IGNAZIO MARIA VALLONE;PIERSANTE SESTINI;CARLO VENTURI;M PIRRELLI;PAOLO BALESTRI;ENNIO POLITO;ANTONIO ACQUAVIVA;GIOVANNA MUNICCHI;PAOLA GENNARI","4;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","CLAUDIO DE FELICE;GABRIELE CENTINI;L. ROSIGNOLI;A. KENANIDIS;FELICE PETRAGLIA;ALFONSO CERASE;MAURO MONDELLI;FABIO REALE;PAOLO GALLUZZI;ANTONIO ACQUAVIVA;GIOVANNA MUNICCHI;SILVIA MARCONCINI;L. PALMA;SANDRA BRACCO;G LATINI;SALVATORE GROSSO;G MORGESE;PIERSANTE SESTINI;M PIRRELLI;ENNIO POLITO","1.53;1.12;1.12;1.12;0.58;0.54;0.45;0.45;0.42;0.4;0.4;0.4;0.4;0.37;0.37;0.34;0.34;0.32;0.32;0.29","ALFONSO CERASE;PAOLO GALLUZZI;CLAUDIO DE FELICE;GABRIELE CENTINI;L. ROSIGNOLI;A. KENANIDIS;SALVATORE GROSSO;G MORGESE;FELICE PETRAGLIA;SANDRA BRACCO;ALFREDO ORRICO;IGNAZIO MARIA VALLONE;CARLO VENTURI;M PIRRELLI;PAOLO BALESTRI;PAOLA GENNARI;LUCIA MONTI;MAURO MONDELLI;FABIO REALE;M. A. FARNETANI","4;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","CLAUDIO DE FELICE;GABRIELE CENTINI;L. ROSIGNOLI;A. KENANIDIS;FELICE PETRAGLIA;ALFONSO CERASE;MAURO MONDELLI;FABIO REALE;PAOLO GALLUZZI;SANDRA BRACCO;SALVATORE GROSSO;G MORGESE;M PIRRELLI;IGNAZIO MARIA VALLONE;ALFREDO ORRICO;FEDERICA GINANNESCHI;ANDREA S. MELANI;FRANCESCO SICURELLI;M. A. FARNETANI;CARLO VENTURI","1.53;1.12;1.12;1.12;0.58;0.54;0.45;0.45;0.42;0.37;0.34;0.34;0.32;0.28;0.28;0.25;0.25;0.25;0.24;0.23","ALFONSO CERASE;PAOLO GALLUZZI;ALBERTO LUINI;CRISTINA GARIBALDI;G. GATTI;JM. PETIT;M. CIOCCA;MARIA CRISTINA LEONARDI;MATTIA INTRA;PAOLO VERONESI;R ORECCHIA;ROBERTA LAZZARI;UMBERTO VERONESI;SANDRA BRACCO;FABIO REALE;MAURO MONDELLI;CLAUDIO DE FELICE;G MORGESE;SALVATORE GROSSO;CARLO VENTURI","197;152;134;134;134;134;134;134;134;134;134;134;134;122;117;117;110;109;109;101","ALFONSO CERASE;PAOLO GALLUZZI;ALBERTO LUINI;G. GATTI;MATTIA INTRA;PAOLO VERONESI;UMBERTO VERONESI;FABIO REALE;CLAUDIO DE FELICE;ALFREDO ORRICO;JOUSSEF HAYEK;LUCIA GALLI;MICHELE ZAPPELLA;ROBERTO CANITANO;SANDRA BRACCO;FRANCESCO GIANNINI;MICHELE FIMIANI;NILA VOLPI;SILVIA PASSERO;SÍMONE ROSSI","154;152;134;134;134;134;134;117;110;95;83;83;83;83;79;75;75;75;75;75","A. KENANIDIS;GABRIELE CENTINI;L. ROSIGNOLI;PAOLO GALLUZZI;CLAUDIO DE FELICE;ALFONSO CERASE;ALFREDO ORRICO;FABIO REALE;FELICE PETRAGLIA;M PIRRELLI;SANDRA BRACCO;ALBERTO FABBRI;ALBERTO LUINI;ANDREA S. MELANI;CARLA VINDIGNI;CARLO VENTURI;DANIELA FINESCHI;ELISABETTA MENCI;ENIVARCO MAGLIONI;FEDERICA GINANNESCHI","4;4;4;4;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATERIALS SCIENCE","30;14;4;3;2;2;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;RADIOLOGY;PATHOLOGY;OBSTETRICS;PSYCHIATRY;PEDIATRICS;ENVIRONMENTAL HEALTH;GYNECOLOGY;NUCLEAR MEDICINE;PHYSICAL THERAPY;ANATOMY;ANESTHESIA;ARTIFICIAL INTELLIGENCE;BIOCHEMISTRY;DERMATOLOGY;NEUROSCIENCE;OPTICS;AEROSPACE ENGINEERING;AGRONOMY;CANCER RESEARCH;CARDIOLOGY;DEVELOPMENTAL PSYCHOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;METALLURGY;OPHTHALMOLOGY;PALEONTOLOGY;TOXICOLOGY","15;12;10;9;7;6;6;4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","PREGNANCY;GENE;CANCER;LYMPHOMA;POPULATION;SPINAL CORD;ULTRASOUND;CARPAL TUNNEL SYNDROME;CHEMOTHERAPY;DYSPLASIA;EPILEPSY;FISTULA;LEUKEMIA;NEUROLOGY;PRESENTATION (OBSTETRICS);PROSPECTIVE COHORT STUDY;ABNORMALITY;ALTERNATIVE MEDICINE;AMBULATORY;ANALYSER;AORTA;ARTERIOVENOUS FISTULA;ARTERIOVENOUS MALFORMATION;ASTHMA;ATROPHY;AUTISM;BACTERIA;BONE MARROW;CASE-CONTROL STUDY;CAVERNOUS SINUS;CEREBRAL CORTEX;CLASSIFIER (UML);CONFIDENCE INTERVAL;CORTEX (ANATOMY);DIABETES MELLITUS;DISEASE;ENCEPHALOPATHY;ENDOCARDITIS;ETIOLOGY;EXERTIONAL DYSPNEA;FEMUR;GADOLINIUM;GOLD STANDARD (TEST);HEART FAILURE;HEMANGIOMA;HYPOPIGMENTATION;INCIDENCE (GEOMETRY);INFECTIVE ENDOCARDITIS;INTELLECTUAL DISABILITY;INTERVENTIONAL NEURORADIOLOGY;INTERVENTIONAL RADIOLOGY;INTUBATION;LUNG;MAGNETIC RESONANCE IMAGING;MECHANICAL VENTILATION;MELANOMA;MITRAL VALVE;MULTIPLE MYELOMA;NASAL BONE;NEBULIZER;NEONATAL INTENSIVE CARE UNIT;NERVE CONDUCTION VELOCITY;NEUROFIBROMATOSIS;NEUROSURGERY;OBSERVATIONAL STUDY;OBSTRUCTIVE SLEEP APNEA;OCCUPATIONAL EXPOSURE;OPTIC NERVE;ORBIT (DYNAMICS);ORTHOPEDIC SURGERY;PATTERN RECOGNITION (PSYCHOLOGY);PERCUTANEOUS;PESTICIDE;QUADRANT (ABDOMEN);RADIATION THERAPY;REHABILITATION;RESPIRATORY DISTRESS;RISK FACTOR;SCINTIGRAPHY;SEPSIS;SHOCK (CIRCULATORY);STAGE (STRATIGRAPHY);TECHNETIUM;THORACOTOMY;THROMBOSIS;THYROID;ULTRASONOGRAPHY;VEIN;VENTRICLE;VISUALIZATION","8;6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GESTATION;FETUS;GESTATIONAL AGE;PARAPLEGIA;PHENOTYPE;3D ULTRASOUND;BIRTH WEIGHT;CARPAL TUNNEL;CARPAL TUNNEL RELEASE;LAMINECTOMY;LOW BIRTH WEIGHT;MUTATION;NEURORADIOLOGY;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER;SPINAL CORD COMPRESSION;TUMOR DEBULKING;ANGELMAN SYNDROME;ARDS;AUTISM SPECTRUM DISORDER;BICUSPID AORTIC VALVE;BREAST CANCER;BRONCHOCONSTRICTION;CAROTID-CAVERNOUS FISTULA;CHROMOSOME;CHRONIC LYMPHOCYTIC LEUKEMIA;COARCTATION OF THE AORTA;CODING REGION;COLORECTAL CANCER;CONTINUOUS POSITIVE AIRWAY PRESSURE;CORTICAL DYSPLASIA;DERMATOSCOPY;DEVELOPMENTAL DISORDER;ECLAMPSIA;EUTHYROID;EXERCISE INTOLERANCE;GANGLIOSIDOSIS;GENOTYPE;INTRAOPERATIVE RADIATION THERAPY;NEONATAL ENCEPHALOPATHY;NEURODEVELOPMENTAL DISORDER;NEUROFIBROMIN 1;PERTECHNETATE;POLYMICROGYRIA;POSITIVE AIRWAY PRESSURE;PREECLAMPSIA;PROTOCOL (SCIENCE);RETINOBLASTOMA;RETT SYNDROME;SEPTIC SHOCK;STAPHYLOCOCCUS AUREUS;STATUS EPILEPTICUS;SUPERIOR OPHTHALMIC VEIN;TECHNETIUM TC 99M SESTAMIBI;THALIDOMIDE;UBIQUITIN;VENOUS THROMBOSIS","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DEBULKING;FIRST TRIMESTER;MISSENSE MUTATION;ADVANCED MATERNAL AGE;BREAST CARCINOMA;BRONCHOPULMONARY DYSPLASIA;DNA MISMATCH REPAIR;EARLY PREGNANCY FACTOR;FACTOR V LEIDEN;GENETIC HETEROGENEITY;GESTATIONAL HYPERTENSION;HELLP SYNDROME;KARYOTYPE;MASTECTOMY;MECP2;METHYLENETETRAHYDROFOLATE REDUCTASE;MONOCHORIONIC TWINS;PRENATAL DIAGNOSIS;SINGLE-STRAND CONFORMATION POLYMORPHISM;SMALL FOR GESTATIONAL AGE;TRIPLE TEST;TWIN PREGNANCY;UBIQUITIN LIGASE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;AGED;LYMPHOMA, NON-HODGKIN;CARPAL TUNNEL SYNDROME;MIDDLE AGED;;CEREBRAL CORTEX;CHILD, PRESCHOOL;GANGLIOSIDOSES, GM2;MAGNETIC RESONANCE IMAGING;MEDIAN NERVE;NEURAL CONDUCTION;SANDHOFF DISEASE;TAY-SACHS DISEASE;ABNORMALITIES, MULTIPLE;ADOLESCENT;CAROTID-CAVERNOUS SINUS FISTULA","27;19;13;10;7;7;6;6;5;5;5;5;5;5;5;5;5;4;4;4","DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;ASTHMA;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;GENETIC AND ENVIRONMENTAL INFLUENCES ON CLEFT LIP AND PALATE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;IMPACT OF ASSISTED REPRODUCTIVE TECHNOLOGY ON PERINATAL OUTCOMES;IMPACT OF PESTICIDES USE IN AGRICULTURE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MELANOMA;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETAL DNA ANALYSIS;NONINVASIVE PRENATAL TESTING;PARAPLEGIA;TRISOMY DETECTION;3D ULTRASOUND;CARPAL TUNNEL SYNDROME;DEBULKING;ETIOLOGY;GRAVES' OPHTHALMOPATHY;METASTATIC EPIDURAL SPINAL CORD COMPRESSION;NEURORADIOLOGY;ORBIT (DYNAMICS);PRESENTATION (OBSTETRICS);SPINAL CORD COMPRESSION;TUMOR DEBULKING;ABNORMALITY;ADVANCED MATERNAL AGE;AMNIOCENTESIS;ANALYSER;ANEUPLOIDY SCREENING","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","ACUTE PARAPLEGIA;CARPAL TUNNEL;CORTICAL DEVELOPMENT;NON-HODGKIN LYMPHOMA;SURGICAL RELEASE;AARSKOGSCOTT SYNDROME;ABNORMAL GADOLINIUM;ABNORMAL VASCULAR;ADULT PATIENTS;ADVANCED MATERNAL;AGRICULTURE RESULTS;AMNIOCENTESIS REPLACE;ANALYSIS SUBJECTIVE;ANGELMAN SYNDROME;ANTERIOR SEGMENT;ARTERIOVENOUS FISTULA;AUREUS INVOLVING;AUTHORS ISARE;AUTISTIC GIRLS;BCELL LYMPHOCYTIC;BIRTH WEIGHT;BONE VISUALIZATION;BREAST CANCER;BRONCHOPULMONARY DYSPLASIA;CANCER SYNDROME;CARDIAC VALVES;CAROTID CAVERNOUS;CASECONTROL STUDY;CAVERNOUS FISTULA;CAVERNOUS SINUS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MATERNAL AGE;CAROTID CAVERNOUS;EXERCISE CHALLENGE;CAVERNOUS FISTULA;EXERTIONAL SYMPTOMS;GRAVES OPHTHALMOPATHY;TRANSABDOMINAL ULTRASOUND;AAS PATIENTS;ADULT PATIENTS;ADVANCED MATERNAL;BONE NB;CHORIONICITY DIAGNOSIS;CHROMOSOMAL ABNORMALITY;DESTRUCTURED RANDOMNESS;EXERCISE TEST;EXPERT SCANNER;GENE CARRIERS;KRETZ VOLUSON;KRETZTECHNIK ZIPF;LAMBDA SIGN;NASAL BONE;NB VISUALIZATION;NETWORK COMPLEXITY;OCULAR INVOLVEMENT;PHENOTYPIC MARKER;PRIMARY CARCINOMA;RANDOMNESS L-Z;SCANNER KRETZTECHNIK;SCREENING TEST;STUDY INCLUDED","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",3,0.09,6,4,0,0,0,0,1,0,3,7,0,0,0,0,5,0,0,0,0,0,0,47.5,47.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2004,50,6.66,2.82,0.62,0.42,0.62,1.41,1.72222222222222,1.23529411764706,1.63157894736842,0.38,0,25,13,5,4,0.5,0.26,0.1,0.08,18.76,0.398694144456553,NA,0.18,0.9,0.533,0.552,0.588,0.543,"CLAUDIO DE FELICE;STEFANO PARRINI;GIUSEPPE LATINI;G LATINI;GIORGIO BIANCIARDI;ANTONIO DEL VECCHIO;PAOLO GALLUZZI;PAOLO TOTI;GIOVANNA CHITANO;FRANCO BAGNOLI;B DE MITRI;RAFFAELLA ZANNOLLI;SABRINA BUONI;G. DI MAGGIO;ROLF ZETTERSTRÖM;ALBERTO VERROTTI;L DILEO;ALFONSO CERASE;MARIO CARMELLINI;A. AUTERI","24;13;12;11;7;6;5;5;5;4;4;3;3;3;3;3;3;2;2;2","CLAUDIO DE FELICE;STEFANO PARRINI;G LATINI;GIUSEPPE LATINI;ANTONIO DEL VECCHIO;GIORGIO BIANCIARDI;GIOVANNA CHITANO;PAOLO GALLUZZI;PAOLO TOTI;B DE MITRI;L DILEO;G. DI MAGGIO;FRANCO BAGNOLI;B VINDIGNI;P GALGANI;ROLF ZETTERSTRÖM;GABRIELE CENTINI;VELIO BOCCI;N. DI PAOLO;ALBERTO VERROTTI","4.76;2.56;2.26;2;1.28;1.24;0.87;0.75;0.74;0.7;0.7;0.57;0.56;0.5;0.5;0.5;0.5;0.5;0.5;0.48","CLAUDIO DE FELICE;STEFANO PARRINI;GIUSEPPE LATINI;GIORGIO BIANCIARDI;PAOLO GALLUZZI;PAOLO TOTI;FRANCO BAGNOLI;RAFFAELLA ZANNOLLI;SABRINA BUONI;G. DI MAGGIO;ALFONSO CERASE;MARIO CARMELLINI;A. AUTERI;EMANUELE BRUNI;CARLO VENTURI;PAOLA PIOMBONI;ALBERTO PALAZZUOLI;LUCA PUCCETTI;MARIO CHIAVARELLI;MICHELE ZAPPELLA","24;13;12;7;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2","CLAUDIO DE FELICE;STEFANO PARRINI;GIUSEPPE LATINI;GIORGIO BIANCIARDI;PAOLO GALLUZZI;PAOLO TOTI;G. DI MAGGIO;FRANCO BAGNOLI;B VINDIGNI;N. DI PAOLO;RAFFAELLA ZANNOLLI;SABRINA BUONI;CARLO VENTURI;A. FOIS;MARIO CHIAVARELLI;FRANCESCO DICIOLLA;MASSIMO MACCHERINI;THEODORA HADIJSTILIANOU;LUCA PADUA;MAURO MONDELLI","4.76;2.56;2;1.24;0.75;0.74;0.57;0.56;0.5;0.5;0.45;0.45;0.43;0.39;0.36;0.36;0.36;0.33;0.33;0.33","CLAUDIO DE FELICE;ANDREA S. MELANI;CRISTINA CINTI;DORIANA ZANCHETTA;MARGHERITA NERI;NATALINO BARBATO;PIERO ALDO CANESSA;PIERSANTE SESTINI;S AIOLFI;PAOLO GALLUZZI;GIUSEPPE LATINI;C. GOGGI;CARLO CAMPANA;CATHERINE KLERSY;FRANCESCO BARALE;MARCO PICCINELLI;MARIO VIGANÒ;PAOLO FUSAR‐POLI;PIERLUIGI POLITI;ANTONIO DEL VECCHIO","182;176;176;176;176;176;176;176;176;111;97;90;90;90;90;90;90;90;90;88","CLAUDIO DE FELICE;ANDREA S. MELANI;PAOLO GALLUZZI;MARCO PICCINELLI;GIANNI POZZI;MARCO R. OGGIONI;MARCELLO ROSSI;ALFONSO CERASE;FABIO GIANNINI;GIAMPAOLO VATTI;MONICA ULIVELLI;S. PASSERO;SABINA BARTALINI;SÍMONE ROSSI;ANDREA CAMPIONE;RAFFAELLA ZANNOLLI;SABRINA BUONI;B. BACCETTI;ELENA MORETTI;EMANUELE BRUNI","180;176;109;90;61;61;59;44;44;44;44;44;44;44;43;43;43;37;37;37","CLAUDIO DE FELICE;PAOLO GALLUZZI;STEFANO PARRINI;A BASILE;ALBERTO PALAZZUOLI;CARLO VENTURI;FRANCO BAGNOLI;G. DI MAGGIO;ILARIA QUATRINI;LUCIA VECCHIATO;MARIA LUISA LA GAMMA;MICHELE ZAPPELLA;PAOLO CALABRIA;RAFFAELLA ZANNOLLI;ROSA SANTOPIETRO;SABRINA BUONI;A. AUTERI;A. FOIS;A. ROSENDO CARRERA;ALDO MARIOTTINI","23;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;MATHEMATICS;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING","48;27;7;4;4;3;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;GASTROENTEROLOGY;PATHOLOGY;PEDIATRICS;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;OBSTETRICS;PSYCHIATRY;ANESTHESIA;OPTICS;ANATOMY;CARDIOLOGY;PHYSIOLOGY;MATHEMATICAL ANALYSIS;RADIOLOGY;BIOCHEMISTRY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;NEUROSCIENCE;PALEONTOLOGY;UROLOGY","35;25;17;12;11;11;9;9;9;9;8;7;6;6;4;3;3;2;2;2;2;2;2","PREGNANCY;POPULATION;GENE;EPILEPSY;REFLECTIVITY;TRANSPLANTATION;KIDNEY;ORAL MUCOSA;SUBCLINICAL INFECTION;ABNORMALITY;ETIOLOGY;HEART FAILURE;HYPERTROPHIC PYLORIC STENOSIS;SPLEEN;ASYMPTOMATIC;BIOPSY;HYPOPLASIA;INCIDENCE (GEOMETRY);MYOCARDIAL INFARCTION;PATHOGENESIS;RESPIRATORY DISTRESS;SIGN (MATHEMATICS);STAGE (STRATIGRAPHY);STIMULATION;SURVIVAL RATE","20;9;6;5;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","GESTATIONAL AGE;BIRTH WEIGHT;FETUS;GESTATION;HEART TRANSPLANTATION;LOW BIRTH WEIGHT;BRAIN NATRIURETIC PEPTIDE;PHENOTYPE;AGAROSE GEL ELECTROPHORESIS;ANGINA;ANTICONVULSANT;ASTROCYTOMA;BLOOD OXYGENATION;BONE MINERAL;CARPAL TUNNEL;CHROMOSOME;COATS' DISEASE;CONTRAINDICATION;CORTICAL DYSPLASIA;DEVELOPMENTAL DISORDER;EPILEPTOGENESIS;EX VIVO;FRACTAL DIMENSION;GASTRIC CARCINOMA;HEART RATE;HYPSARRHYTHMIA;ILLNESS SEVERITY;INFARCTION;INFERTILITY;INHALER;KIDNEY TRANSPLANTATION;LENNOX–GASTAUT SYNDROME;LIFE EXPECTANCY;MINNESOTA MULTIPHASIC PERSONALITY INVENTORY;MUTANT;MUTATION;NATRIURETIC PEPTIDE;NEONATOLOGY;NEURODEVELOPMENTAL DISORDER;NEURORADIOLOGY;OFFSPRING;PERCUTANEOUS CORONARY INTERVENTION;POLYMICROGYRIA;POSITIVE PRESSURE VENTILATION;PROGRAMMED CELL DEATH;RADIOFREQUENCY ABLATION;REFLEX EPILEPSY;RETINOBLASTOMA;RETT SYNDROME;SPERMIOGENESIS;STATUS EPILEPTICUS;STREPTOCOCCUS;STREPTOCOCCUS PNEUMONIAE;SUBCLAVIAN STEAL SYNDROME;TOPIRAMATE;TORTUOSITY;UNIVARIATE ANALYSIS;UNSTABLE ANGINA;VAGUS NERVE;VASCULAR SURGERY;VASCULITIS;VIRULENCE;WEST SYNDROME","14;12;8;6;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHORIOAMNIONITIS;BRONCHOPULMONARY DYSPLASIA;SMALL FOR GESTATIONAL AGE;INTRAUTERINE GROWTH RESTRICTION;ANAPLASTIC ASTROCYTOMA;ANEUPLOIDY;BRADYCARDIA;DRY-POWDER INHALER;FETAL HEART;HISTIDINE KINASE;IN UTERO;MALE INFERTILITY;MECP2;METERED-DOSE INHALER;OSTEOPENIA;PERCUTANEOUS ETHANOL INJECTION;PNEUMOCOCCAL INFECTIONS;RETINOPATHY OF PREMATURITY;SEMEN ANALYSIS;STREPTOCOCCUS AGALACTIAE;STREPTOCOCCUS SUIS;TAKAYASU ARTERITIS;TAKAYASU'S ARTERITIS;UMBILICAL ARTERY;VAGUS NERVE STIMULATION;VIGABATRIN","6;4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;CHORIOAMNIONITIS;MIDDLE AGED;MOUTH MUCOSA;AGED;BRAIN;HEART TRANSPLANTATION;EPILEPSY;INFANT, NEWBORN;SKIN;TIME FACTORS;ANTICONVULSANTS;BRAIN NEOPLASMS;DNA-BINDING PROTEINS;FOLLOW-UP STUDIES;FRUCTOSE","30;26;20;19;14;14;14;12;9;8;8;7;7;7;7;6;6;6;6;6","NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;EPIDEMIOLOGY AND CAUSES OF PRETERM BIRTH;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;ORGAN TRANSPLANTATION AND REJECTION;ANKYLOGLOSSIA AND ITS IMPACT ON BREASTFEEDING AND SPEECH;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EPILEPSY AND SEIZURES;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;CANCER OF UNKNOWN PRIMARY SITE;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;DIAGNOSIS AND MANAGEMENT OF IGG4-RELATED DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS;ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION;GLIOMAS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER","7;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CHORIOAMNIONITIS;BRONCHOPULMONARY DYSPLASIA;ORAL MUCOSA;SUBCLINICAL INFECTION;ABNORMALITY;ETIOLOGY;FETAL PROGRAMMING;HEART TRANSPLANT;HYPERTROPHIC PYLORIC STENOSIS;PRETERM INFANTS;BRAIN NATRIURETIC PEPTIDE;EHLERS-DANLOS SYNDROME;FETAL HEART;FETAL LUNG DEVELOPMENT;INTRAUTERINE GROWTH RESTRICTION;LINGUAL FRENULUM;METABOLIC SYNDROME;PATHOGENESIS;PYLORIC STENOSIS;RETT SYNDROME","6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","ORAL MUCOSAL;ABNORMAL ORAL;CLINICAL SIGN;LIGHT REFLECTANCE;MUCOSAL LIGHT;BIRTH WEIGHT;BRONCHOPULMONARY DYSPLASIA;INTRAUTERINE GROWTH;LOW BIRTH;WEIGHT INFANTS;ABDOMINAL ORGAN;ADULT AGE;BRAIN NATRIURETIC;CAUSING METABOLIC;EHLERS-DANLOS SYNDROME;EXTREMELY LOW;FETAL HEART;FETAL PROGRAMMING;GROWTH RESTRICTION;GROWTH RETARDATION;HEART RATE;HEART TRANSPLANTATION;HISTOLOGIC CHORIOAMNIONITIS;HYPERTROPHIC PYLORIC;ILLNESS SEVERITY;INFANTILE HYPERTROPHIC;METABOLIC SYNDROME;NATRIURETIC PEPTIDE;ORGAN GROWTH;PEPTIDE LEVELS","6;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BIRTH WEIGHT;GESTATIONAL AGE;WEEKS BIRTH;ORAL MUCOSA;VLBW INFANTS;MF ABNORMALITIES;SIGNIFICANTLY LOWER;WK BIRTH;ACH PARENTS;ACUTE CO-MORBIDITY;FETAL GROWTH;ILLNESS SEVERITY;LOW BIRTH;ORAL MUCOSAL;SGA INFANTS;TRANSPLANTED PATIENTS;YRS NA;ABDOMINAL ORGANS;ACUTE REJECTION;AGE RANGE;AGE WK;BLOOD VESSEL;CURVE ANALYSIS;EXTERNAL EAR;HEART TRANSPLANTATION;IDIOPATHIC IUGR;INTUBATION POLICY;LIGHT REFLECTANCE;MINIMAL INTUBATION;NGML RANGE","29;25;10;7;7;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4",4,0.08,11.56,3.5,0,0,0,1.75,2,0,0,3.5,1,0,4,0,0,0,0,3.25,1,0,0,51.25,51.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,1.14,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","1;1","BIOTECHNOLOGY;RARE DISEASES","1;1",NA,NA,NA,NA,"LEUKEMIA / LEUKAEMIA","1",NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2005,54,7.88888888888889,2.61111111111111,0.518518518518518,0.37037037037037,0.611111111111111,1.42424242424242,1.47368421052632,1.17647058823529,1.32,0.37037037037037,4,20,18,9,3,0.37,0.33,0.17,0.06,38.06,0.718792509264086,NA,0.185185185185185,0.851851851851852,0.428,0.415,0.308,0.388,"CLAUDIO DE FELICE;GIUSEPPE LATINI;MICHELE ZAPPELLA;SALVATORE GROSSO;PAOLO BALESTRI;JOUSSEF HAYEK;PAOLO TOTI;STEFANO PARRINI;ALFONSO CERASE;MARIO CARMELLINI;SABRINA BUONI;G. DI MAGGIO;G MORGESE;FRANCESCA MARI;E. ZEI;ANTONIO FEDERICO;E. GAGGIOTTI;GUIDO GAROSI;FRANCO BAGNOLI;RAFFAELLA ZANNOLLI","11;7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2","CLAUDIO DE FELICE;GIUSEPPE LATINI;B. BACCETTI;MICHELE MAIO;E. GAGGIOTTI;GUIDO GAROSI;STEFANO PARRINI;PAOLO TOTI;GABRIELE TONNI;ANDREA S. MELANI;G. DI MAGGIO;SALVATORE GROSSO;PAOLO BALESTRI;N. DI PAOLO;G. SACCHI;ALFONSO CERASE;M FRATICELLI;MARCO DʼAMICO;AURELIO LIMIDO;MICHELE ZAPPELLA","3.52;1.32;1.14;1;0.67;0.65;0.62;0.52;0.5;0.46;0.45;0.42;0.42;0.42;0.42;0.41;0.4;0.4;0.4;0.38","CLAUDIO DE FELICE;MICHELE ZAPPELLA;SALVATORE GROSSO;PAOLO BALESTRI;JOUSSEF HAYEK;ALFONSO CERASE;MARIO CARMELLINI;G. DI MAGGIO;G MORGESE;FRANCESCA MARI;E. ZEI;ANTONIO FEDERICO;E. GAGGIOTTI;GUIDO GAROSI;FRANCO BAGNOLI;PAOLO GALLUZZI;M FRATICELLI;MARCO DʼAMICO;ANDREA COLLINI;B. BACCETTI","11;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","CLAUDIO DE FELICE;B. BACCETTI;MICHELE MAIO;E. GAGGIOTTI;GUIDO GAROSI;ANDREA S. MELANI;G. DI MAGGIO;SALVATORE GROSSO;PAOLO BALESTRI;N. DI PAOLO;ALFONSO CERASE;M FRATICELLI;MARCO DʼAMICO;AURELIO LIMIDO;MICHELE ZAPPELLA;G MORGESE;MARIO CARMELLINI;E. ZEI;JOUSSEF HAYEK;ANTONIO FEDERICO","3.52;1.14;1;0.67;0.65;0.46;0.45;0.42;0.42;0.42;0.41;0.4;0.4;0.4;0.38;0.37;0.37;0.37;0.33;0.33","A. DEL FAVERO;ALESSANDRA MICOZZI;ANNAMARIA NOSARI;BERNARDINO ALLIONE;DANIELA CILLONI;DOMENICO D’ANTONIO;ELIANA ZUFFA;FRANCESCO FABBIANO;FRANCESCO LAURIA;FRANCESCO MENICHETTI;GIAMPAOLO BUCANEVE;GIORGINA SPECCHIA;GIORGIO LA NASA;GIOVANNI MARTINELLI;MARCO DIONISI;MAURIZIO BUELLI;PIETRO MARTINO;RENATO CANTAFFA;ROBIN FOÀ;SERGIO AMADORI","616;616;616;616;616;616;616;616;616;616;616;616;616;616;616;616;616;616;616;616","FRANCESCO LAURIA;JOUSSEF HAYEK;MICHELE ZAPPELLA;CLAUDIO DE FELICE;FRANCESCA MARI;B. BACCETTI;ANDREA S. MELANI;G MORGESE;PAOLO BALESTRI;SALVATORE GROSSO;ANGELO BENEDETTI;DUCCIO MARIA CORDELLI;E. GAGGIOTTI;F. REALE;GUIDO GAROSI;NICOLA DI PAOLO;GABRIELE CENTINI;L. ROSIGNOLI;A ORSI;ALFREDO ORRICO","616;416;416;203;90;84;81;77;77;77;76;68;49;48;45;45;42;42;40;34","CLAUDIO DE FELICE;MICHELE ZAPPELLA;JOUSSEF HAYEK;E. GAGGIOTTI;ALFONSO CERASE;E. ZEI;G. DI MAGGIO;GUIDO GAROSI;ANDREA COLLINI;ANDREA S. MELANI;B. BACCETTI;FRANCO BAGNOLI;G MORGESE;GIULIANA RUGGIERI;MARCO BERNINI;MARIO CARMELLINI;N. DI PAOLO;PAOLO BALESTRI;PAOLO GALLUZZI;SALVATORE GROSSO","11;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;COMPUTER SCIENCE;GEOLOGY;PSYCHOLOGY;ECONOMICS;MATHEMATICS;PHILOSOPHY","46;24;7;6;5;3;3;3;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;PEDIATRICS;PSYCHIATRY;PATHOLOGY;ANESTHESIA;GASTROENTEROLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;ANATOMY;BIOCHEMISTRY;ENDOCRINOLOGY;GENERAL SURGERY;ENVIRONMENTAL HEALTH;CELL BIOLOGY;NEUROSCIENCE;ONCOLOGY;OPTICS;PHARMACOLOGY;RADIOLOGY","30;20;13;12;11;10;9;8;7;6;5;5;5;5;4;3;3;3;3;3;3","GENE;PREGNANCY;EPILEPSY;CANCER;POPULATION;ANTIBODY;COMPLICATION;ETIOLOGY;KIDNEY;NEONATAL INTENSIVE CARE UNIT;PERITONEAL DIALYSIS;PROSPECTIVE COHORT STUDY;RECEIVER OPERATING CHARACTERISTIC;SPERM;TRANSPLANTATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ASTHMA;ELECTROENCEPHALOGRAPHY;HEAD TRAUMA;INFLAMMATION;INTENSIVE CARE;LUNG;MEDICAL LITERATURE;MULTIPLE SCLEROSIS;NEUROLOGY;URINARY SYSTEM","12;9;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;BIRTH WEIGHT;FETUS;GESTATIONAL AGE;LOW BIRTH WEIGHT;PHENOTYPE;RETT SYNDROME;BRONCHOALVEOLAR LAVAGE;DIURESIS;EPILEPTIC SPASMS;KIDNEY TRANSPLANTATION;MONOCLONAL ANTIBODY;3D ULTRASOUND;ACTIVE SITE;ACUTE-PHASE PROTEIN;ADENOCARCINOMA;ANNEXIN;AUTOANTIBODY;BONE MINERAL;BRACHIAL ARTERY;BRACHYDACTYLY;CALCINEURIN;CARBAMAZEPINE;CELLULAR INFILTRATION;CHILDHOOD ABSENCE EPILEPSY;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CLUSTER HEADACHE;COLORECTAL CANCER;CUMULATIVE INCIDENCE;DIPICOLINIC ACID;DYSTROPHIC CALCIFICATION;ECONOMIC SHORTAGE;ENDOSOME;ENTERAL ADMINISTRATION;EOSINOPHIL;EPIGENETICS;EPITOPE;ESCHERICHIA COLI;FACTOR VII;GABAPENTIN;GENERALIZED EPILEPSY;GERMLINE;GLYCAN;GRANULATION TISSUE;HAZARD RATIO;ICTAL;ILLNESS SEVERITY;ILOPROST;INFERTILITY;INHALER;IRRITABILITY;LEVETIRACETAM;LEVOFLOXACIN;LIPID RAFT;LUNG DISEASE;MALACIA;MITOCHONDRIAL DNA;MYOCLONIC EPILEPSY;MYOCLONIC JERK;NEONATOLOGY;NEURALGIA;NEURORADIOLOGY;NEUTROPENIA;NIEMANN–PICK DISEASE;NUCLEOTIDE;OPTICAL MICROSCOPE;PEAK FLOW METER;PERFORATION;PERIPHERAL BLOOD MONONUCLEAR CELL;PHOSPHATASE;PLACEBO;PLOIDY;POLARIZATION MICROSCOPY;POLYMERASE CHAIN REACTION;POSITIVE PREDICATIVE VALUE;POSTHERPETIC NEURALGIA;PROGRAMMED CELL DEATH;PROTEIN S;REPERFUSION INJURY;SEMIOLOGY;SOMNOLENCE;SPIKE-AND-WAVE;SPLENECTOMY;TELOMERASE;TELOMERE;TOLERABILITY;TRACHEAL INTUBATION;TRYPTASE;UPPER URINARY TRACT;VIRAL DISEASE;WATER TRANSPORT","6;3;3;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PROBAND;CHORIOAMNIONITIS;GERMLINE MUTATION;MECP2;PRENATAL DIAGNOSIS;ANEUPLOIDY;ANTI-NUCLEAR ANTIBODY;BRONCHOPULMONARY DYSPLASIA;CD52;DNA MISMATCH REPAIR;DRY-POWDER INHALER;EOSINOPHILIC PNEUMONIA;FEBRILE NEUTROPENIA;FLUORESCENCE IN SITU HYBRIDIZATION;GERMLINE MOSAICISM;GLYCOMICS;HERPESVIRIDAE;HETEROPLASMY;HISTONE METHYLTRANSFERASE;KARYOTYPE;MALE INFERTILITY;MISSENSE MUTATION;NON-MENDELIAN INHERITANCE;NPC1;OSTEOPENIA;OXCARBAZEPINE;PERIPLASMIC SPACE;POINT MUTATION;PROPIDIUM IODIDE;REVERSE TRANSCRIPTASE;TELOMERASE REVERSE TRANSCRIPTASE;TRANSVERSION","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;TREATMENT OUTCOME;ADULT;AGED;ANTICONVULSANTS;KIDNEY TRANSPLANTATION;SCLEROSIS;CHORIOAMNIONITIS;SPERMATOZOA;CHILD;HEART DEFECTS, CONGENITAL;INFANT, NEWBORN;ITALY;MOUTH MUCOSA;NEOPLASMS;PERITONEUM","39;27;27;12;11;9;8;8;8;8;8;7;7;6;6;6;6;6;6;6","NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;EPILEPSY AND SEIZURES;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;MANAGEMENT AND PATHOPHYSIOLOGY OF TRAUMATIC BRAIN INJURY;PREVALENCE AND MANAGEMENT OF KIDNEY STONES;;BIOLOGY AND PATHOLOGY OF KERATINS AND RELATED DISORDERS;CELLULAR SENESCENCE AND AGING-RELATED DISEASES;CHRONIC RHINOSINUSITIS AND NASAL POLYPS;CONGENITAL CORONARY ARTERY ANOMALIES AND THEIR MANAGEMENT;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EPIDEMIOLOGY AND CAUSES OF PRETERM BIRTH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION","4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","EPILEPSY;ETIOLOGY;PROBAND;RETT SYNDROME;CHORIOAMNIONITIS;EPILEPTIC SPASMS;HEAD TRAUMA;INFANT MORTALITY;INTRACRANIAL HYPOTENSION;MECP2;MEDICAL LITERATURE;PERITONEAL DIALYSIS;PRETERM INFANTS;SEIZURES;TREATMENT;;3D ULTRASOUND;ABNORMALITY;ACHONDROPLASIA;ANTIGEN PRESENTATION","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","BRONCHOALVEOLAR LAVAGE;EXTRACRANIAL SURGERY;GENE MUTATION;HEAD TRAUMA;ITALIAN SURVEY;LIST SIN;MAILING LIST;ORAL MUCOSAL;OXYGEN THERAPY;PERITONEAL SCLEROSIS;RETT SYNDROME;SEVERE HEAD;TRAUMA MANAGEMENT;AARSKOGSCOTT SYNDROME;ABNORMAL ORAL;ABNORMALITIES INIDE;ABSENCE SEIZURES;AC POLYMORPHISM;ACID PHOSPHATASE;ADD-ON TRIAL;ADHERENCE MISOTA;AFFECTING IL;ANTIBODY DIRECTED;ANTIGEN CD;ASSISTED REPRODUCTION;ATTENTIONDEFICITHYPERACTIVITY DISORDER;BACTERIAL INFECTION;BIOCHEMICAL CHARACTERIZATION;BIRTH WEIGHT;BRAIN INJURY","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HR CI;ITALIAN SOCIETY;ITALIAN STUDY;NEONATAL NEPHROLOGY;NEONATOLOGY ROMA;ROMA ITALYSEARCH;BRINDISI ITALY;FOLIC ACID;HEAD TRAUMA;SEVERE HEAD;BLOOD PRODUCTS;CLUSTER HEADACHE;TERM NEWBORNS;ANTONIO CAIULO;CAIULO MD;CATALDI MD;CLINICAL PHYSIOLOGY;DE FELICE;FELICE MD;HOSPITAL BRINDISI;INTENSIVE CARE;ITALIAN ANAESTHETISTS;ITALY CLINICAL;LATINI MD;LECCE SECTION;LIQUID OXYGEN;MASSAFRA MD;NATIONAL RESEARCH;NEUROSURGICAL FACILITIES;ORBITAL MYOSITIS","8;8;8;8;8;8;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",7,0.13,3,3.5,0,0,0,0,7,0,1,3.5,0,0,1,0,1,0,0,1,0,0,0,26.5,26.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,3.75,93,5.21,1,0.2,23,0,1,1,0,2,0,0,1,0,3,1,0,0,0,0,0,0,5,0,0,4,1,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY","5;4;2;1","CANCER;CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;LUNG CANCER;ORPHAN DRUG;HEMATOLOGY","4;4;3;2;2;2;2;1","CANCER","4","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","5;2;1","LUNG CANCER;COLON AND RECTAL CANCER;GASTROINTESTINAL TRACT;MYELOMA","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2006,57,7.89473684210526,2.71929824561404,0.508771929824561,0.421052631578947,0.526315789473684,1.35964912280702,1.20833333333333,1.2,1.2,0.31578947368421,3,19,16,10,8,0.33,0.28,0.18,0.14,40.6,0.79479084073311,NA,0.175438596491228,0.824561403508772,0.395,0.312,0.291,0.313,"CLAUDIO DE FELICE;JOUSSEF HAYEK;TOMMASO GORI;GIUSEPPE LATINI;RAFFAELLA ZANNOLLI;JOHN D. PARKER;ALFREDO ORRICO;VINCENZO SORRENTINO;SABRINA BUONI;RANUCCIO NUTI;MARCO PAULLI;MARCO R. OGGIONI;GABRIELE TONNI;ALBERTO FABBRI;MICHELE ZAPPELLA;SILVIA SICURO;GIUSEPPE DI STOLFO;SAVERIO DRAGONI;FRANCESCA MACUCCI;SANDRO FORCONI","6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CLAUDIO DE FELICE;G. BOTTA;NULL AUTHOR_ID;GABRIELE TONNI;GIUSEPPE LATINI;GABRIELE CENTINI;ANDREA S. MELANI;TOMMASO GORI;RANUCCIO NUTI;MARCO R. OGGIONI;S ULIVIERI;LETIZIA S BRACCI;G OLIVERI;JOUSSEF HAYEK;JOHN D. PARKER;SILVIA SICURO;GIUSEPPE DI STOLFO;SAVERIO DRAGONI;SANDRO FORCONI;FRANCESCA IOVINE","1.88;1;1;0.83;0.71;0.67;0.61;0.56;0.56;0.54;0.5;0.5;0.5;0.5;0.45;0.45;0.45;0.45;0.45;0.45","CLAUDIO DE FELICE;JOUSSEF HAYEK;TOMMASO GORI;RAFFAELLA ZANNOLLI;JOHN D. PARKER;ALFREDO ORRICO;VINCENZO SORRENTINO;SABRINA BUONI;RANUCCIO NUTI;MARCO R. OGGIONI;ALBERTO FABBRI;MICHELE ZAPPELLA;SILVIA SICURO;GIUSEPPE DI STOLFO;SAVERIO DRAGONI;FRANCESCA MACUCCI;SANDRO FORCONI;LUCIA GALLI;MARIO CARMELLINI;FRANCESCA IOVINE","6;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","CLAUDIO DE FELICE;G. BOTTA;NULL AUTHOR_ID;GABRIELE CENTINI;ANDREA S. MELANI;TOMMASO GORI;RANUCCIO NUTI;MARCO R. OGGIONI;S ULIVIERI;LETIZIA S BRACCI;JOUSSEF HAYEK;JOHN D. PARKER;SILVIA SICURO;GIUSEPPE DI STOLFO;SAVERIO DRAGONI;SANDRO FORCONI;FRANCESCA IOVINE;ALBERTO PALAZZUOLI;ALFREDO ORRICO;VINCENZO SORRENTINO","1.88;1;1;0.67;0.61;0.56;0.56;0.54;0.5;0.5;0.5;0.45;0.45;0.45;0.45;0.45;0.45;0.45;0.42;0.42","MARCO R. OGGIONI;GIANNI POZZI;ARAS KADIOGLU;CLAUDIA TRAPPETTI;FRANCESCO IANNELLI;MARCO CASSONE;PETER W. ANDREW;SUSANNA RICCI;ALBERTO FABBRI;ELENA VASSALLO;FRANCA FAGIOLI;GIUSEPPE OLIVERI;IVANA FERRERO;KATIA MARESCHI;LETIZIA MAZZINI;LUCIA TESTA;RICCARDO BOCCALETTI;SERGIO LIVIGNI;ANTONIO ORDÓÑEZ;D DUVEAU","334;311;272;272;272;272;272;272;209;197;197;197;197;197;197;197;197;197;189;189","MARCO R. OGGIONI;GIANNI POZZI;GIUSEPPE OLIVERI;MASSIMO MACCHERINI;ALBERTO FABBRI;ALFREDO ORRICO;LUCIA GALLI;VINCENZO SORRENTINO;RANUCCIO NUTI;FRANCO ROVIELLO;JOUSSEF HAYEK;TOMMASO GORI;ANDREA S. MELANI;ANDREA COLLINI;CARMINE DE BARTOLOMEIS;GIULIANA RUGGIERI;MARCO BERNINI;MARIO CARMELLINI;ROBERTO BARNI;MICHELA FALCIANI","334;311;197;189;185;142;142;142;139;138;138;126;119;77;77;77;77;77;77;76","CLAUDIO DE FELICE;JOUSSEF HAYEK;TOMMASO GORI;RANUCCIO NUTI;ALFREDO ORRICO;LUCIA GALLI;MICHELE ZAPPELLA;VINCENZO SORRENTINO;MARCO R. OGGIONI;A ORSI;ALBERTO FABBRI;ALBERTO PALAZZUOLI;ANDREA COLLINI;B. BACCETTI;CARMINE DE BARTOLOMEIS;ELENA MORETTI;FRANCESCA IOVINE;GIANNI POZZI;GIULIA COLLODEL;GIULIANA RUGGIERI","6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;ART;MATERIALS SCIENCE;POLITICAL SCIENCE;SOCIOLOGY","47;27;8;8;6;3;3;3;2;2;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;IMMUNOLOGY;CARDIOLOGY;ANESTHESIA;GASTROENTEROLOGY;MICROBIOLOGY;ENDOCRINOLOGY;RADIOLOGY;ONCOLOGY;OPTICS;PEDIATRICS;PSYCHIATRY;ANATOMY;ANDROLOGY;ARTIFICIAL INTELLIGENCE;INTENSIVE CARE MEDICINE;MOLECULAR BIOLOGY;PALEONTOLOGY;PHYSICAL THERAPY;QUANTUM MECHANICS","28;17;14;14;11;11;7;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3","GENE;ANTIBODY;DISEASE;PREGNANCY;BACTERIA;CANCER;IN VITRO;PATHOGENESIS;TRANSPLANTATION;ENDOTHELIAL DYSFUNCTION;ENZYME;LYMPHOMA;MYOCARDIAL INFARCTION;POPULATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANTIBIOTICS;ARTERY;ASTHMA;BLOOD FLOW;BONE MARROW;COPD;CORONARY ARTERY DISEASE;DIABETES MELLITUS;DNA;ENDOTHELIUM;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INHALATION;INTRACELLULAR;ISCHEMIA;LYMPH NODE;MICROCIRCULATION;NEUROLOGY;OBSERVATIONAL STUDY;PATHOLOGICAL;RANDOMIZED CONTROLLED TRIAL;SEMEN;SPERM;STAGE (STRATIGRAPHY);STEM CELL;ULTRASTRUCTURE;VASODILATION","12;6;5;5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACUTE CORONARY SYNDROME;B CELL;KIDNEY TRANSPLANTATION;STREPTOCOCCUS PNEUMONIAE;BRONCHODILATOR;CHROMOSOME;COLORECTAL CANCER;CYTOTOXIC T CELL;FETUS;LASER DOPPLER VELOCIMETRY;MALT LYMPHOMA;MUTATION;NEURORADIOLOGY;PHENOTYPE;RADIAL ARTERY;REACTIVE HYPEREMIA;REPERFUSION INJURY;RETT SYNDROME;ABDOMINAL WALL DEFECT;ABORTION;ACUTE MOTOR AXONAL NEUROPATHY;AEROSOLIZATION;AGAROSE GEL ELECTROPHORESIS;ALLELE;ALVEOLAR RIDGE;AMYOTROPHIC LATERAL SCLEROSIS;ANTIPHOSPHOLIPID SYNDROME;AUTISTIC SPECTRUM;AUTOIMMUNE HEMOLYTIC ANEMIA;AUTOLYSIS (BIOLOGY);AZATHIOPRINE;BACTERIAL PROTEIN;BALNEOTHERAPY;BLEPHAROPHIMOSIS;BORRELIA BURGDORFERI;BRACHIAL ARTERY;BRACHYDACTYLY;BRAIN ABSCESS;BREAST CANCER;CICLOSPORIN;CLINICAL ENDPOINT;CONSTRUCT VALIDITY;CRANIOFACIAL ABNORMALITY;CUMULATIVE INCIDENCE;CYTOTOXICITY;DENDRITIC CELL;DERMATOSCOPY;DNA DAMAGE;DYSLIPIDEMIA;ECONOMIC SHORTAGE;EPIGENETICS;ESSENTIAL THROMBOCYTHEMIA;EXON;FERTILITY;GENE CLUSTER;GENE EXPRESSION;GESTATION;GESTATIONAL AGE;GLUCOSIDASES;GLUCOSIDE;HAEMATOPOIESIS;HAZARD RATIO;HEART TRANSPLANTATION;HEMIFACIAL MICROSOMIA;HEPATITIS C VIRUS;HUM;HUMAN PATHOGEN;HYPOGAMMAGLOBULINEMIA;IC50;IMMUNODEFICIENCY;IMMUNOSTAINING;INFERTILITY;INHALER;INTERLEUKIN 10;INTRACELLULAR PARASITE;ISOZYME;LACTATE DEHYDROGENASE;LIVE BIRTH;MANUAL THERAPY;MEIOSIS;MELANOSOME;METALLOPROTEINASE;METHYLATION;MICROSOME;MOLECULAR PATHOLOGY;MYCOBACTERIUM;MYELOFIBROSIS;NEUROCHEMISTRY;NEVUS;NIFEDIPINE;NON-COMPETITIVE INHIBITION;OSTEOARTHRITIS;OVARIAN CANCER;PERCUTANEOUS CORONARY INTERVENTION;PERIPHERAL NERVOUS SYSTEM;PERIPHERAL NEUROPATHY;PERSISTENT PULMONARY HYPERTENSION;PHOTOTOXICITY;PHTHISIS BULBI;POLYPHENOL;PROGRAMMED CELL DEATH;PROINFLAMMATORY CYTOKINE;QUANTUM YIELD;RENAL TRANSPLANT;RESTENOSIS;RETINOBLASTOMA;REVASCULARIZATION;RITUXIMAB;RYANODINE RECEPTOR;SEMEN QUALITY;SINGLET OXYGEN;SOLITARY PULMONARY NODULE;SPERMATID;SPLENECTOMY;T CELL;TACROLIMUS;TUMOR DEBULKING;TUNEL ASSAY;UNIVARIATE ANALYSIS;UNSTABLE ANGINA;VACUOLE;VARIABLE EXPRESSION;VASOMOTION;VIRAL LOAD;VIRULENCE;WAITING LIST","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MARGINAL ZONE;FLUORESCENCE IN SITU HYBRIDIZATION;ALPHA (FINANCE);BORRELIA;BRONCHOPULMONARY DYSPLASIA;CATECHIN;CD40;CD86;DEBULKING;DNA FRAGMENTATION;DNA METHYLATION;DNA MISMATCH REPAIR;DRUG-ELUTING STENT;DRY-POWDER INHALER;ESTROGEN RECEPTOR;FLAVONOLS;GENETIC HETEROGENEITY;HOLOPROSENCEPHALY;IN SITU NICK-END LABELING;INTERLEUKIN 12;MALE INFERTILITY;MECP2;METHYLTRANSFERASE;MICROSATELLITE;MUCOSA-ASSOCIATED LYMPHOID TISSUE;OMPHALOCELE;PANEL REACTIVE ANTIBODY;PNEUMOCOCCAL INFECTIONS;PRENATAL DIAGNOSIS;PROPIDIUM IODIDE;RHODOCOCCUS EQUI;RYR1;SEROSTATUS;SPLENIC MARGINAL ZONE LYMPHOMA;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;THYMOGLOBULIN;VARICOCELE","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;MIDDLE AGED;FEMALE;ADULT;AGED;STREPTOCOCCUS PNEUMONIAE;;IMMUNOSUPPRESSIVE AGENTS;RADIAL ARTERY;RETROSPECTIVE STUDIES;CHILD;LYMPHOMA, B-CELL, MARGINAL ZONE;SIROLIMUS;AUTISTIC DISORDER;BACTERIAL PROTEINS;ITALY;OSTEOPOROSIS;SPERMATOZOA;STOMACH NEOPLASMS","45;31;26;24;15;13;12;8;8;8;8;7;7;7;6;6;6;6;6;6","LYMPHOID NEOPLASMS;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;GENETIC AND ENVIRONMENTAL INFLUENCES ON CLEFT LIP AND PALATE;MALE REPRODUCTIVE HEALTH;PULMONARY DRUG DELIVERY TECHNIQUES;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS OF GENE INTERACTION NETWORKS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;EPILEPSY AND SEIZURES;FEEDING DISORDERS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS;FIBROBLAST GROWTH FACTOR SIGNALING PATHWAY;GENETIC ADAPTATION OF LACTASE PERSISTENCE IN HUMANS;GENOMIC REARRANGEMENT DISORDERS IN SKIN DISEASES;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;HEALTH EFFECTS OF TEA POLYPHENOLS","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PATHOGENESIS;ENDOTHELIAL DYSFUNCTION;B-CELL RECEPTOR SIGNALING;FETAL MRI;ISCHEMIA-REPERFUSION INJURY;NEURORADIOLOGY;PULMONARY DRUG DELIVERY;REACTIVE HYPEREMIA;RETT SYNDROME;SEMEN ANALYSIS;SPERM DNA FRAGMENTATION;SPERM QUALITY;ABDOMINAL CAVITY;ABDOMINAL WALL DEFECT;ACHONDROPLASIA;AEROSOLIZATION;AGAROSE GEL ELECTROPHORESIS;ALPHA (FINANCE);ALVEOLAR RIDGE;ANTIBODY-MEDIATED REJECTION","4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","ABNORMAL ORAL;ACUTE CORONARY;CORONARY SYNDROMES;LIGHT REFLECTANCE;MARGINAL ZONE;MUCOSAL LIGHT;ORAL MUCOSAL;STREPTOCOCCUS PNEUMONIAE;TRUNCATING MUTATION;AARSKOGSCOTT SYNDROME;ABSCESS DUE;ACUTE HEART;ACUTE REJECTION;ADVANCED LUNG;ALA SOFTWARE;ALOBAR HOLOPROSENCEPHALY;AMYOTROPHIC LATERAL;ANALYSIS ALA;ANTIPROTHROMBIN ANTIBODIES;ARTERY ENDOTHELIAL;ATTI DEL;AUTISM BLOCKAGE;AUTOIMMUNE HEMOLYTIC;AUTOLOGOUS MESENCHYMAL;AVIUM INFECTION;B-CELL LYMPHOMA;B-CELL MALT;BENIGN OUTCOME;BLEPHAROPHIMOSIS PTOSIS;BLIND CONTROLLED","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CROSSREF PUBMED;PUBMED SCOPUS;RENAL TRANSPLANT;SYMPATHETIC DYSTROPHY;BONE MARROW;BONE PAIN;DYSTROPHY SYNDROME;LOWER LIMBS;PAIN SYNDROME;PUBMED GOOGLE;BIOLOGY SECTION;HUM REPROD;MALE INFERTILITY;SECTION UNIVERSITY;SURGERY BIOLOGY;ACH PARENTS;AZIENDA OSPEDALIERA;INFERTILITY AZIENDA;ITALY REGIONAL;OSPEDALIERA UNIVERSITARIA;REFERRAL CENTER;REGIONAL REFERRAL;SENESE SIENA;SIENA ITALY;SIENA ITALYSEARCH;SIENA SIENA;UNIVERSITARIA SENESE;ALREFLEX SYMPATHETIC;TRANSPLANT PATIENTS;FIBROUS SHEATH","17;17;14;12;11;11;11;11;10;10;9;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8;8;7;7;6",7,0.12,4.3,4.5,2,0,0,0,2.5,0,0,5.5,0,0,3.25,0,2.5,0,1,3,1,0,0,65,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,5.5,608.33,7.41,0,0,41.75,0,0,6,0,1,0,1,0,0,3,0,0,0,0,0,0,0,8,0,0,3,5,0,0,0,0,0,0,0,0,"Canada;Italy;Switzerland","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;38 ECONOMICS;3801 APPLIED ECONOMICS","8;4;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;AGING;BIODEFENSE;EMERGING INFECTIOUS DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEMATOLOGY;IMMUNIZATION;INFECTIOUS DISEASES;INFLUENZA;LUNG;LUNG CANCER;LYMPHOMA;PATIENT SAFETY;PNEUMONIA & INFLUENZA;PREVENTION;VACCINE RELATED","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;EYE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","2;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","5;1","LUNG CANCER;NON-HODGKIN'S LYMPHOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2007,55,6.8,2.50909090909091,0.454545454545455,0.345454545454545,0.545454545454545,1.32692307692308,1.38888888888889,1,1.30434782608696,0.218181818181818,2,28,12,6,6,0.51,0.22,0.11,0.11,35.47,0.672137588341464,NA,0.254545454545455,0.781818181818182,0.452,0.32,0.368,0.336,"JOUSSEF HAYEK;S ULIVIERI;CLAUDIO DE FELICE;TOMMASO GORI;G OLIVERI;RAFFAELLA ZANNOLLI;SABRINA BUONI;RANUCCIO NUTI;MASSIMO FINESCHI;GABRIELE TONNI;ANTONIO FEDERICO;CLELIA MIRACCO;G. FILOSOMI;FRANCESCA MACUCCI;CARLO PIERLI;GIUSEPPE LATINI;ALFONSO CERASE;ALFREDO ORRICO;ALEXANDER O. VORTMEYER;PAOLO GALLUZZI","6;5;5;5;5;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","S ULIVIERI;G OLIVERI;TOMMASO GORI;FRANCESCO PIPPI;ANDREA S. MELANI;G. FILOSOMI;CLAUDIO DE FELICE;MASSIMO FINESCHI;CARLO PIERLI;NICOLA DI PAOLO;JOUSSEF HAYEK;ANDREA COLLINI;RANUCCIO NUTI;A BRAVI;GABRIELE TONNI;M. CARMELLINIA;FRANCESCA IOVINE;STEVEN E. MUTSAERS;ALBERTO PALAZZUOLI;GIUSEPPE LATINI","1.75;1.75;1.09;1;1;1;0.92;0.83;0.83;0.75;0.67;0.64;0.61;0.58;0.55;0.5;0.5;0.5;0.5;0.47","JOUSSEF HAYEK;S ULIVIERI;CLAUDIO DE FELICE;TOMMASO GORI;RANUCCIO NUTI;MASSIMO FINESCHI;ANTONIO FEDERICO;CLELIA MIRACCO;CARLO PIERLI;ALFONSO CERASE;ALFREDO ORRICO;PAOLO GALLUZZI;DONATELLA DONATI;FRANCESCA SERAFINI;FRANCESCA IOVINE;MASSIMO VIVIANO;PAOLA PIOMBONI;ALBERTO PALAZZUOLI;MICHELE ZAPPELLA;GIUSEPPE MORGANTE","6;5;5;5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","S ULIVIERI;TOMMASO GORI;FRANCESCO PIPPI;ANDREA S. MELANI;CLAUDIO DE FELICE;MASSIMO FINESCHI;CARLO PIERLI;NICOLA DI PAOLO;JOUSSEF HAYEK;ANDREA COLLINI;RANUCCIO NUTI;A BRAVI;M. CARMELLINIA;FRANCESCA IOVINE;ALBERTO PALAZZUOLI;GIULIA COLLODEL;ANTONIO FEDERICO;CLELIA MIRACCO;ALFONSO CERASE;FRANCESCA SERAFINI","1.75;1.09;1;1;0.92;0.83;0.83;0.75;0.67;0.64;0.61;0.58;0.5;0.5;0.5;0.42;0.37;0.35;0.34;0.33","ALFREDO ORRICO;ARMAND BOTTANI;ALEXANDER DREWEKE;ALEXANDRA CABRAL;ANDRÉ REIS;ANITA RAUCH;CHRISTIANE ZWEIER;EMILIA K. BIJLSMA;INA GÖHRING;JILL CLAYTON‐SMITH;JORGE SARAIVA;JULIANE HOYER;KOENRAAD DEVRIENDT;MAARIT PEIPPO;MONIKA COHEN;PETER NÜRNBERG;RAOUL C. M. HENNEKAM;SÉRGIO B. SOUSA;THOMY DE RAVEL;WILLIAM REARDON","315;315;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292;292","ALFREDO ORRICO;DONATELLA DONATI;GIUSEPPE OLIVERI;CLAUDIO DE FELICE;TOMMASO GORI;GIULIA COLLODEL;JOUSSEF HAYEK;ANDREA S. MELANI;LUCIO ANDREASSI;B. BACCETTI;ELENA MORETTI;MARCELLO ROSSI;MASSIMO FINESCHI;A BRAVI;LAURA GAMBERA;FRANCESCA SERAFINI;GIUSEPPE MORGANTE;PAOLA PIOMBONI;VINCENZO DE LEO;BRUNO DE CAPUA","315;244;223;177;151;116;112;108;99;97;97;97;84;83;72;65;65;65;65;60","JOUSSEF HAYEK;CLAUDIO DE FELICE;S ULIVIERI;TOMMASO GORI;CARLO PIERLI;MASSIMO FINESCHI;A BRAVI;ALBERTO PALAZZUOLI;ALFONSO CERASE;ALFREDO ORRICO;ANDREA COLLINI;BRUNO DE CAPUA;DONATELLA DONATI;GIULIA COLLODEL;LAURA GAMBERA;LUCA VOLTERRANI;MARIA ANTONIETTA MAZZEI;MICHELE ZAPPELLA;NICOLA DI PAOLO;PAOLO GALLUZZI","6;5;5;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;POLITICAL SCIENCE","52;23;7;4;3;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;PATHOLOGY;RADIOLOGY;SURGERY;ANATOMY;CARDIOLOGY;IMMUNOLOGY;ANESTHESIA;PSYCHIATRY;ENDOCRINOLOGY;DERMATOLOGY;NEUROSCIENCE;PEDIATRICS;VIROLOGY;ANDROLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;GYNECOLOGY;OBSTETRICS","28;16;10;10;10;10;9;8;7;6;6;5;4;4;4;4;3;3;3;3;3;3","GENE;PREGNANCY;MYOCARDIAL INFARCTION;TRANSPLANTATION;MAGNETIC RESONANCE IMAGING;VIRUS;ABSCESS;BLOOD PRESSURE;CORONARY ARTERY DISEASE;DISEASE;EPILEPSY;IN VITRO;POPULATION;SPERM;STEM CELL;THROMBOSIS;VASODILATION;ASTHMA;CELL CULTURE;CENTRAL NERVOUS SYSTEM;CHEMOTHERAPY;COMPUTED TOMOGRAPHY;DIPLOPIA;ECTODERMAL DYSPLASIA;ENZYME;FOREHEAD;HEART FAILURE;HORMONE;HYPOPLASIA;IMMUNE SYSTEM;IMMUNOSUPPRESSION;ISCHEMIA;LUNG;LYMPHOMA;MACROCEPHALY;MESENCHYMAL STEM CELL;OSTEOPOROSIS;OXYGENATION;PERCUTANEOUS;RECEPTOR;SIROLIMUS;SPINAL CORD;STENOSIS","8;7;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PHENOTYPE;RETT SYNDROME;VIRAL DISEASE;ACUTE CORONARY SYNDROME;BONE MINERAL;BRAIN ABSCESS;CORONARY ANGIOGRAPHY;FETUS;GESTATION;PERCUTANEOUS CORONARY INTERVENTION;SPERM MOTILITY;VIRAL LOAD;VIRAL REPLICATION;ABORTION;ACROSOME REACTION;ACUTE SUBDURAL HEMATOMA;AGENESIS OF THE CORPUS CALLOSUM;AGONIST;AMYOTROPHIC LATERAL SCLEROSIS;ANGINA;ANIRIDIA;ANTIPHOSPHOLIPID SYNDROME;AORTIC ANEURYSM;AORTIC DISSECTION;AORTIC VALVE REPLACEMENT;ASTROCYTE;ASTROGLIOSIS;AUDITORY BRAINSTEM RESPONSE;BRAIN NATRIURETIC PEPTIDE;BREAST CANCER;BRONCHIECTASIS;CALCINEURIN;CARDIAC OUTPUT;CDC42;CELL THERAPY;CENTRAL NEUROCYTOMA;CEREBELLAR VERMIS;CEREBRAL VENOUS SINUS THROMBOSIS;CORONARY ARTERIES;CORONARY CIRCULATION;CORONARY DISEASE;CORONARY FLOW RESERVE;CORONARY OCCLUSION;CORONARY THROMBOSIS;CORPUS CALLOSUM AGENESIS;CORTICAL DYSPLASIA;CUTANEOUS LEISHMANIASIS;CYCLOOXYGENASE;CYCLOPHOSPHAMIDE;DIFFUSION MRI;ELECTIVE CESAREAN SECTION;ENDOCRINE SYSTEM;EXPIRATION;G PROTEIN-COUPLED RECEPTOR;GENERAL HEALTH QUESTIONNAIRE;GENOME;GESTATIONAL AGE;GLIAL FIBRILLARY ACIDIC PROTEIN;GUANINE NUCLEOTIDE EXCHANGE FACTOR;HAEMATOPOIESIS;HEART RATE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEMIPARESIS;HUMAN CHORIONIC GONADOTROPIN;HUMAN CYTOMEGALOVIRUS;HYPOHIDROTIC ECTODERMAL DYSPLASIA;IN VITRO FERTILISATION;INFARCTION;INFERTILITY;INHALER;INSEMINATION;LEFT VENTRICULAR HYPERTROPHY;LIFE EXPECTANCY;METRONIDAZOLE;MICROGLIA;MIDDLE FRONTAL GYRUS;MOTOR CORTEX;MOTOR NEURON;MUTATION;MYOCARDIAL STUNNING;NATRIURETIC PEPTIDE;NEURAL STEM CELL;NEUROBLASTOMA;NEURORADIOLOGY;ODONTOGENIC INFECTION;OXYGEN SATURATION;PARATHYROID HORMONE;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;POLYMERASE CHAIN REACTION;POLYMICROGYRIA;PREGNANCY RATE;PRIMITIVE NEUROECTODERMAL TUMOR;PROGENITOR CELL;PROTEIN KINASE A;PROTEIN KINASE C;PROTOZOAL DISEASE;PSYCHOLOGICAL DISTRESS;PSYCHOMOTOR LEARNING;PSYCHOMOTOR RETARDATION;RADICULAR CYST;REACTIVE HYPEREMIA;RENAL TRANSPLANT;REPRODUCTIVE HEALTH;RESPIRATORY SOUNDS;RITUXIMAB;SCOPUS;SENSORINEURAL HEARING LOSS;SPERM QUALITY;STEM-CELL THERAPY;TACROLIMUS;THROMBOCYTOPENIC PURPURA;TRANSCRANIAL MAGNETIC STIMULATION;TRANSCRIPTION FACTOR;TROPISM;TROPONIN;UMBILICAL VEIN;UNSTABLE ANGINA;VENOUS THROMBOSIS;VIABILITY ASSAY;WHITE MATTER;XENOBIOTIC","4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HERPESVIRIDAE;FIRST TRIMESTER;MISSENSE MUTATION;OSTEOPENIA;ADENOSINE RECEPTOR;CONGENITAL HEARING LOSS;CORONARY ANGIOGRAM;CORTICOSPINAL TRACT;EMBRYO QUALITY;ENDOCRINE DISRUPTOR;ENHANCER;FLUDARABINE;FRACTIONAL FLOW RESERVE;GROWTH RESTRICTION;HAPLOINSUFFICIENCY;INTRACYTOPLASMIC SPERM INJECTION;INTRAUTERINE GROWTH RESTRICTION;INTRAUTERINE INSEMINATION;LYMPHEDEMA;MALE INFERTILITY;MECP2;METERED-DOSE INHALER;PRENATAL DIAGNOSIS;PROVIRUS;RIGHT CORONARY ARTERY;ROFECOXIB;SMALL FOR GESTATIONAL AGE;STROKE VOLUME;TIMI;UMBILICAL ARTERY","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;BRAIN;MIDDLE AGED;AGED;INTELLECTUAL DISABILITY;CHILD;ADOLESCENT;CEREBRAL CORTEX;SPERMATOZOA;HERPESVIRUS 6, HUMAN;ITALY;PREGNANCY;TIME FACTORS;BRAIN ABSCESS;ECTODERMAL DYSPLASIA;ROSEOLOVIRUS INFECTIONS;","49;28;28;25;16;15;13;11;10;8;8;8;7;7;7;7;6;6;6;5","MALE REPRODUCTIVE HEALTH;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;EPILEPSY AND SEIZURES;GLIOMAS;PATHOPHYSIOLOGY OF MYOCARDIAL REPERFUSION INJURY;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS OF CARDIAC AND RESPIRATORY SOUNDS;AORTIC ATHEROSCLEROTIC DISEASE AND EMBOLIC EVENTS;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF SPINAL INFECTIONS","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;RETT SYNDROME;SPERM QUALITY;BRAIN ABSCESS;CARDIAC IMAGING;HUMAN HERPESVIRUS 6;IMMUNOSUPPRESSION;ISCHEMIC PRECONDITIONING;MACROCEPHALY;OSTEOPENIA;SEMEN ANALYSIS;SIROLIMUS;SPERM DNA FRAGMENTATION;TREATMENT;ACROSOME REACTION;ACUTE SUBDURAL HEMATOMA;ADENOSINE A2B RECEPTOR;ADENOSINE A3 RECEPTOR;AEROBIC EXERCISE;AEROSOL THERAPY","3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","BRAIN ABSCESS;CORONARY FLOW;RETT SYNDROME;AARSKOGSCOTT SYNDROME;ABACTERIAL LEUKOCYTOSIS;ABACTERIAL LEUKOCYTOSPERMIA;ACTIVE ANTIRETROVIRAL;ACTIVE HUMAN;ACUTE CORONARY;ACUTE SUBDURAL;ACYL-COA DEHYDROGENASE;ADULT PATIENTS;AFFECT HAEMODYNAMICS;AICARDI SYNDROME;AMYOTROPHIC LATERAL;ANTICOAGULANT THERAPY;ANTIRETROVIRAL THERAPY;AORTIC DISSECTIONS;AUTOLOGOUS HEMATOPOIETIC;AXONAL DAMAGE;BHV REPLICATION;BIOCHEMICAL GENETIC;BONE MARROW;BONE PAIN;BONE ULTRASONOGRAPHY;BOVINE HERPESVIRUS;BOVINE KIDNEY;BRAIN AXONAL;BRAIN CORRELATION;BRAIN DERMOID","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CROSSREF PUBMED;PUBMED SCOPUS;MENTAL RETARDATION;GENET -CROSSREF;PITT-HOPKINS SYNDROME;MED GENET;BASIC HELIX-LOOP-HELIX;MOLECULAR KARYOTYPING;SEVERE MENTAL;WIDE MOUTH;AURANEN MP;DYSMORPHOL -CROSSREF;KO VALANNE;LK LARSEN;MM SIMOLA;MP IGNATIUS;PHENOTYPECLIN DYSMORPHOL;PUBMED GOOGLE;SIMOLA KO;TRANSCRIPTION FACTOR;VALANNE LK;PHENOTYPIC OVERLAP;RETARDATION WIDE;SYNDROME MIM;B-LYMPHOCYTE DEVELOPMENT;BIOL -CROSSREF;BRAIN MATERIAL;BULGING CAUDATE;CELL BIOL;COMBINED DOSAGE","54;54;22;20;19;13;9;8;8;8;7;7;7;7;7;7;7;7;7;7;7;6;6;6;5;5;5;5;5;5",6,0.11,12.02,10.25,1,1.5,0,0,4.75,0,1,10.75,0,0,1,0,8.5,0,1,1,0,0,0,136,136.25,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,3,2.17,3,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BELLIENI CARLO VALERIO;BUONOCORE GIUSEPPE;SISTO R","1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;ISTITUTO SUPERIORE PER LA PREVENZIONE E LA SICUREZZA DEL LAVORO ISPEL;UNIVERSITA DEGLI STUDI DI SIENA","1;1;1","40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;51 PHYSICAL SCIENCES","1;1;1",NA,NA,NA,NA,"G10L17/00;G10L17/26","1;1","G10L17/26","1",15,6.82,233.73,15.15,2,0.13,28.2,1,0,8,0,4,0,1,1,0,10,1,0,0,0,0,0,0,12,3,0,11,4,0,0,0,0,0,0,0,0,"Belgium;Germany;Portugal;United States","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4208 TRADITIONAL, COMPLEMENTARY AND INTEGRATIVE MEDICINE","14;6;5;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;BRAIN DISORDERS;NEUROSCIENCES;PATIENT SAFETY;AGING;BIOTECHNOLOGY;DIGESTIVE DISEASES;NEURODEGENERATIVE;ORPHAN DRUG;PREVENTION;ARTHRITIS;CARDIOVASCULAR;CHRONIC PAIN;EPILEPSY;INFANT MORTALITY;LYMPHOMA","9;8;6;5;5;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;NEUROLOGICAL;BLOOD;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;STROKE","6;2;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.7 PHYSICAL","13;3;2;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;BREAST CANCER;GENITAL SYSTEM, FEMALE;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER;PANCREATIC CANCER","3;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","6;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2008,58,7.67241379310345,2.82758620689655,0.586206896551724,0.413793103448276,0.586206896551724,1.42608695652174,1.30769230769231,1.14285714285714,1.36,0.241379310344828,2,17,9,16,9,0.29,0.16,0.28,0.16,26.09,0.475402179103717,NA,0.155172413793103,0.741379310344828,0.474,0.337,0.298,0.345,"S ULIVIERI;CLAUDIO DE FELICE;ALFONSO CERASE;JOUSSEF HAYEK;G OLIVERI;GABRIELE TONNI;PAOLO TOTI;GIUSEPPE LATINI;S. BATTISTELLI;MARIO CARMELLINI;SALVATORE GROSSO;MARIA ANTONIETTA MENCARELLI;ROBERTO DELL’AVANZATO;FRANCESCA MARI;ILARIA LONGO;FRANCESCA ARIANI;ROBERTO PETRIOLI;A VITTORIA;ANDREA COLLINI;ALESSANDRA RENIERI","7;7;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","S ULIVIERI;G OLIVERI;B. BACCETTI;CLAUDIO DE FELICE;G. FILOSOMI;ALFONSO CERASE;L MONTOMOLI;PIETRO SARTORELLI;MASSIMO FINESCHI;CLELIA MIRACCO;GIUSEPPE LATINI;GABRIELE TONNI;GUIDO GAROSI;TOMMASO GORI;ANTONIO DEL VECCHIO;MARIO CARMELLINI;CARMINE FRANCO MUCCIO;ANDREA COLLINI;GENNARO ESPOSITO;GIULIANA RUGGIERI","2.95;1.7;1.14;1;0.92;0.88;0.67;0.67;0.64;0.64;0.57;0.56;0.53;0.5;0.46;0.45;0.45;0.45;0.45;0.45","S ULIVIERI;CLAUDIO DE FELICE;ALFONSO CERASE;JOUSSEF HAYEK;G OLIVERI;GABRIELE TONNI;PAOLO TOTI;GIUSEPPE LATINI;S. BATTISTELLI;MARIO CARMELLINI;SALVATORE GROSSO;ROBERTO DELL’AVANZATO;ROBERTO PETRIOLI;A VITTORIA;ANDREA COLLINI;G. FILOSOMI;GIULIANA RUGGIERI;A ORSI;ANTONIO DEL VECCHIO;L MONTOMOLI","7;7;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2","S ULIVIERI;G OLIVERI;B. BACCETTI;CLAUDIO DE FELICE;G. FILOSOMI;ALFONSO CERASE;L MONTOMOLI;PIETRO SARTORELLI;MASSIMO FINESCHI;GIUSEPPE LATINI;GABRIELE TONNI;GUIDO GAROSI;TOMMASO GORI;ANTONIO DEL VECCHIO;MARIO CARMELLINI;ANDREA COLLINI;GIULIANA RUGGIERI;PAOLO TOTI;JOUSSEF HAYEK;S. BATTISTELLI","2.95;1.7;1.14;1;0.92;0.88;0.67;0.67;0.64;0.57;0.56;0.53;0.5;0.46;0.45;0.45;0.45;0.4;0.38;0.38","JOUSSEF HAYEK;CLAUDIO DE FELICE;PAOLO TOTI;ALESSANDRA RENIERI;FRANCESCA ARIANI;FRANCESCA MARI;ILARIA LONGO;ILARIA MELONI;MARIA ANTONIETTA MENCARELLI;SALVATORE GROSSO;GIUSEPPE LATINI;ANDREA PAMMOLLI;ANTON FERDINANDO CARLI;FURIO PACINI;GIULIA BUSONERO;GIUSEPPE CARUSO;KALLIOPI PAZAITOU‐PANAYIOTOU;LUCIA BRILLI;MARCO CAPEZZONE;SILVANO CAPITANI","209;203;192;184;184;184;184;184;184;147;142;134;134;134;134;134;134;134;134;134","JOUSSEF HAYEK;CLAUDIO DE FELICE;FURIO PACINI;GIULIA BUSONERO;LUCIA BRILLI;MARCO CAPEZZONE;SILVIA CANTARA;STEFANIA MARCHISOTTA;STEFANO TONINELLI;B. BACCETTI;SERENA CAPITANI;ALFONSO CERASE;MICHELE ZAPPELLA;ALBERTO FABBRI;F. REALE;GIUSEPPE COVIELLO;ROBERTO CANITANO;ROBERTO DELL’AVANZATO;ROBERTO PETRIOLI;ANDREA COLLINI","209;165;134;134;134;134;134;134;126;113;112;100;97;83;74;72;64;56;56;53","S ULIVIERI;CLAUDIO DE FELICE;ALFONSO CERASE;JOUSSEF HAYEK;A VITTORIA;A ORSI;ANDREA COLLINI;GIULIANA RUGGIERI;MARIO CARMELLINI;ROBERTO DELL’AVANZATO;ROBERTO PETRIOLI;A GENOVESE;B. BACCETTI;DORICA CATALDO;FRANCESCO DOTTA;FRANCO ROVIELLO;GABRIELE DONATI;GIUSEPPINA VONELLA;GUIDO GAROSI;LORENZO DE SANTI","7;5;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;ART;ENGINEERING;ECONOMICS;HISTORY;MATHEMATICS;PHILOSOPHY","54;23;7;5;4;4;3;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;ANATOMY;GASTROENTEROLOGY;RADIOLOGY;IMMUNOLOGY;ONCOLOGY;CARDIOLOGY;NEUROSCIENCE;PEDIATRICS;PSYCHIATRY;ANESTHESIA;ENVIRONMENTAL HEALTH;AUDIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;OPTICS;ORGANIC CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION","28;18;14;13;9;8;8;7;7;5;5;5;5;4;4;3;3;3;3;3;3","DISEASE;CANCER;PREGNANCY;GENE;LESION;MAGNETIC RESONANCE IMAGING;THROMBOSIS;TRANSPLANTATION;FIBRINOGEN;POPULATION;ADVERSE EFFECT;ANTIBODY;EPILEPSY;INCIDENCE (GEOMETRY);INFLAMMATION;ABSCESS;ALTERNATIVE MEDICINE;BACTERIA;BRAINSTEM;CARPAL TUNNEL SYNDROME;CHEMOTHERAPY;COAGULATION;DIABETES MELLITUS;DIFFERENTIAL DIAGNOSIS;ELECTROMYOGRAPHY;ELECTROPHYSIOLOGY;HEMOSTASIS;HEPARIN;IMMUNE SYSTEM;IN VITRO;LUMBAR;LYMPHOMA;MEDIAN NERVE;MEMBRANE;MULTIPLE MYELOMA;MULTIPLE SCLEROSIS;PHTHALATE;PONS;RANDOMIZED CONTROLLED TRIAL;RESPIRATORY SYSTEM;SUBCLINICAL INFECTION;VENTRICLE","7;6;6;5;5;5;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;THROMBOPHILIA;FETUS;MUTATION;PHENOTYPE;ACUTE-PHASE PROTEIN;ANTITHROMBIN;BIRTH WEIGHT;BRAIN ABSCESS;BREAST CANCER;CARPAL TUNNEL;CHROMOSOME;FACTOR VII;GESTATIONAL AGE;INSULIN RESISTANCE;PERIPHERAL BLOOD MONONUCLEAR CELL;PHOSPHOLIPID;RETT SYNDROME;T CELL;WHITE MATTER","4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CARDIOLIPIN;HOLOPROSENCEPHALY;MECP2;MISSENSE MUTATION;ABSOLUTE NEUTROPHIL COUNT;ADENOID HYPERTROPHY;ALENDRONIC ACID;BACTEROIDETES;BARE METAL;CADASIL;CD40;CD86;CHORIOAMNIONITIS;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;DRUG-ELUTING STENT;EXTRACORPOREAL PHOTOPHERESIS;FEBRILE NEUTROPENIA;FLUDARABINE;GASTRO-;HYDRANENCEPHALY;IMPAIRED GLUCOSE TOLERANCE;INTRACYTOPLASMIC SPERM INJECTION;INTRAVENTRICULAR HEMORRHAGE;LEUKOARAIOSIS;MEDIAL LONGITUDINAL FASCICULUS;METASTATIC BREAST CANCER;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;OCCIPITAL NEURALGIA;OCULOMOTOR NUCLEUS;PAPILLARY THYROID CANCER;PARAMEDIAN PONTINE RETICULAR FORMATION;PROBAND;RADIOIMMUNOTHERAPY;SUBTELOMERE;TAMOXIFEN;TANDEM EXON DUPLICATION;TEGMENTUM;THYMIC INVOLUTION;XQ28","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;;CHILD;MAGNETIC RESONANCE IMAGING;ADOLESCENT;BRAIN NEOPLASMS;INFANT, NEWBORN;ITALY;POSTOPERATIVE COMPLICATIONS;BRAIN ABSCESS;COLORECTAL NEOPLASMS;EPILEPSY;FACIAL NERVE DISEASES;KIDNEY TRANSPLANTATION;RETT SYNDROME","48;36;34;23;20;15;9;9;9;8;8;8;8;8;7;7;7;7;7;7","NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;KIDNEY TRANSPLANTATION;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCEMENTS IN TRANSPLANTATION PROCEDURES AND OUTCOMES;BLUETOOTH LOW ENERGY TECHNOLOGY OVERVIEW AND EVALUATION;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;CANCER OF UNKNOWN PRIMARY SITE;CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;CLINICAL CHARACTERISTICS AND MANAGEMENT OF SARCOIDOSIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION","3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ANTIPHOSPHOLIPID SYNDROME;BRAIN ABSCESS;CEREBROSPINAL FLUID LEAKS;COAGULATION;FACTOR VII;INTRACRANIAL HYPOTENSION;MECP2;PONS;PRETERM INFANTS;RETT SYNDROME;SUBCLINICAL INFECTION;3D ULTRASOUND;ABSOLUTE NEUTROPHIL COUNT;ACROSOME REACTION;ACUTE OTITIS MEDIA;ADENOID HYPERTROPHY;ALENDRONIC ACID;ANEURYSMAL BONE CYST;ANTICIPATION (ARTIFICIAL INTELLIGENCE);ANTIEPILEPTIC DRUGS","2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;COLORECTAL CANCER;NON-METASTATIC COLORECTAL;ACUTE-PHASE RESPONSE;ANTIPHOSPHOLIPID ANTIBODIES;CARPAL TUNNEL;COAGULATION FACTOR;DE NOVO;DIABETES MELLITUS;FACTOR LEVELS;MULTIPLE MYELOMA;MULTIPLE SCLEROSIS;MYELOMA PATIENTS;RETT SYNDROME;TRANSPLANT RECIPIENTS;ABSCESS SECONDARY;ACUTE BACTERIAL;ACUTE PONTINE;ACUTE VESTIBULAR;ADVERSE EVENTS;ADVERSE RESPIRATORY;AFFECTS CO-STIMULATORY;ALOBAR HOLOPROSENCEPHALY;ANEURYSMAL BONE;ANIMAL EXPERIMENTATION;ANTICIPATION SUGGESTIVE;ANTIMONY COBALT;AUTOSOMAL DOMINANT;BACTERIAL CONJUNCTIVITIS;BARE METAL","4;4;4;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NONREACTED SPERMATOZOA;COLORECTAL CANCER;REACTED SPERMATOZOA;FNMTC PATIENTS;ACROSOME REACTION;BLOOD SAMPLES;BODY WEIGHT;CANCER PATIENTS;IMPLANTATION RATE;NON-METASTATIC COLORECTAL;OOCYTES INJECTED;POLARIZED LIGHT;SPERM INJECTION;ACUTE-PHASE REACTANTS;BARE METAL;CONTROL SUBJECTS;DIALYSIS SOLUTIONS;EARLIER AGE;ECP-TREATED LYMPHOCYTES;INTRACYTOPLASMIC SPERM;METAL STENT;PARENTCHILD RELATIONSHIP;PLASMA LEVELS;REPRODUCTIVE MEDICINE;TOTAL BLOOD;VERTICAL SACCADES;ABSORBED DOSES;ACROSOME NONREACTED;ANTI-Β -GLYCOPROTEIN;ANTIPHOSPHOLIPID ANTIBODIES","9;6;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",3,0.05,3,4.5,0,0,0,0,0,0,0,4.5,0,0,1,0,4.75,0,0,0,1,0,0,63,63,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,8,3,1.83,2,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BELLIENI CARLO VALERIO;BUONOCORE GIUSEPPE;SISTO RENATA","1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;UNIVERSITA DEGLI STUDI DI SIENA","1;1","40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;51 PHYSICAL SCIENCES","1;1;1",NA,NA,NA,NA,"G10L17/00;G10L17/26;G10L21/06","1;1;1","G10L17/26","1",18,5.45,261.67,17.31,1,0.06,16.94,0,3,7,0,6,0,2,0,0,12,0,0,0,0,0,0,0,18,0,0,12,6,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;52 PSYCHOLOGY","18;11;6;3;2;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;RARE DISEASES;BIOTECHNOLOGY;LUNG;PATIENT SAFETY;AGING;BREAST CANCER;CARDIOVASCULAR;COLO-RECTAL CANCER;DIGESTIVE DISEASES;HEART DISEASE;LUNG CANCER;ARTHRITIS;CHILDHOOD LEUKEMIA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH","12;10;9;4;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1","CANCER;CARDIOVASCULAR;MUSCULOSKELETAL;NEUROLOGICAL;RENAL AND UROGENITAL;RESPIRATORY","11;2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING;6.4 SURGERY;6.7 PHYSICAL","14;4;2;2;1;1","LUNG CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;BREAST CANCER;MELANOMA;GASTROINTESTINAL TRACT;RETINOBLASTOMA","4;3;3;2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;1.4 CANCER PROGRESSION AND METASTASIS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","9;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2009,80,7.425,2.1125,0.475,0.425,0.5375,1.42016806722689,1.52,1.36,1.43333333333333,0.3,0,26,21,10,14,0.32,0.26,0.12,0.17,38.62,0.835004744003939,NA,0.225,0.6875,0.455,0.409,0.417,0.392,"ALFONSO CERASE;S ULIVIERI;CARLO VENTURI;GABRIELE CENTINI;SABRINA BUONI;CLELIA MIRACCO;GABRIELE TONNI;ANTONIO FEDERICO;L. ROSIGNOLI;F. VARRONE;CARLA BATTISTI;G. MARZOCCA;G OLIVERI;GIUSEPPE OLIVERI;ALFREDO ORRICO;IGNAZIO MARIA VALLONE;CARLO PETRINI;GIAN MARÍA ROSSOLINI;JOUSSEF HAYEK;MASSIMO MACCHERINI","10;7;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3","S ULIVIERI;ALFONSO CERASE;GABRIELE CENTINI;G OLIVERI;L. ROSIGNOLI;F. VARRONE;G. MARZOCCA;CARLO VENTURI;GABRIELE TONNI;CLELIA MIRACCO;GIUSEPPE OLIVERI;M. LO GATTO;ANTONIO FEDERICO;CARLA BATTISTI;CARLO PETRINI;IGNAZIO MARIA VALLONE;SABRINA BUONI;F. NATRELLA;MASSIMO FINESCHI;G.B. SCARFÒ","1.85;1.66;1.6;1.21;1.07;0.95;0.95;0.94;0.93;0.8;0.74;0.67;0.64;0.64;0.58;0.53;0.52;0.5;0.5;0.5","ALFONSO CERASE;S ULIVIERI;CARLO VENTURI;GABRIELE CENTINI;SABRINA BUONI;L. ROSIGNOLI;F. VARRONE;CARLA BATTISTI;G. MARZOCCA;GIUSEPPE OLIVERI;ALFREDO ORRICO;IGNAZIO MARIA VALLONE;CARLO PETRINI;GIAN MARÍA ROSSOLINI;JOUSSEF HAYEK;MASSIMO MACCHERINI;SONIA DE FRANCESCO;RAFFAELLA ZANNOLLI;VINCENZO SORRENTINO;R MALATESTI","10;7;6;6;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2","S ULIVIERI;ALFONSO CERASE;GABRIELE CENTINI;L. ROSIGNOLI;F. VARRONE;G. MARZOCCA;CARLO VENTURI;GIUSEPPE OLIVERI;M. LO GATTO;CARLA BATTISTI;CARLO PETRINI;IGNAZIO MARIA VALLONE;SABRINA BUONI;F. NATRELLA;MASSIMO FINESCHI;G.B. SCARFÒ;FRANCESCA GUIDERI;NICOLA DI PAOLO;ALFREDO ORRICO;PIERSANTE SESTINI","1.85;1.66;1.6;1.07;0.95;0.95;0.94;0.74;0.67;0.64;0.58;0.53;0.52;0.5;0.5;0.5;0.5;0.5;0.42;0.42","CATERINA STELITANO;FRANCESCO ZAJA;LUIGI RIGACCI;ALBA A. BRANDES;ALBERTO FABBRI;ANDRÉS JM FERRERI;ATTILIO GUARINI;CATRINA UHLMANN;DANIELE VALLISA;EMANUELE ZUCCA;FEDERICO CALIGARIS‐CAPPIO;FIORELLA ILARIUCCI;FRANCO CAVALLI;GAETANO CORAZZELLI;GERASIMUS A PANGALIS;GIAN MARCO AONDIO;GIUSEPPE AVVISATI;GIUSEPPE ROSSI;GRAZIELLA PINOTTI;HENRY GÓMEZ","744;744;744;624;624;624;624;624;624;624;624;624;624;624;624;624;624;624;624;624","ALBERTO FABBRI;ALFONSO CERASE;ALFREDO ORRICO;SABRINA BUONI;ALDO CAPOROSSI;COSIMO MAZZOTTA;DANIELA CERRETANI;STEFANO BAIOCCHI;TOMASO CAPOROSSI;GIAN MARÍA ROSSOLINI;VITTORIO FOSSOMBRONI;GIANNI POZZI;MARCO R. OGGIONI;MASSIMO MACCHERINI;JOUSSEF HAYEK;CARLO VENTURI;DONATELLA RASPADORI;ELISA SOZZI;EMANUELE CENCINI;FRANCESCO FORCONI","624;372;357;261;219;219;211;211;211;194;151;149;149;137;129;128;120;120;120;120","ALFONSO CERASE;S ULIVIERI;CARLO VENTURI;GABRIELE CENTINI;G. MARZOCCA;L. ROSIGNOLI;SABRINA BUONI;GIAN MARÍA ROSSOLINI;IGNAZIO MARIA VALLONE;JOUSSEF HAYEK;MASSIMO MACCHERINI;GIUSEPPE OLIVERI;ALDO CAPOROSSI;ALFREDO ORRICO;CLAUDIO DE FELICE;COSIMO MAZZOTTA;SONIA BERNAZZALI;A ORSI;ALBERTO FABBRI;ALESSANDRA VELLA","9;7;6;6;4;4;4;3;3;3;3;3;2;2;2;2;2;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;PHILOSOPHY;ART;POLITICAL SCIENCE;SOCIOLOGY","71;36;7;6;6;6;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;RADIOLOGY;BIOCHEMISTRY;PSYCHIATRY;CARDIOLOGY;GASTROENTEROLOGY;ANATOMY;IMMUNOLOGY;PEDIATRICS;ENDOCRINOLOGY;OBSTETRICS;ANESTHESIA;GYNECOLOGY;MICROBIOLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;DERMATOLOGY;LIBRARY SCIENCE;ONCOLOGY;QUANTUM MECHANICS;UROLOGY","34;32;25;23;19;13;11;9;8;7;7;6;5;5;4;4;4;4;4;3;3;3;3;3","GENE;PREGNANCY;DISEASE;ALTERNATIVE MEDICINE;CANCER;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;HEART FAILURE;LAPAROTOMY;RANDOMIZED CONTROLLED TRIAL;RECTUM;ABDOMEN;ADVERSE EFFECT;APOPTOSIS;AUTISM;BACTERIA;CENTRAL NERVOUS SYSTEM;CHEMOTHERAPY;COMPLICATION;EXPLORATORY LAPAROTOMY;HEMATOMA;IMMUNOHISTOCHEMISTRY;LESION;LUMBAR;NEUROLOGY;POPULATION;STENOSIS;ULTRASOUND;VIRUS","16;10;9;7;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PHENOTYPE;FETUS;HEART TRANSPLANTATION;COLORECTAL CANCER;MUTATION;OSTEOARTHRITIS;PLASMID;CHROMOSOME;CLINICAL ENDPOINT;ESCHERICHIA COLI;GENOME;GESTATION;HYDRONEPHROSIS;LEUKOENCEPHALOPATHY;MELPHALAN;NEURORADIOLOGY;RETINOBLASTOMA;RETT SYNDROME;RNA;TOLERABILITY;UNIVARIATE ANALYSIS","6;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ABDOMINOPERINEAL RESECTION;CADASIL;MECP2;MISSENSE MUTATION;PRENATAL DIAGNOSIS;ACINETOBACTER BAUMANNII;ACRODERMATITIS ENTEROPATHICA;ADVANCED MATERNAL AGE;ALTERNATIVE SPLICING;AMNIOTIC FLUID;ANEUPLOIDY;ARTICULAR CARTILAGE;AUTONOMIC NERVOUS SYSTEM;BALLOONING;BOSENTAN;BRONCHOPULMONARY DYSPLASIA;CEREBRAL VASOSPASM;CHRONIC ALLOGRAFT NEPHROPATHY;COMPLEMENT FIXATION TEST;COMPLEMENTATION;COPY-NUMBER VARIATION;CXCL10;CYSTATHIONINE BETA SYNTHASE;CYSTINE;DIRECT REPEAT;DUCTUS VENOSUS;ENDOTHELIN RECEPTOR ANTAGONIST;ENTEROBACTERIACEAE;FIRST TRIMESTER;FLUORESCENCE IN SITU HYBRIDIZATION;FRACTIONAL FLOW RESERVE;GERMLINE MUTATION;HAPLOINSUFFICIENCY;HORIZONTAL GENE TRANSFER;IGHV@;IL-2 RECEPTOR;INTRACYTOPLASMIC SPERM INJECTION;KARYOTYPE;KLEBSIELLA;KLEBSIELLA PNEUMONIAE;MALE INFERTILITY;MONOCLONAL;NEUROENDOCRINE DIFFERENTIATION;PAPILLARY THYROID CANCER;PROCTITIS;PTEN;REVERSE TRANSCRIPTASE;RIFABUTIN;RNA SPLICING;SEMEN ANALYSIS;SPINAL EPIDURAL HEMATOMA;SYNOVIAL FLUID;TELOMERASE REVERSE TRANSCRIPTASE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;;TREATMENT OUTCOME;MAGNETIC RESONANCE IMAGING;SEIZURES;BRAIN NEOPLASMS;BRAIN;EPILEPSY;INTELLECTUAL DISABILITY;AGED, 80 AND OVER;ANTI-BACTERIAL AGENTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;GRAFT REJECTION;HEMATOMA, EPIDURAL, SPINAL;IMMUNOSUPPRESSIVE AGENTS","59;39;38;27;22;20;18;14;12;10;9;8;8;8;7;7;7;7;7;7","PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;OCULAR CANCER RESEARCH AND TREATMENT;SPINAL HEMATOMAS AND RELATED CONDITIONS;CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GLIOMAS;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;ORGAN TRANSPLANTATION AND REJECTION;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN TRANSPLANTATION PROCEDURES AND OUTCOMES;ANORECTAL SURGICAL PROCEDURES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOLOGICAL AND CLINICAL EFFECTS OF IONIZING RADIATION;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;CELLULAR SENESCENCE AND AGING-RELATED DISEASES;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS","4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","SPINAL HEMATOMA;POSTOPERATIVE COMPLICATIONS;EXPLORATORY LAPAROTOMY;FETAL DNA ANALYSIS;RADIOTHERAPY;ABDOMINOPERINEAL RESECTION;AMNIOCENTESIS;CADASIL;CEREBROVASCULAR DYSFUNCTION;CLINICAL ENDPOINT;DISPOSITION;ECHOCARDIOGRAM GUIDELINES;EPIDURAL HEMATOMA;MATERNAL PLASMA DNA SEQUENCING;MECP2;MELPHALAN;MUSIC THERAPY;NEURORADIOLOGY;NONINVASIVE PRENATAL TESTING;POSTOPERATIVE PAIN","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","APPLICATION METHODS;COMMENSAL ENTEROBACTERIA;CON INFILTRAZIONE;DI ETP;ETP RETTO;HEART FAILURE;HIGH-DOSE METHOTREXATE;INFILTRAZIONE URETERALE;PELVICA DI;RECIDIVA PELVICA;REPORT RECIDIVA;RETT SYNDROME;RETTO CON;SYSTEM APPLICATION;TAMMEF SYSTEM;URETERALE TRATTAMENTO;ACQUIRED IMMUNODEFICIENCY;ACUTE ABDOMEN;ACUTE REJECTION;AGENTS IMPROVE;AGGRESSIVE BEHAVIOR;AML PATIENTS;ANAEMIC HEART;ANKYLOSING SPONDYLITIS;ANTISMOKING STUDY;APICAL BALLOONING;ARTICULAR CHONDROCYTES;AUTONOMIC NERVOUS;AUTOSOMAL-RECESSIVE PITT-HOPKINS-LIKE;BENIGN ORBITAL","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MATERNAL AGE;ACUTE REJECTION;CXCL SERUM;NUCHAL TRANSLUCENCY;THYROID CANCER;HEALTHY CHILDREN;HIGH-DOSE METHOTREXATE;HTX RECIPIENTS;NEUROPSYCHIATRIC DISORDERS;SIALIC ACID;SYNAPTIC ROLE;CHILDREN LIVING;CHROMOSOMAL ANOMALIES;COMMENSAL ENTEROBACTERIA;COMPLETE REMISSION;CT SCANS;DETACHED TAIL;ELLIS-VAN CREVELD;FOXP MRNA;HEART TRANSPLANTATION;LUMBAR SPINAL;MOLECULAR MECHANISM;PRIMARY CNS;SERUM LEVELS;SMOKING CESSATION;ACRODENTAL DYSOSTOSIS;ACTION STAGE;ACTIVE ZONES;ACTIVE-ZONE PROTEIN;AGE MONTHS","6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2",7,0.09,4.5,2,0,1,0,0,5.5,0,1,2,0,0,2,1,1,0,0,2,0,0.5,0,57,57.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,6.11,315,8.85,4,0.4,73.8,0,0,4,0,3,0,1,2,0,7,2,0,0,0,0,0,0,10,0,0,9,1,0,0,0,0,0,0,0,0,"United States;Japan","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","10;4;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;BIOTECHNOLOGY;PATIENT SAFETY;PEDIATRIC;PREVENTION;TRANSPLANTATION;ASSISTIVE TECHNOLOGY;AUTOIMMUNE DISEASE;BIOENGINEERING;CHILDHOOD LEUKEMIA;EMERGING INFECTIOUS DISEASES;GENETICS;IMMUNIZATION;INFECTIOUS DISEASES;INFLUENZA;LUNG","7;6;5;5;5;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;RESPIRATORY","4;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;1;1","LEUKEMIA / LEUKAEMIA;HODGKIN'S DISEASE;LUNG CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA","3;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","5;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;51 PHYSICAL SCIENCES;5106 NUCLEAR AND PLASMA PHYSICS","3;1;1;1;1","BIOTECHNOLOGY;CANCER;CLINICAL RESEARCH","1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","1","MELANOMA","1",NA,NA
"AOU_SENESE",2010,73,10.6301369863014,2.72602739726027,0.47945205479452,0.273972602739726,0.616438356164384,1.35374149659864,1.16666666666667,1.17647058823529,1.21621621621622,0.246575342465753,2,28,19,11,11,0.38,0.26,0.15,0.15,29.64,0.655973582986822,NA,0.26027397260274,0.684931506849315,0.374,0.364,0.372,0.363,"ALFONSO CERASE;TOMÁS BERL;CLAUDIO DE FELICE;JOUSSEF HAYEK;FRANCESCO LAURIA;INDER S. ANAND;PETER A. MCCULLOUGH;G. SHEINFELD;SABRINA BUONI;RINALDO BELLOMO;ILONA BOBEK;S ULIVIERI;SACHIN SONI;ANDREW SHAW;PIOTR PONIKOWSKI;NADIA ASPROMONTE;MIKKO HAAPIO;CARLO VENTURI;GIORGIO VESCOVO;SUNIL MANKAD","9;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","ALFONSO CERASE;MICHELE MAIO;GUIDO GAROSI;CARLO VENTURI;S ULIVIERI;GIACOMO ZANELLI;GABRIELE CENTINI;L. ROSIGNOLI;CLELIA MIRACCO;SERGIO MONDILLO;MARIO CHIAVARELLI;CLAUDIO DE FELICE;JOUSSEF HAYEK;VALERIO ZACÀ;MATTEO BELLINI;FRANCESCO LAURIA;MONICA ONORATI;GIUSEPPE VUOLO;ILARIA GAGGELLI;ANDREA TIRONE","1.62;1;1;0.71;0.69;0.53;0.5;0.5;0.5;0.48;0.48;0.39;0.37;0.37;0.37;0.36;0.35;0.34;0.34;0.34","ALFONSO CERASE;CLAUDIO DE FELICE;JOUSSEF HAYEK;FRANCESCO LAURIA;SABRINA BUONI;S ULIVIERI;CARLO VENTURI;ALBERTO PALAZZUOLI;FRANCESCO FORCONI;MONICA BOCCHIA;CORRADO PEDRAZZANI;MICHELA RONDONI;SERGIO MONDILLO;FRANCO ROVIELLO;GIOVANNI CORSO;MONICA ONORATI;CLELIA MIRACCO;DANIELE MARRELLI;MARIA ANTONIETTA MAZZEI;FRANCO BAGNOLI","9;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2","ALFONSO CERASE;MICHELE MAIO;GUIDO GAROSI;CARLO VENTURI;S ULIVIERI;GIACOMO ZANELLI;GABRIELE CENTINI;L. ROSIGNOLI;CLELIA MIRACCO;SERGIO MONDILLO;MARIO CHIAVARELLI;CLAUDIO DE FELICE;JOUSSEF HAYEK;VALERIO ZACÀ;MATTEO BELLINI;FRANCESCO LAURIA;MONICA ONORATI;ANDREA TIRONE;MARIA ANTONIETTA MAZZEI;CARLO PIERLI","1.62;1;1;0.71;0.69;0.53;0.5;0.5;0.5;0.48;0.48;0.39;0.37;0.37;0.37;0.36;0.35;0.34;0.33;0.3","FELICETTO FERRARA;FRANCESCO ZAJA;MARTA LISA BATTISTA;MARZIA DEFINA;MICHELE BACCARANI;MIRIAM ISOLA;MONICA BOCCHIA;NICOLA VIANELLI;RENATO FANIN;ANDREA DI SANTO;ANNALISA MONTANARO;ANTON FERDINANDO CARLI;FURIO PACINI;GIULIA BUSONERO;GIUSEPPE CARUSO;LUCIA BRILLI;MARCO CAPEZZONE;PAOLO TOTI;SERENA CAPUANO;SILVIA CANTARA","356;356;356;356;356;356;356;356;356;302;302;302;302;302;302;302;302;302;302;302","MARZIA DEFINA;MONICA BOCCHIA;SILVIA CANTARA;ALBERTO PALAZZUOLI;GIANDOMENICO ROVIELLO;GIUSEPPE MAROTTA;MARIO CHIAVARELLI;JOUSSEF HAYEK;SABRINA BUONI;MATEUS BERNI;CARLA VINDIGNI;CLAUDIO DE FELICE;FRANCESCO LAURIA;ALFONSO CERASE;CATERINA BALDI;ELENA FRATI;FERNANDO NARGI;L. MENZA;MAURO GALEAZZI;MOHAMMED HAMMOUD","356;356;302;257;153;153;153;145;111;103;99;98;82;66;60;60;60;60;60;60","ALFONSO CERASE;FRANCESCO LAURIA;JOUSSEF HAYEK;ALBERTO PALAZZUOLI;CLAUDIO DE FELICE;SABRINA BUONI;MONICA ONORATI;S ULIVIERI;FRANCESCO FORCONI;MICHELA RONDONI;ALESSANDRO NERI;ANDREA TIRONE;ANNA DE NICOLA;CARLO PIERLI;CARLO VENTURI;CORRADO PEDRAZZANI;DANIELE MARRELLI;ELISA SOZZI;FRANCO BAGNOLI;FRANCO ROVIELLO","6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;GEOGRAPHY;PSYCHOLOGY;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE","67;23;8;5;5;5;4;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;GENETICS;CARDIOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;PSYCHIATRY;ANATOMY;ONCOLOGY;PEDIATRICS;STATISTICS;CANCER RESEARCH;ENDOCRINOLOGY;OPTICS;ANESTHESIA;ARTIFICIAL INTELLIGENCE;BIOCHEMISTRY;DERMATOLOGY;ENVIRONMENTAL HEALTH;VIROLOGY","45;22;19;17;16;9;9;8;7;7;5;5;5;5;4;4;4;3;3;3;3;3;3","GENE;DISEASE;CANCER;LESION;LYMPHOMA;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;CHEMOTHERAPY;HEART FAILURE;INCIDENCE (GEOMETRY);KIDNEY DISEASE;LUNG;PREGNANCY;REGIMEN;RENAL FUNCTION;ADVERSE EFFECT;BONE MARROW;COMPLICATION;IMMUNOHISTOCHEMISTRY;LEUKEMIA;MULTIVARIATE ANALYSIS;MYOCARDIAL INFARCTION;POPULATION;STEM CELL;ULTRASOUND","11;8;6;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","PHENOTYPE;RITUXIMAB;CARDIORENAL SYNDROME;CHRONIC LYMPHOCYTIC LEUKEMIA;RETT SYNDROME;UNIVARIATE ANALYSIS;ADENOCARCINOMA;DIFFUSION MRI;FETUS;HEART TRANSPLANTATION;MUTATION;SALVAGE THERAPY;3D ULTRASOUND;ADALIMUMAB;ADJUVANT RADIOTHERAPY;AIR TRAPPING;ALLELE;ANTERIOR SPINAL ARTERY;AORTIC ANEURYSM;B SYMPTOMS;B-CELL LYMPHOMA;BASAL GANGLIA;BIRTH WEIGHT;BREAKPOINT CLUSTER REGION;BRONCHIECTASIS;BRONCHODILATOR;CALCINEURIN;CARDIOGENIC SHOCK;CELL TYPE;CELLULAR DIFFERENTIATION;CEREBELLAR ARTERY;CEREBRAL INFARCTION;CEREBROTENDINOUS XANTHOMATOSIS;CERVIX;CHOREA;CHOREOATHETOSIS;CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION;COLORECTAL CANCER;CONSTRUCT VALIDITY;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;CYTARABINE;DARIER'S DISEASE;DNA DAMAGE;DNA SEQUENCING;ECONOMIC SHORTAGE;EFFECTIVE DIFFUSION COEFFICIENT;ELECTRONYSTAGMOGRAPHY;EMBRYONIC STEM CELL;ENCEPHALITIS;EOSINOPHIL;EOSINOPHILIC ESOPHAGITIS;EPILEPSY SYNDROMES;ETANERCEPT;FIBROBLAST;FLUID-ATTENUATED INVERSION RECOVERY;FUSION GENE;GENE EXPRESSION;GENOTYPE;GESTATION;GESTATIONAL AGE;GLYCEMIC;HAEMATOPOIESIS;HAZARD RATIO;HEART RUPTURE;HIGH-POWER FIELD;HUMAN DISEASE;HYPERINTENSITY;IMATINIB;IMMUNE THROMBOCYTOPENIA;INFARCTION;INFERTILITY;INFLIXIMAB;INFRATEMPORAL FOSSA;INTERLEUKIN;INTERLEUKIN 6;INTERNUCLEAR OPHTHALMOPLEGIA;INTERSTITIAL LUNG DISEASE;KERATINOCYTE;KIDNEY TRANSPLANTATION;LEFLUNOMIDE;LEUKOENCEPHALOPATHY;LIPID PEROXIDATION;LOG-RANK TEST;LUNG FUNCTION;MEDIAN FOLLOW-UP;METASTASIS;MITRAL VALVE REPLACEMENT;MUCOSITIS;NEURORADIOLOGY;OCTREOTIDE;ORGAN DYSFUNCTION;OSTEOARTHRITIS;OXIDATIVE DAMAGE;PARAPLEGIA;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;PILONIDAL DISEASE;PITUITARY ADENOMA;POSTERIOR INFERIOR CEREBELLAR ARTERY;PROBIOTIC;PROGENITOR CELL;PROGRAMMED CELL DEATH;PROINFLAMMATORY CYTOKINE;PSYCHOLOGICAL DISTRESS;RECURRENCE QUANTIFICATION ANALYSIS;REFLUX;REGULATOR;RESPIRATORY DISEASE;RESTENOSIS;RESTRICTION ENZYME;RETINAL DETACHMENT;SACCHAROMYCES CEREVISIAE;SALBUTAMOL;SINUS (BOTANY);STEROL;STRESS ECHOCARDIOGRAPHY;SYSTEMIC MASTOCYTOSIS;THORACIC AORTA;THYROID NODULES;TRANSCRANIAL MAGNETIC STIMULATION;TRANSCRIPTION FACTOR;TRANSVAGINAL ULTRASOUND;TYPE 2 DIABETES;TYPE 2 DIABETES MELLITUS;ULNAR NERVE;UNIVARIATE;UROCORTIN;UTERINE CAVITY;VASOSPASM;VISCERAL LEISHMANIASIS","4;4;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","IGHV@;MECP2;MISSENSE MUTATION;ALPHA (FINANCE);AMNIOTIC BAND SYNDROME;ANENCEPHALY;ATHETOSIS;BCL-2 FAMILY;CARDIAC ALLOGRAFT VASCULOPATHY;CEREBRAL VASOSPASM;CERVICAL CANAL;CHOLESTANOL;CLINICAL PHENOTYPE;CORONARY STENT;CORTICOSPINAL TRACT;CUBITAL TUNNEL SYNDROME;CUTANEOUS MASTOCYTOSIS;CYSTIC HYGROMA;DERMAL FIBROBLAST;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;DRUG-ELUTING STENT;DYSKINESIA;ESOPHAGITIS;FLUDARABINE;FUSION TRANSCRIPT;GASTROSCHISIS;GENE MUTATION;GENOME INSTABILITY;GENOTYPE-PHENOTYPE DISTINCTION;HEARTBURN;HYDROPS FETALIS;HYSTEROSALPINGOGRAPHY;IMATINIB MESYLATE;INDUCED PLURIPOTENT STEM CELL;LACTOBACILLUS RHAMNOSUS;LEISHMANIA DONOVANI;MEDIASTINAL LYMPH NODE;MICROSATELLITE;MOLECULAR CLONING;OMPHALOCELE;OXALIPLATIN;PITUITARY APOPLEXY;PLACENTA;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;RUNX1;SCLERAL BUCKLING;SINGLE-NUCLEOTIDE POLYMORPHISM;SKIN EQUIVALENT;SOX2;STEM CELL FACTOR;TARGET LESION;THORACIC AORTIC ANEURYSM;VIRAL ENCEPHALITIS","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;AGED;MIDDLE AGED;;TREATMENT OUTCOME;HEART FAILURE;YOUNG ADULT;ADOLESCENT;AGED, 80 AND OVER;ITALY;RETT SYNDROME;ACUTE KIDNEY INJURY;CHILD;ANTIBODIES, MONOCLONAL;BRAIN;CHILD, PRESCHOOL;KIDNEY DISEASES","58;39;33;26;26;24;13;12;11;11;10;10;10;10;9;9;8;8;8;8","CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GLIOMAS;HYPERGLYCEMIC CHOREA AND BASAL GANGLIA LESIONS;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;ACUTE MYELOID LEUKEMIA;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ANALYSIS OF CARDIAC AND RESPIRATORY SOUNDS;ANORECTAL SURGICAL PROCEDURES;ASTHMA;ATRIAL FIBRILLATION;CANCER IMMUNOTHERAPY;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS","3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;CARDIORENAL SYNDROME;IGHV@;RETT SYNDROME;UNIVARIATE ANALYSIS;HEART TRANSPLANT;INTUSSUSCEPTION;MECP2;ORBIT (DYNAMICS);REFRACTORY (PLANETARY SCIENCE);RENAL FUNCTION;RITUXIMAB;SALVAGE THERAPY;STROKE (ENGINE);3D ULTRASOUND;ADHESIVE BONDING;ADJUVANT RADIOTHERAPY;AIR TRAPPING;ALPHA (FINANCE);AML","4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CONSENSUS CONFERENCE;RETT SYNDROME;ADQI CONSENSUS;BOWEL ADENOCARCINOMA;CARDIO-RENAL SYNDROMES;CHRONIC LYMPHOCYTIC;IMMUNE THROMBOCYTOPENIA;LYMPHOCYTIC LEUKEMIA;MAGNETIC RESONANCE;PRIMARY IMMUNE;SYNDROME CLINICAL;AARSKOGSCOTT SYNDROME;ACTH CORTISOL;ACUTE DIALYSIS;ACUTE ISCHEMIC;ADULT PATIENTS;AML PATIENTS;ANATOMIC REPAIR;ANGIOPLASTY ARRHYTHMOLOGICAL;APPARENT DIFFUSION;ARRHYTHMOLOGICAL CONSIDERATIONS;ARTHRITIS LEFLUNOMIDE-ANTI-TNF-ALPHA;B-CELL SURVIVAL;BIOLOGIC FEATURES;BRAIN DYSFUNCTION;BRONCHODILATOR RESPONSE;CANCER TREATMENT;CARDIAC LYMPHOMA;CARDIORENAL SYNDROMES;CARE UNITS","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","STENT GRAFTS;STENT GRAFT;THORACIC STENT;AORTIC ANEURYSM;THORACIC AORTA;PUBMED SCOPUS;THORACIC ENDOVASCULAR;FALSE CHANNEL;AORTIC DISSECTION;SURG -ABSTRACT;SURGICAL TOOL;AORTIC REPAIR;ENDOVASCULAR AORTIC;SIENA COLLARED;AORTIC LESIONS;DESCENDING AORTA;MITRAL REGURGITATION;SIENA GRAFT;THORACOABDOMINAL AORTA;VASC SURG;VISCERAL ARTERIES;ANEURYSM REPAIR;COMPUTED TOMOGRAPHY;ENDOVASCULAR ANEURYSM;HAND OA;HYBRID ANATOMIC;INVOLVING VISCERAL;MOLECULAR ANALYSIS;TOMOGRAPHY SCAN;VISCERAL DEBRANCHING","24;23;21;13;13;11;11;10;9;9;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5",6,0.08,3,1,0,0,0,0,0,0,1,2,0,1,1,0,2.5,0,0,1,0,0,0,74.25,74.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,5.27,579.45,8.96,1,0.08,46.75,0,0,4,0,3,0,2,3,0,8,3,0,0,0,0,0,0,12,0,0,11,1,0,0,0,0,0,0,0,0,"United States","5","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3204 IMMUNOLOGY;3215 REPRODUCTIVE MEDICINE;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS","12;5;4;4;2;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;AGING;LUNG;LYMPHOMA;PATIENT SAFETY;ARTHRITIS;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;COST EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;IMMUNIZATION","9;8;6;6;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;MUSCULOSKELETAL;RESPIRATORY","4;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","9;2;2;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;HODGKIN'S DISEASE;LIVER CANCER;LUNG CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","3;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.2 SURVEILLANCE","6;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;46 INFORMATION AND COMPUTING SCIENCES","1;1;1",NA,NA,"INFECTION","1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SENESE",2011,89,9.70786516853933,2.42696629213483,0.48314606741573,0.415730337078652,0.539325842696629,1.5,1.22857142857143,1.27586206896552,1.26315789473684,0.471910112359551,2,37,25,12,6,0.42,0.28,0.13,0.07,46.79,1.09997181515651,NA,0.337078651685393,0.842696629213483,0.438,0.389,0.403,0.401,"ALFONSO CERASE;JOUSSEF HAYEK;CARLO VENTURI;CLAUDIO DE FELICE;LUCIA MONTI;SILVIA LEONCINI;GIAN MARÍA ROSSOLINI;CINZIA SIGNORINI;GIUSEPPE VALACCHI;PAOLA PIOMBONI;LUCIA CICCOLI;VINCENZO DE LEO;ALESSANDRA PECORELLI;PAOLO GALLUZZI;ALESSANDRO GOZZETTI;SARA LEONINI;ALESSANDRA RENIERI;VALERIO ZACÀ;CARLO SASSI;RANUCCIO NUTI","12;8;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3","ALFONSO CERASE;ALBERTO PALAZZUOLI;VINCENZO DE LEO;ANDREA S. MELANI;GIUSEPPE MORGANTE;CLAUDIO DE FELICE;CARLO VENTURI;JOUSSEF HAYEK;PAOLA PIOMBONI;LUCIA MONTI;ALESSANDRO GOZZETTI;SARA LEONINI;S ULIVIERI;GIAN MARÍA ROSSOLINI;SIMONETTA GIANNI;PAOLO MICHELE OLIA;GIUSEPPE OLIVERI;SILVIA LEONCINI;CINZIA SIGNORINI;GIUSEPPE VALACCHI","1.82;1.18;1.12;1.09;0.82;0.79;0.76;0.75;0.73;0.66;0.65;0.63;0.59;0.59;0.5;0.5;0.49;0.46;0.46;0.46","ALFONSO CERASE;JOUSSEF HAYEK;CARLO VENTURI;CLAUDIO DE FELICE;LUCIA MONTI;GIAN MARÍA ROSSOLINI;PAOLA PIOMBONI;VINCENZO DE LEO;PAOLO GALLUZZI;ALESSANDRO GOZZETTI;SARA LEONINI;ALESSANDRA RENIERI;VALERIO ZACÀ;CARLO SASSI;S ULIVIERI;MARIA ANTONIETTA MENCARELLI;MASSIMO FINESCHI;SERGIO MONDILLO;FRANCESCA MARI;ALBERTO PALAZZUOLI","12;8;6;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3","ALFONSO CERASE;ALBERTO PALAZZUOLI;VINCENZO DE LEO;ANDREA S. MELANI;GIUSEPPE MORGANTE;CLAUDIO DE FELICE;CARLO VENTURI;JOUSSEF HAYEK;PAOLA PIOMBONI;LUCIA MONTI;ALESSANDRO GOZZETTI;SARA LEONINI;S ULIVIERI;GIAN MARÍA ROSSOLINI;SIMONETTA GIANNI;PAOLO MICHELE OLIA;GIUSEPPE OLIVERI;STEFANO TONINELLI;VALERIO ZACÀ;PAOLO GALLUZZI","1.82;1.18;1.12;1.09;0.82;0.79;0.76;0.75;0.73;0.66;0.65;0.63;0.59;0.59;0.5;0.5;0.49;0.45;0.44;0.44","ANDREA S. MELANI;CRISTINA CINTI;MARCO BONAVIA;MARCO LODI;MARGHERITA NERI;MARIA ALIANI;MARIA SERRA;NICOLA SCICHILONE;PAOLA MARTUCCI;PIERSANTE SESTINI;VINCENZO CILENTI;JOUSSEF HAYEK;SÍMONE ROSSI;CLAUDIO DE FELICE;CINZIA SIGNORINI;GIUSEPPE VALACCHI;LUCIA CICCOLI;SILVIA LEONCINI;FURIO PACINI;ALESSANDRA RENIERI","867;853;853;853;853;853;853;853;853;853;853;425;374;338;320;320;320;320;290;283","ANDREA S. MELANI;SÍMONE ROSSI;CLAUDIO DE FELICE;ALESSANDRA RENIERI;PAOLO GALLUZZI;GABRIELE CEVENINI;ALFONSO CERASE;ALESSANDRO ROSSI;EMILIANO SANTARNECCHI;GIOVANNI BIANCO;MASSIMILIANO DEL TESTA;MATTEO FEURRA;JOUSSEF HAYEK;ELISA SOZZI;FRANCESCO FORCONI;GIAN MARÍA ROSSOLINI;VINCENZO DE LEO;PAOLA PIOMBONI;CARLO VENTURI;PIERPAOLO CORREALE","867;374;338;283;266;256;249;225;225;225;225;225;198;175;175;153;138;137;127;121","ALFONSO CERASE;CARLO VENTURI;CLAUDIO DE FELICE;JOUSSEF HAYEK;LUCIA MONTI;ALESSANDRA RENIERI;GIAN MARÍA ROSSOLINI;PAOLO GALLUZZI;VINCENZO DE LEO;MASSIMO FINESCHI;VALERIO ZACÀ;CARLO PIERLI;CARLO SASSI;GIUSEPPE MORGANTE;PAOLA PIOMBONI;SÍMONE ROSSI;S ULIVIERI;ANDREA DE LUCA;ANDREA S. MELANI;ANNA BRAFA","10;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;MATERIALS SCIENCE;ENGINEERING;SOCIOLOGY;GEOGRAPHY;PHILOSOPHY;POLITICAL SCIENCE","79;30;12;12;6;6;6;5;4;2;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;RADIOLOGY;PATHOLOGY;CARDIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;ENDOCRINOLOGY;OPTICS;PEDIATRICS;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;MICROBIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;ONCOLOGY;ORGANIC CHEMISTRY;STATISTICS","49;23;20;17;14;13;10;10;10;9;8;6;6;5;5;5;5;5;5;5;5","GENE;MAGNETIC RESONANCE IMAGING;CANCER;HEART FAILURE;MYOCARDIAL INFARCTION;PREGNANCY;DISEASE;POPULATION;REGIMEN;BACTERIA;INCIDENCE (GEOMETRY);ANTIBIOTICS;BLOOD PRESSURE;CHEMOTHERAPY;COMPLICATION;CORONARY ARTERY DISEASE;HORMONE;IMMUNE SYSTEM;LESION;LEUKEMIA;LYMPHOMA;NEUROLOGY;OXIDATIVE STRESS;PRESENTATION (OBSTETRICS);SPERM;SPINAL CORD;STENT;STIMULATION","19;9;7;7;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PHENOTYPE;RETT SYNDROME;MUTATION;CLONE (JAVA METHOD);DIFFUSION MRI;EJECTION FRACTION;GENOTYPE;NEURORADIOLOGY;PSEUDOMONAS AERUGINOSA;AORTIC DISSECTION;BRAIN NATRIURETIC PEPTIDE;CARBAPENEM;CHROMOSOME;COLORECTAL CANCER;DIASTOLE;ESCHERICHIA COLI;GESTATION;HAIRY CELL LEUKEMIA;HUMAN GENETICS;INFERTILITY;INSULIN RESISTANCE;NATRIURETIC PEPTIDE;PERCUTANEOUS CORONARY INTERVENTION;POLYUNSATURATED FATTY ACID;ST ELEVATION;THYROID CANCER;TRANSCRANIAL MAGNETIC STIMULATION;VIRAL LOAD;WHITE MATTER","5;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACINETOBACTER BAUMANNII;ANTIRETROVIRAL THERAPY;KARYOTYPE;MECP2;MISSENSE MUTATION;POLYCYSTIC OVARY;SANGER SEQUENCING;ADENOSINE DEAMINASE DEFICIENCY;ADENOSINE RECEPTOR;ADULT STEM CELL;ALPHA (FINANCE);ALPORT SYNDROME;ANEUPLOIDY;ANTIBACTERIAL PEPTIDE;APGAR SCORE;AUTOSOME;BECLOMETASONE DIPROPIONATE;CARDIAC RESYNCHRONIZATION THERAPY;CHEMOKINE RECEPTOR;CRITICAL LIMB ISCHEMIA;CROSSOVER STUDY;DIASTOLIC FUNCTION;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;DOCOSAHEXAENOIC ACID;DRY-POWDER INHALER;ERLOTINIB;EXTRAMEDULLARY HEMATOPOIESIS;FLUDARABINE;FOLLICULAR FLUID;FRACTIONAL ANISOTROPY;FRAMESHIFT MUTATION;GASTROINTESTINAL CANCER;GESTATIONAL DIABETES;GESTATIONAL HYPERTENSION;GLOBUS PALLIDUS;HAPLOINSUFFICIENCY;IMATINIB MESYLATE;INDUCED PLURIPOTENT STEM CELL;INTERNATIONAL PROGNOSTIC INDEX;INTRACYTOPLASMIC SPERM INJECTION;INTRAUTERINE GROWTH RESTRICTION;IPRATROPIUM;IPRATROPIUM BROMIDE;KLEBSIELLA PNEUMONIAE;LEFT ATRIAL MYXOMA;LEISHMANIA INFANTUM;MALE INFERTILITY;MICAFUNGIN;MOLECULAR EPIDEMIOLOGY;MULTILOCUS SEQUENCE TYPING;NALIDIXIC ACID;NON-SMALL CELL LUNG CANCER (NSCLC);ORAL ANTICOAGULANT;OVULATION INDUCTION;PAPILLARY THYROID CANCER;PRIMARY MOTOR CORTEX;PROTHROMBIN COMPLEX CONCENTRATE;PULSED-FIELD GEL ELECTROPHORESIS;PURINE ANALOGUE;RADIOIMMUNOTHERAPY;RESPIRATORY RATE;SPECKLE TRACKING ECHOCARDIOGRAPHY;THORACIC AORTIC ANEURYSM;THORACIC VERTEBRAE;TIMI;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;TUMOR-INFILTRATING LYMPHOCYTES;V600E;WERNICKE'S ENCEPHALOPATHY","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;RETT SYNDROME;;CHILD;ADOLESCENT;YOUNG ADULT;BIOMARKERS;BRAIN NEOPLASMS;ADENOCARCINOMA;CHILD, PRESCHOOL;ITALY;TREATMENT OUTCOME;BETA-LACTAMASES;BRAIN;RETROSPECTIVE STUDIES","69;49;41;30;26;23;19;18;16;13;12;11;11;10;10;10;10;9;9;9","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;NEURONAL OSCILLATIONS IN CORTICAL NETWORKS;PULMONARY DRUG DELIVERY TECHNIQUES;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN LUNG CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;ATRIAL FIBRILLATION;AUTOMATED ANALYSIS OF BLOOD CELL IMAGES;BIOLOGICAL EFFECTS OF ELECTROMAGNETIC FIELDS;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CANCER IMMUNOTHERAPY","7;4;4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","RETT SYNDROME;REGIMEN;AORTIC DISSECTION;CLONE (JAVA METHOD);NEURORADIOLOGY;PERFUSION IMAGING;PRESENTATION (OBSTETRICS);TYPE B AORTIC DISSECTION;ACINETOBACTER BAUMANNII;ANTIMICROBIAL RESISTANCE GENES;B-TYPE NATRIURETIC PEPTIDE;BRAIN NATRIURETIC PEPTIDE;CARBAPENEM;CARDIAC IMAGING;CARDIOTHORACIC SURGERY;DIFFUSION MRI;ECHOCARDIOGRAPHY;ENDOVASCULAR REPAIR;HIV;HUMAN GENETICS","6;5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","RETT SYNDROME;B-TYPE NATRIURETIC;CANCER PATIENTS;CARDIAC STRUCTURE;CORONARY DISEASE;CORONARY SYNDROMES;ELEVATION CORONARY;HYDROGEN PEROXIDE;LEFT ATRIAL;MULTICENTRIC STUDY;NATRIURETIC PEPTIDE;NON-ST ELEVATION;OXIDATIVE DAMAGE;SPINAL CORD;SPINE SURGERY;SYSTOLIC FUNCTION;THORACIC ENDOVASCULAR;THYROID CANCER;WOUND IRRIGATION;AARSKOGSCOTT SYNDROME;ACINETOBACTER BAUMANNII;ACROSOME REACTION;ADA-DEFICIENT SCID;ADENOSINE METABOLISM;ADENOSINERGIC MACHINERY;ADVANCED COLORECTAL;ADVANCED NON-SMALL-CELL-LUNG;AEROSOL PERFORMANCE;AERUGINOSA INFECTION;ALPHA RHYTHMS","6;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;RETT SYNDROME;HIV RNA;MONTHS CI;SIENA ITALYSEARCH;TYPICAL RTT;BNP LEVELS;CARBAPENEMASE ACTIVITY;HEALTHY CONTROLS;ION MZ;PRECURSOR ION;SIENA SIENA;TRANSPLANTS UNIVERSITY;RTT PATIENTS;TUMOR INFILTRATION;UCN MRNA;ALESSANDRO GOZZETTI;ALLE SCOTTE;AZIENDA OSPEDALIERA;F-DIHOMO-ISOP LEVELS;GALANO J-M;HEAD COIL;HEART SURGERY;MARIA ALLE;MATIC CUBE;MONTH HIV;MRNA EXPRESSION;OSPEDALIERA UNIVERSITARIA;PRODUCT IONS","31;27;14;12;9;8;8;7;7;7;7;7;7;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5",18,0.2,5.31,2,4,1,0,5.5,2,0,3.25,2,0,1,2,0,1,1,1,1,1.5,0,0,81.75,81.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,5.89,292.7,8.7,3,0.25,54.42,1,1,2,0,6,0,0,2,0,8,2,0,0,0,0,0,0,12,0,0,10,2,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","11;7;3;3;1;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;LYMPHOMA;LUNG;PATIENT SAFETY;AGING;ARTHRITIS;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CARDIOVASCULAR;DIGESTIVE DISEASES;HEALTH SERVICES;HEART DISEASE;LUNG CANCER;NEUROBLASTOMA;NEUROSCIENCES","10;7;7;6;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","6;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;3.4 VACCINES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS","9;4;1;1;1;1","NON-HODGKIN'S LYMPHOMA;LUNG CANCER;NEUROBLASTOMA;STOMACH CANCER","4;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","5",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PUBLIC LIBRARY OF SCIENCE","5","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;37 EARTH SCIENCES;3705 GEOLOGY;48 LAW AND LEGAL STUDIES;4804 LAW IN CONTEXT;51 PHYSICAL SCIENCES","6;2;2;2;1;1;1;1","CLINICAL RESEARCH;HIV/AIDS;INFECTIOUS DISEASES","1;1;1","INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","BIOMEDICAL","1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","1;1","NOT SITE-SPECIFIC CANCER","1",NA,NA
"AOU_SENESE",2012,117,11.0598290598291,2.65811965811966,0.418803418803419,0.35042735042735,0.606837606837607,1.5024154589372,1.16666666666667,1.46428571428571,1.26785714285714,0.521367521367521,4,58,23,18,7,0.5,0.2,0.15,0.06,34.91,0.83570444095792,4.54430379746835,0.358974358974359,0.88034188034188,0.444,0.317,0.395,0.363,"ALESSANDRA RENIERI;ALFONSO CERASE;JOUSSEF HAYEK;GIAN MARÍA ROSSOLINI;PAOLO A. ASCIERTO;SÍMONE ROSSI;MICHELE MAIO;THEODORA HADJISTILIANOU;GIUSEPPE MARTINI;SIMONA NANNI;LUCIA PALLECCHI;PAOLO GALLUZZI;M. VASCOTTO;MARCO R. OGGIONI;PAOLO BALESTRI;ALESSANDRO TESTORI;ALESSANDRA TUCCIO;FRANCESCA MARI;G. BODDI;GIANNI POZZI","9;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4","FURIO PACINI;GIUSEPPE BUONOCORE;SÍMONE ROSSI;LUIGI MECCARIELLO;ALFONSO CERASE;ALESSANDRA RENIERI;MATTEO FEURRA;JOUSSEF HAYEK;SIMONA NANNI;M. VASCOTTO;PAOLO BALESTRI;ALESSANDRA TUCCIO;G. BODDI;GIAN MARÍA ROSSOLINI;MARCO R. OGGIONI;GIANNI POZZI;GIOVANNI BIANCO;MASSIMO FINESCHI;THEODORA HADJISTILIANOU;F. NATRELLA","2.16;1.06;1.01;1;0.9;0.7;0.66;0.64;0.58;0.58;0.58;0.58;0.58;0.55;0.53;0.53;0.52;0.52;0.5;0.5","ALESSANDRA RENIERI;ALFONSO CERASE;JOUSSEF HAYEK;GIAN MARÍA ROSSOLINI;SÍMONE ROSSI;MICHELE MAIO;THEODORA HADJISTILIANOU;GIUSEPPE MARTINI;SIMONA NANNI;PAOLO GALLUZZI;M. VASCOTTO;MARCO R. OGGIONI;PAOLO BALESTRI;ALESSANDRA TUCCIO;FRANCESCA MARI;G. BODDI;GIANNI POZZI;MARIA ANTONIETTA MAZZEI;FURIO PACINI;ROSSANA TASSI","9;7;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","FURIO PACINI;GIUSEPPE BUONOCORE;SÍMONE ROSSI;LUIGI MECCARIELLO;ALFONSO CERASE;ALESSANDRA RENIERI;MATTEO FEURRA;JOUSSEF HAYEK;SIMONA NANNI;M. VASCOTTO;PAOLO BALESTRI;ALESSANDRA TUCCIO;G. BODDI;GIAN MARÍA ROSSOLINI;MARCO R. OGGIONI;GIANNI POZZI;GIOVANNI BIANCO;MASSIMO FINESCHI;THEODORA HADJISTILIANOU;F. NATRELLA","2.16;1.06;1.01;1;0.9;0.7;0.66;0.64;0.58;0.58;0.58;0.58;0.58;0.55;0.53;0.53;0.52;0.52;0.5;0.5","PAOLO A. ASCIERTO;ESTER FONSATTI;AMELIA LISSIA;ANTONELLA MANCA;ANTONIO COSSU;CORRADO CARACÒ;CORRADO RUBINO;DANIELA MASSI;ELENA PAGANI;GERARDO BOTTI;GIUSEPPE PALMIERI;MARIA COLOMBINO;MARIA CRISTINA SINI;MARIAELENA CAPONE;MILENA CASULA;NICOLA MOZZILLO;OSCAR NAPPI;RENATO FRANCO;STEFANIA STAIBANO;VINCENZO DE GIORGI","750;713;437;437;437;437;437;437;437;437;437;437;437;437;437;437;437;437;437;437","ANTONELLA MANCA;GIUSEPPE PALMIERI;MARIA CRISTINA SINI;MILENA CASULA;ANTIOCO SANNA;LUCIA MONTI;MICHELE MAIO;GIAN MARÍA ROSSOLINI;ANNA MARIA DI GIACOMO;ESTER FONSATTI;DIEGO ANNESI;MARCO R. OGGIONI;JOUSSEF HAYEK;ELENA BARGAGLI;FABRIZIO MEZZASALMA;PAOLA ROTTOLI;GIANNI POZZI;L. DI COSMO;ALFONSO CERASE;SÍMONE ROSSI","435;435;435;435;387;387;339;321;307;278;276;227;222;200;200;200;193;183;155;152","ALFONSO CERASE;SÍMONE ROSSI;GIAN MARÍA ROSSOLINI;ALESSANDRA RENIERI;MICHELE MAIO;JOUSSEF HAYEK;GIUSEPPE MARTINI;MARCO R. OGGIONI;FELICE PETRAGLIA;FURIO PACINI;PAOLO GALLUZZI;ROSSANA TASSI;ANNA MARIA DI GIACOMO;CLAUDIO DE FELICE;GIANNI POZZI;THEODORA HADJISTILIANOU;GIOVANNI BIANCO;MASSIMO MACCHERINI;ALBERTO FABBRI;ALESSANDRA VELLA","7;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;ECONOMICS;MATERIALS SCIENCE;MATHEMATICS;SOCIOLOGY;GEOGRAPHY;HISTORY","102;41;14;12;9;9;8;4;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;BIOCHEMISTRY;RADIOLOGY;ONCOLOGY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;MICROBIOLOGY;NEUROSCIENCE;PEDIATRICS;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;PHYSICAL THERAPY;PSYCHIATRY;ANATOMY;CARDIOLOGY;IMMUNOLOGY","70;31;28;25;19;15;14;12;11;11;11;10;8;8;8;8;8;7;7;6","GENE;CANCER;DISEASE;CLINICAL TRIAL;ALTERNATIVE MEDICINE;CHEMOTHERAPY;POPULATION;MAGNETIC RESONANCE IMAGING;MELANOMA;ASYMPTOMATIC;BACTERIA;INCIDENCE (GEOMETRY);OBSERVATIONAL STUDY;PREGNANCY;RECEPTOR;ASTHMA;BIOPSY;COHORT;HEART FAILURE;IMMUNE SYSTEM;LYMPHOMA;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;STENOSIS;STIMULATION;STROKE (ENGINE);SUBCLINICAL INFECTION;TRANSPLANTATION","28;19;11;9;8;8;8;7;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;IMMUNOTHERAPY;ESCHERICHIA COLI;RETT SYNDROME;THYROID CANCER;PHASES OF CLINICAL RESEARCH;RETINOBLASTOMA;TRANSCRANIAL MAGNETIC STIMULATION;BRONCHODILATOR;GENOTYPE;KIDNEY TRANSPLANTATION;MUTATION;PHENOTYPE;PLACEBO;VIRULENCE;ANTIBIOTIC RESISTANCE;AORTIC VALVE REPLACEMENT;BIOFILM;BIRTH WEIGHT;BRONCHOSPASM;CIPROFLOXACIN;COELIAC DISEASE;DIFFUSION MRI;EFFECTIVE DIFFUSION COEFFICIENT;EJECTION FRACTION;EXON;FETUS;GENE EXPRESSION;GENOME;GHRELIN;HEART TRANSPLANTATION;INHALER;ISCHEMIC STROKE;LENALIDOMIDE;LIPID PEROXIDATION;MOTOR CORTEX;MUTANT;OSTEOARTHRITIS;PARKINSONISM;QUINOLONE;RNA;SEROLOGY;SPIROMETRY;STAPHYLOCOCCUS AUREUS;THROMBOLYSIS;THYROID NODULES;TRANSCRIPTION FACTOR;VIABILITY ASSAY;WHEEZE;WHITE MATTER","7;6;5;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","IPILIMUMAB;MECP2;KRAS;LENVATINIB;MEDULLARY THYROID CANCER;MODIFIED RANKIN SCALE;NALIDIXIC ACID;4-HYDROXYNONENAL;ABDOMINOPERINEAL RESECTION;AMPK;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA;ANTIRETROVIRAL THERAPY;ATG8;ATP-BINDING CASSETTE TRANSPORTER;AUTOPHAGOSOME;BAG3;BELL'S PALSY;CAGA;CARBOPLATIN;CELL FATE DETERMINATION;CELLOBIOSE;CHEMOKINE RECEPTOR;CHROMOSOME INSTABILITY;CLADE;COPY-NUMBER VARIATION;CORTICOBASAL DEGENERATION;CROSSOVER STUDY;DEMENTIA WITH LEWY BODIES;DIFFUSING CAPACITY;DNA GYRASE;DNA METHYLATION;DOPAMINE TRANSPORTER;DRY-POWDER INHALER;ELDER ABUSE;ENDOVASCULAR ANEURYSM REPAIR;ENTEROBACTERIACEAE;EXTRACORPOREAL PHOTOPHERESIS;FLUORESCENCE IN SITU HYBRIDIZATION;GENICULATE GANGLION;GENOMICS;GENOTYPING;GLYCOBIOLOGY;IGHV@;IMIPENEM;INJURY SEVERITY SCORE;INTERNAL ANAL SPHINCTER;KIDNEY TRANSPLANT;KLEBSIELLA PNEUMONIAE;KNEE SURGERY;LIPID-ANCHORED PROTEIN;METAPLASTICITY;METERED-DOSE INHALER;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROARRAY;MOLECULAR EPIDEMIOLOGY;MOTOR IMAGERY;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPLEX POLYMERASE CHAIN REACTION;MUTATION TESTING;NPC1;OBESTATIN;OLIGOMER RESTRICTION;OPERON;PAPILLARY THYROID CANCER;PAZOPANIB;PEP GROUP TRANSLOCATION;PERMEASE;PHARMACOGENETICS;PLACENTA;POMALIDOMIDE;PRIMARY MOTOR CORTEX;PRIMARY TUMOR;PROTEIN PHOSPHORYLATION;RAMSAY HUNT SYNDROME;RESPONSE REGULATOR;RNA INTERFERENCE;RNA SPLICING;SEMEN ANALYSIS;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;STAPHYLOCOCCUS EPIDERMIDIS;STREPTOCOCCUS GORDONII;STREPTOCOCCUS MITIS;SYMPORTER;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;TRANSCRIPTIONAL REGULATION;TUMOR-INFILTRATING LYMPHOCYTES;V600E;X-INACTIVATION;XQ28","5;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;ANTI-BACTERIAL AGENTS;RETINOBLASTOMA;ESCHERICHIA COLI;ITALY;MELANOMA;RETINAL NEOPLASMS;RETT SYNDROME;SKIN NEOPLASMS;TREATMENT OUTCOME;CHILD;HEART VALVE PROSTHESIS IMPLANTATION;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ESCHERICHIA COLI INFECTIONS","75;54;47;39;33;28;28;17;15;13;13;13;13;13;13;13;12;12;11;10","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;OCULAR CANCER RESEARCH AND TREATMENT;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;LYMPHOID NEOPLASMS;MAMMALIAN MAP KINASE SIGNALING PATHWAYS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MELANOMA;ORGAN TRANSPLANTATION AND REJECTION;ASTHMA;CANCER IMMUNOTHERAPY;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;DIAGNOSIS, TREATMENT, AND EPIDEMIOLOGY OF NONTUBERCULOUS MYCOBACTERIAL DISEASES;MANAGEMENT OF VALVULAR HEART DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;PULMONARY DRUG DELIVERY TECHNIQUES","6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MELANOMA;RETINOBLASTOMA;RETT SYNDROME;DIAGNOSIS;MEDULLARY THYROID CANCER;SUBCLINICAL INFECTION;EVEROLIMUS;MECP2;PROSTHETIC VALVES EVALUATION;STROKE (ENGINE);TOTAL KNEE REPLACEMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ANTIMICROBIAL RESISTANCE;ASTHMA;BRAF GENE;COUGH REFLEX SENSITIVITY;DIFFERENTIATED THYROID CANCER;DRY POWDER INHALERS;EXPANDED ACCESS;EXTRACORPOREAL","6;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","RETT SYNDROME;PRELIMINARY RESULTS;ADVANCED MELANOMA;EVEROLIMUS REGISTRY;ITALIAN EVEROLIMUS;PHASE II;REGISTRY CERTIC;THYROID CANCER;ADVANCED MEDULLARY;AORTIC VALVE;ASTHMA MANAGEMENT;CANCER MTC;CHILDREN CLINICAL;CLINICAL PRACTICE;CLINICAL UTILITY;COELIAC DISEASE;COLORECTAL CANCER;CORTICOSPINAL EXCITABILITY;DISEASE DIAGNOSIS;ELECTROMAGNETIC FIELDS;ENDOCRINOLOGY RESEARCH;HEART TRANSPLANT;II TRIAL;INHIBITOR LENVATINIB;INTERRUPTER RESISTANCE;IPILIMUMAB IPI;KINASE INHIBITOR;KNEE ARTHROPLASTY;MEDULLARY THYROID;MELANOMA MM","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TRANSPLANT RECIPIENTS;RENAL FUNCTION;DE NOVO;PHASE III;SURVIVAL RATES;EFFECTIVE DOSE;HEART TRANSPLANT;BRISTOL-MYERS SQUIBB;SURVIVAL RATE;YR SURVIVAL;CLINICAL TRIALS;DOPPLER RI;KIDNEY TRANSPLANT;LONG-TERM SURVIVAL;NEWLY DIAGNOSED;POPLITEUS TENDON;STUDY ENTRY;SURVIVAL BENEFIT;THYROID CANCER;TYPICAL SYMPTOMS;ADVERSE EVENTS;CLINICAL PRACTICE;DISEASE PROGRESSION;HEMORRHAGIC SHOCK;NEURAL DIFFERENTIATION;NUTRITIONAL RISK;QUINOLONE RESISTANCE;STOCK OWNERSHIP;SUBSTRATE SPECIFICITY;ABSTRACT PURPOSE","12;10;9;9;9;8;8;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4",24,0.21,3.71,4.25,2.5,1,0,1,4,0,1,5.25,0,1,3,0,2.5,1,1,3,1.25,0,0,98,98,1,0,0,1,0,0,0,0,1,0,0,0,2,0,0,21,2,1.29,3,0,2,2,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"MAIO MICHELE;SIGALOTTI LUCA","2;2","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;CENTRO DI RIFERIMENTO ONCOLOGICO - ISTITUTO NAZIONALE TUMORI - AVIANO;CT DI RIFERIMENTO ONCOLOGICO ISTITUTO NAZ TUMORI AVIANO;MAIO MICHELE;SIGALOTTI LUCA","2;1;1;1;1","31 BIOLOGICAL SCIENCES;3105 GENETICS","4;2","CANCER;GENETICS;PATIENT SAFETY","2;2;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2","C12Q1/68","2","C12N15/1072;C12Q1/6886;C12Q2600/112;C12Q2600/118;C12Q2600/154;C12Q2600/158","2;2;2;2;2;2",19,4.88,302,9.84,7,0.37,43.95,0,0,9,0,5,0,0,5,0,13,4,0,0,0,0,0,0,18,1,0,17,2,0,0,0,0,0,0,0,0,"United States;Italy","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3212 OPHTHALMOLOGY AND OPTOMETRY;3215 REPRODUCTIVE MEDICINE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","18;8;7;5;3;2;2;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;LYMPHOMA;PEDIATRIC;BIOMEDICAL IMAGING;IMMUNIZATION;LUNG;STEM CELL RESEARCH;VACCINE RELATED;AGING;BIOTECHNOLOGY;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;DEPRESSION;EMERGENCY CARE;HODGKIN'S DISEASE;LUNG CANCER","17;12;9;9;8;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER","10","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.4 POPULATION SCREENING;5.2 CELLULAR AND GENE THERAPIES","14;5;3;2;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;MELANOMA;HODGKIN'S DISEASE;LUNG CANCER;MYELOMA;RETINOBLASTOMA","5;3;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","11;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,"PUBLIC LIBRARY OF SCIENCE","33","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;40 ENGINEERING;44 HUMAN SOCIETY;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;4905 STATISTICS;51 PHYSICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;4405 GENDER STUDIES;46 INFORMATION AND COMPUTING SCIENCES;4613 THEORY OF COMPUTATION;47 LANGUAGE, COMMUNICATION AND CULTURE;48 LAW AND LEGAL STUDIES;3104 EVOLUTIONARY BIOLOGY;3106 INDUSTRIAL BIOTECHNOLOGY;3204 IMMUNOLOGY","21;18;8;7;5;4;4;3;3;3;2;2;2;2;2;2;2;1;1;1","INFECTIOUS DISEASES;LUNG;PNEUMONIA;ANTIMICROBIAL RESISTANCE;GENETICS;HIV/AIDS;PNEUMONIA & INFLUENZA;BIOTECHNOLOGY;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HUMAN GENOME;PREVENTION","6;3;3;2;2;2;2;1;1;1;1;1","INFECTION;GENERIC HEALTH RELEVANCE","5;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY);5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1;1;1;1","CLINICAL;POPULATION & SOCIETY","2;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","4;1;1","NOT SITE-SPECIFIC CANCER","1","16 PEACE, JUSTICE AND STRONG INSTITUTIONS","1"
"AOU_SENESE",2013,115,11.3130434782609,2.99130434782609,0.373913043478261,0.426086956521739,0.6,1.47008547008547,1.13157894736842,1.225,1.16949152542373,0.51304347826087,0,56,28,16,4,0.49,0.24,0.14,0.03,35.79,1.02575734014769,4.5530612244898,0.304347826086957,0.895652173913044,0.373,0.438,0.435,0.43,"ALFONSO CERASE;CLAUDIO DE FELICE;JOUSSEF HAYEK;ALESSANDRA RENIERI;ALESSANDRA PECORELLI;SILVIA LEONCINI;CINZIA SIGNORINI;LUCIA CICCOLI;GIUSEPPE VALACCHI;SÍMONE ROSSI;EMMA CERIALE;SERGIO MONDILLO;GABRIELE MESSINA;FRANCESCA MARI;PIETRO MANZI;TOMMASO BOCCI;ALBERTO PRIORI;D LENZI;ROSSANA TASSI;FLAVIO D’ASCENZI","10;9;9;8;7;7;7;7;6;6;5;5;5;5;5;5;5;5;5;4","ALFONSO CERASE;CLAUDIO DE FELICE;SÍMONE ROSSI;TOMMASO BOCCI;ALBERTO PRIORI;EMMA CERIALE;GABRIELE MESSINA;PIETRO MANZI;D LENZI;SERGIO MONDILLO;ROSSANA TASSI;JOUSSEF HAYEK;MARIA RAFFAELLA AMBROSIO;SANDRA BURGASSI;FRANCESCA GUIDERI;SANDRA BRACCO;ALESSANDRA RUFA;FLAVIO D’ASCENZI;CARLO PIERLI;ALESSANDRA PECORELLI","1.51;0.92;0.79;0.74;0.74;0.69;0.69;0.69;0.69;0.66;0.64;0.64;0.58;0.57;0.55;0.55;0.54;0.53;0.53;0.53","ALFONSO CERASE;CLAUDIO DE FELICE;JOUSSEF HAYEK;ALESSANDRA RENIERI;ALESSANDRA PECORELLI;SILVIA LEONCINI;SÍMONE ROSSI;SERGIO MONDILLO;FRANCESCA MARI;PIETRO MANZI;TOMMASO BOCCI;D LENZI;ROSSANA TASSI;FLAVIO D’ASCENZI;ALESSIO CORTELAZZO;FRANCESCA GUIDERI;SANDRA BRACCO;CARLO PIERLI;MAURIZIO ACAMPA;GIUSEPPE MARTINI","10;9;9;8;7;7;6;5;5;5;5;5;5;4;4;4;4;4;4;4","ALFONSO CERASE;CLAUDIO DE FELICE;SÍMONE ROSSI;TOMMASO BOCCI;PIETRO MANZI;D LENZI;SERGIO MONDILLO;ROSSANA TASSI;JOUSSEF HAYEK;MARIA RAFFAELLA AMBROSIO;FRANCESCA GUIDERI;SANDRA BRACCO;FLAVIO D’ASCENZI;CARLO PIERLI;ALESSANDRA PECORELLI;SILVIA LEONCINI;ALESSANDRA RENIERI;GIUSEPPE MARTINI;MAURIZIO ACAMPA;MASSIMO FINESCHI","1.51;0.92;0.79;0.74;0.69;0.69;0.66;0.64;0.64;0.58;0.55;0.55;0.53;0.53;0.53;0.53;0.5;0.47;0.46;0.43","MICHELE MAIO;PAUL LORIGAN;ANTONI RIBAS;AXEL HAUSCHILD;BO HUANG;BRIGITTE DRÉNO;CLAUS GARBE;CORNELIS J.A. PUNT;DMITRI PAVLOV;GERALD P. LINETTE;GRANT A. MCARTHUR;HELEN GOGAS;JACEK MACKIEWICZ;JACOB SCHACHTER;JESÚS GÓMEZ-NAVARRO;JOHN B.A.G. HAANEN;JOHN M. KIRKWOOD;KARI KENDRA;MARGARET MARSHALL;MARIBEL MÁRMOL","759;759;752;752;752;752;752;752;752;752;752;752;752;752;752;752;752;752;752;752","MICHELE MAIO;ALESSANDRA RENIERI;CLAUDIO DE FELICE;FRANCESCA MARI;SÍMONE ROSSI;MATTEO FEURRA;ALFONSO CERASE;SIMONE GROTTI;ANNABELLA MAROZZA;ROSSELLA VIVARELLI;CARLA VINDIGNI;ALESSANDRO ROSSI;EMILIANO SANTARNECCHI;GIOVANNI BIANCO;BEATRIZ CARVALHO;CARLA OLIVEÍRA;DANIELE MARRELLI;FRANCO ROVIELLO;GIOVANNI CORSO;JOANA CARVALHO","759;485;424;421;341;284;275;234;215;207;177;172;172;172;161;161;161;161;161;161","ALFONSO CERASE;ALESSANDRA RENIERI;CLAUDIO DE FELICE;SÍMONE ROSSI;D LENZI;FRANCESCA MARI;PIETRO MANZI;ROSSANA TASSI;CARLO PIERLI;GIUSEPPE MARTINI;MAURIZIO ACAMPA;SANDRA BRACCO;TOMMASO BOCCI;ALESSANDRO GOZZETTI;BRUNO FREDIANI;FRANCESCA GUIDERI;JOUSSEF HAYEK;MATTEO FEURRA;MICHELE MAIO;SERGIO MONDILLO","9;8;8;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;ENGINEERING;PHYSICS;ECONOMICS;COMPUTER SCIENCE;MATHEMATICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;BUSINESS;HISTORY;PHILOSOPHY","107;39;15;9;9;9;5;4;3;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;GENETICS;IMMUNOLOGY;CARDIOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;ONCOLOGY;NEUROSCIENCE;PSYCHIATRY;ENDOCRINOLOGY;PHYSICAL THERAPY;ENVIRONMENTAL HEALTH;PEDIATRICS;MECHANICAL ENGINEERING;ANATOMY;AUDIOLOGY;CANCER RESEARCH;NURSING;OPTICS;PHYSICAL MEDICINE AND REHABILITATION","70;28;24;23;22;17;16;15;12;12;11;10;9;9;8;8;7;6;5;5;5;5;5","GENE;DISEASE;CANCER;STIMULATION;CONFIDENCE INTERVAL;MAGNETIC RESONANCE IMAGING;CHEMOTHERAPY;MYOCARDIAL INFARCTION;POPULATION;STROKE (ENGINE);ALTERNATIVE MEDICINE;ISCHEMIA;PREGNANCY;BIOPSY;COHORT;REGIMEN;ANTIBIOTICS;ASYMPTOMATIC;HEART FAILURE;IN VITRO;INCIDENCE (GEOMETRY);OXIDATIVE STRESS;PROSPECTIVE COHORT STUDY;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;STENT","18;13;10;10;8;8;7;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","PHENOTYPE;MUTATION;RETT SYNDROME;TRANSCRANIAL MAGNETIC STIMULATION;GESTATIONAL AGE;MOTOR CORTEX;ISCHEMIC STROKE;HAZARD RATIO;TRANSCRANIAL DIRECT-CURRENT STIMULATION;ACUTE CORONARY SYNDROME;ARTERIAL DISEASE;CHROMATIN;CLINICAL ENDPOINT;DACARBAZINE;DIFFUSION MRI;EJECTION FRACTION;ENTEROCOCCUS;ETANERCEPT;GENE EXPRESSION;GLOMERULONEPHRITIS;IMMUNOTHERAPY;LIPID PEROXIDATION;NEURODEVELOPMENTAL DISORDER;NEUTROPENIA;OSTEOARTHRITIS;PEDIGREE CHART;PERFUSION SCANNING;PERIPHERAL BLOOD MONONUCLEAR CELL;PHASES OF CLINICAL RESEARCH;PLACEBO;POLYUNSATURATED FATTY ACID;RESTENOSIS;REVASCULARIZATION;RITUXIMAB;SLEEP QUALITY;THALIDOMIDE;THROMBOLYSIS;WHITE MATTER","8;7;7;6;5;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MECP2;BRONCHOPULMONARY DYSPLASIA;INTRAVENTRICULAR HEMORRHAGE;MODIFIED RANKIN SCALE;ALPORT SYNDROME;BENDAMUSTINE;CRITICAL LIMB ISCHEMIA;EXOME SEQUENCING;IPILIMUMAB;PERIVENTRICULAR LEUKOMALACIA;PITTSBURGH SLEEP QUALITY INDEX;PRIMARY MOTOR CORTEX;RETINOPATHY OF PREMATURITY;SPECKLE TRACKING ECHOCARDIOGRAPHY;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;ABDUCENS NERVE;ANTIMICROBIAL STEWARDSHIP;ARID1A;BARE METAL;BRAIN STIMULATION REWARD;CADASIL;CAGA;CHLORAMBUCIL;CHROMATIN REMODELING;CORNEAL COLLAGEN CROSS-LINKING;CORTICOSPINAL TRACT;CROSSOVER STUDY;CYTOREDUCTIVE SURGERY;DNA MICROARRAY;DRUG-ELUTING STENT;DRY-POWDER INHALER;EICOSAPENTAENOIC ACID;FLUDARABINE;FRONTOTEMPORAL DEMENTIA;GENE EXPRESSION PROFILING;GENETIC HETEROGENEITY;GLOMERULAR BASEMENT MEMBRANE;HAPLOINSUFFICIENCY;HEART RATE VARIABILITY;INTRAPERITONEAL CHEMOTHERAPY;LEUKAPHERESIS;MEDIAL LONGITUDINAL FASCICULUS;METAPLASTICITY;MICROARRAY ANALYSIS TECHNIQUES;MICRODELETION SYNDROME;MISSENSE MUTATION;MOTOR IMAGERY;NOD2;OVAL WINDOW;OXALIPLATIN;PAPILLARY CARCINOMA;PAPILLARY THYROID CANCER;PARAMEDIAN PONTINE RETICULAR FORMATION;RILUZOLE;RUBELLA;SCAVENGER RECEPTOR;SERUM AMYLOID A PROTEIN;SURFACTANT THERAPY;TAKOTSUBO SYNDROME;TARGET LESION;TEGMENTUM;TYPE IV COLLAGEN;WILD TYPE","5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;AGED;MIDDLE AGED;TREATMENT OUTCOME;ADOLESCENT;RETT SYNDROME;STROKE;AGED, 80 AND OVER;CHILD;CORONARY ARTERY DISEASE;YOUNG ADULT;HIV INFECTIONS;PROSPECTIVE STUDIES;ABNORMALITIES, MULTIPLE;CHILD, PRESCHOOL;PERIPHERAL ARTERIAL DISEASE","69;52;50;44;31;31;31;20;15;14;14;11;11;11;11;10;10;9;9;9","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;INFECTION CONTROL IN HEALTHCARE SETTINGS;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;CANCER IMMUNOTHERAPY;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;MAMMALIAN MAP KINASE SIGNALING PATHWAYS;MANAGEMENT OF VALVULAR HEART DISEASE;ORGAN TRANSPLANTATION AND REJECTION;PRINCIPLES AND INTERVENTIONS IN STROKE REHABILITATION;RHEUMATOID ARTHRITIS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ANALYSIS OF GENE INTERACTION NETWORKS;ANTIBIOTIC RESISTANCE IN AQUATIC ENVIRONMENTS AND WASTEWATER;ASTHMA","8;7;4;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1","RETT SYNDROME;STROKE (ENGINE);TRANSCRANIAL MAGNETIC STIMULATION;CORTICAL EXCITABILITY;TRANSCRANIAL DIRECT CURRENT STIMULATION;MECP2;REGIMEN;AUTISM;BRONCHOPULMONARY DYSPLASIA;CORD BLOOD;HOSPITAL SURFACES;INFARCTION TREATMENT;NEUROPHYSIOLOGICAL EFFECTS;TREATMENT;ALPORT SYNDROME;ASTHMA;BENDAMUSTINE;CANCER;CARDIAC IMAGING;CARDIOVASCULAR EVALUATION","7;7;7;6;6;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2","RETT SYNDROME;CURRENT STIMULATION;COHERENCE TOMOGRAPHY;DIRECT CURRENT;OPTICAL COHERENCE;PATIENTS UNDERGOING;ALPORT SYNDROME;AORTIC VALVE;CANCER PATIENTS;CLINICAL FEATURES;CORD BLOOD;CRITICAL LIMB;DE NOVO;DISINFECTING TECHNIQUES;ENVIRONMENTAL CONTAMINANTS;FATTY ACIDS;FREE RADICAL-RELATED;HOSPITAL SETTINGS;HUMAN VISUAL;LEFT ATRIAL;LIMB ISCHEMIA;MULTICENTER STUDY;MULTIPLE MYELOMA;PATIENTS TREATED;PHASE II;POST-POLIO SYNDROME;RADICAL-RELATED DISEASES;RHEUMATOID ARTHRITIS;STENT THROMBOSIS;STIMULATION TDCS","7;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PATIENTS TREATED;RAI ACTIVITIES;RETT SYNDROME;STENT GRAFT;COMPUTER KEYBOARDS;TELEPHONE HANDSETS;CARDIAC MORTALITY;FATTY ACIDS;IH PYLORII;RELAY STENT;ACUTE PHASE;AORTIC INJURY;MEDIAN AGE;SYNDROME RTT;TROPISM PREDICTION;TYPICAL SYMPTOMS;ΑCOLIV CHAIN;Ω- PUFAS;AORTIC REPAIR;COMPUTED TOMOGRAPHY;DIABETIC PATIENTS;EFFECTIVE TREATMENT;ENDOVASCULAR AORTIC;ERYTHROCYTE MEMBRANE;HEALTHCARE-ASSOCIATED INFECTIONS;HIV-INFECTED PATIENTS;HOSPITAL UNITS;IMMUNOCOMPETENT PATIENTS;LIPID PEROXIDATION;LUMBAR LORDOSIS","20;10;10;8;7;7;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4",22,0.19,9.86,11.25,3,1,0,2.5,3,0,1,11.25,1,1,9,0,0,1,3,7,3,0,0,107.75,107.75,2,2,1,2,0,0,0,0,0,0,0,0,5,0,0,3,3.2,4.65,3.4,0,5,4,1,0,1,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"MAIO MICHELE;SIGALOTTI LUCA;DE FELICE CLAUDIO;HAYEK JOUSSEF;NUTI FRANCESCA;PAPINI ANNA MARIA;REAL-FERNANDEZ FELICIANA;ROVERO PAOLO;SABATINO GIUSEPPINA;TIBERI CATERINA","4;4;1;1;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;CENTRO DI RIFERIMENTO ONCOLOGICO;CENTRO DI RIFERIMENTO ONCOLOGICO - ISTITUTO NAZIONALE TUMORI - AVIANO;CENTRO DI RIFERIMENTO ONCOLOGICO ISTITUTO NAZ TUMORI AVIANO;CT DI RIFERIMENTO ONCOLOGICO ISTITUTO NAZ TUMORI AVIANO;MAIO MICHELE;NUTI FRANCESCA;PAPINI ANNA MARIA;REAL-FERNANDEZ FELICIANA;ROVERO PAOLO","5;1;1;1;1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","8;4;2;1","CANCER;GENETICS;PATIENT SAFETY;HUMAN GENOME;RARE DISEASES","4;4;3;1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","4;1;1","C12Q1/68;C12N15/10","3;1","C12N15/1072;C12Q1/6886;C12Q2600/112;C12Q2600/118;C12Q2600/154;C12Q2600/158;C07K9/001","4;4;4;4;4;4;1",13,5.38,458.38,5.73,6,0.46,110.31,0,1,3,0,5,0,0,4,0,10,3,0,0,0,0,0,0,13,0,0,13,0,0,0,0,0,0,0,0,0,"United States;Switzerland","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS","13;7;4;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;LUNG;AUTOIMMUNE DISEASE;LYMPHOMA;PREVENTION;ACUTE RESPIRATORY DISTRESS SYNDROME;CONTRACEPTION/REPRODUCTION;EMERGING INFECTIOUS DISEASES;IMMUNIZATION;INFECTIOUS DISEASES;NEUROSCIENCES;ORPHAN DRUG;PATIENT SAFETY;PEDIATRIC;VACCINE RELATED","13;11;7;7;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;RESPIRATORY;INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH","4;2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","9;3;1","LEUKEMIA / LEUKAEMIA;MELANOMA;NON-HODGKIN'S LYMPHOMA","4;4;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","7",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,"PUBLIC LIBRARY OF SCIENCE","20","32 BIOMEDICAL AND CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;31 BIOLOGICAL SCIENCES;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3107 MICROBIOLOGY;3204 IMMUNOLOGY;34 CHEMICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;49 MATHEMATICAL SCIENCES;51 PHYSICAL SCIENCES;5203 CLINICAL AND HEALTH PSYCHOLOGY","23;8;6;6;5;2;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;HIV/AIDS;INFECTIOUS DISEASES;PREVENTION;NEUROSCIENCES;PERIPHERAL NEUROPATHY;ANTIMICROBIAL RESISTANCE;BIODEFENSE;BRAIN DISORDERS;EMERGING INFECTIOUS DISEASES;GENETICS;NEURODEGENERATIVE;PEDIATRIC;RARE DISEASES;RETT SYNDROME;VACCINE RELATED","4;4;4;3;2;2;1;1;1;1;1;1;1;1;1;1","INFECTION;NEUROLOGICAL;MENTAL HEALTH","7;4;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1;1;1;1","BIOMEDICAL;CLINICAL","3;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","7;4;1","BRAIN TUMOR","1",NA,NA
"AOU_SENESE",2014,127,12.0944881889764,2.79527559055118,0.362204724409449,0.354330708661417,0.519685039370079,1.35632183908046,1.1219512195122,1.18421052631579,1.11864406779661,0.480314960629921,0,56,29,18,8,0.44,0.23,0.14,0.06,43.65,1.15510924533918,4.82407407407407,0.393700787401575,0.913385826771654,0.362,0.432,0.471,0.465,"JOUSSEF HAYEK;CLAUDIO DE FELICE;ALESSANDRA PECORELLI;CINZIA SIGNORINI;LUCIA CICCOLI;SILVIA LEONCINI;GIUSEPPE VALACCHI;ALFONSO CERASE;RANUCCIO NUTI;ANDREA DE LUCA;PAOLO GALLUZZI;FRANCESCA MARI;ALBERTO FABBRI;ALESSANDRA RENIERI;GIUSEPPE BELMONTE;MARIA TERESA DOTTI;SÍMONE ROSSI;THIERRY DURAND;DAVID CIONCOLONI;MARCO R. OGGIONI","13;12;11;11;11;10;10;7;7;6;5;5;5;5;5;5;5;5;4;4","JOUSSEF HAYEK;CLAUDIO DE FELICE;RANUCCIO NUTI;ALFONSO CERASE;CINZIA SIGNORINI;ALESSANDRA PECORELLI;LUCIA CICCOLI;GIUSEPPE VALACCHI;SILVIA LEONCINI;DAVID CIONCOLONI;ANDREA DE LUCA;MARCO R. OGGIONI;SÍMONE ROSSI;PAOLO GALLUZZI;CLELIA MIRACCO;MARIA TERESA DOTTI;ALESSANDRO ROSSI;FELICE PETRAGLIA;FABIO FERRETTI;SERGIO MONDILLO","1.11;0.96;0.91;0.87;0.84;0.78;0.78;0.78;0.71;0.58;0.56;0.53;0.51;0.51;0.49;0.49;0.48;0.48;0.48;0.45","JOUSSEF HAYEK;CLAUDIO DE FELICE;ALESSANDRA PECORELLI;CINZIA SIGNORINI;SILVIA LEONCINI;ALFONSO CERASE;RANUCCIO NUTI;ANDREA DE LUCA;PAOLO GALLUZZI;FRANCESCA MARI;ALBERTO FABBRI;ALESSANDRA RENIERI;MARIA TERESA DOTTI;SÍMONE ROSSI;DAVID CIONCOLONI;MARCO R. OGGIONI;MARIA ANTONIETTA MENCARELLI;ANTONIO FEDERICO;PIETRO PIU;GLORIA ZOLLO","13;12;11;11;10;7;7;6;5;5;5;5;5;5;4;4;4;4;4;4","JOUSSEF HAYEK;CLAUDIO DE FELICE;RANUCCIO NUTI;ALFONSO CERASE;CINZIA SIGNORINI;ALESSANDRA PECORELLI;SILVIA LEONCINI;DAVID CIONCOLONI;ANDREA DE LUCA;MARCO R. OGGIONI;SÍMONE ROSSI;PAOLO GALLUZZI;CLELIA MIRACCO;MARIA TERESA DOTTI;ALESSANDRO ROSSI;FELICE PETRAGLIA;FABIO FERRETTI;SERGIO MONDILLO;ANTONIO FEDERICO;STEFANO GONNELLI","1.11;0.96;0.91;0.87;0.84;0.78;0.71;0.58;0.56;0.53;0.51;0.51;0.49;0.49;0.48;0.48;0.48;0.45;0.45;0.43","ANTONI RIBAS;BRIGITTE DRÉNO;CAROLINE DUTRIAUX;CLAUS GARBE;DANIIL STROYAKOVSKIY;GABRIELLA LISZKAY;GRANT A. MCARTHUR;ILSUNG CHANG;JAMES LARKIN;L. THOMAS;LEV DEMIDOV;LUIS DE LA CRUZ‐MERINO;MARIO MANDALÁ;MICHELE MAIO;MIKA A. SOVAK;NICHOLAS W. CHOONG;PAOLO A. ASCIERTO;STEPHEN P. HACK;VICTORIA ATKINSON;A TINCANI","1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;1855;828","JAMES LARKIN;F BELLISAI;M. GALEAZZI;JOUSSEF HAYEK;ALESSANDRA PECORELLI;SILVIA LEONCINI;EDOARDO G. GIANNINI;ALESSANDRA RENIERI;GLORIA ZOLLO;GIUSEPPE MARTINI;FRANCESCA MARI;MARIA ANTONIETTA MENCARELLI;CLAUDIO DE FELICE;SIMONE GROTTI;CINZIA SIGNORINI;MARCO R. OGGIONI;RANUCCIO NUTI;ALBERTO PALAZZUOLI;BEATRICE FRANCI;GAETANO RUOCCO","1855;828;828;423;345;288;210;186;139;135;132;132;131;124;116;113;113;101;101;101","JOUSSEF HAYEK;ALESSANDRA PECORELLI;SILVIA LEONCINI;ANDREA DE LUCA;CLAUDIO DE FELICE;ALBERTO FABBRI;ALESSANDRA RENIERI;ALFONSO CERASE;RANUCCIO NUTI;ALESSANDRO GOZZETTI;BARBARA ROSSETTI;CLÁUDIA BIANCO;FRANCESCA MARI;GIUSEPPE MARTINI;GLORIA ZOLLO;MARCO R. OGGIONI;MARIA ANTONIETTA MENCARELLI;PAOLO GALLUZZI;SÍMONE ROSSI;ADRIANO SPREAFICO","9;7;6;6;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;ECONOMICS;GEOLOGY;PHILOSOPHY;SOCIOLOGY;ART;ENVIRONMENTAL SCIENCE","118;48;20;13;11;8;4;4;4;2;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;BIOCHEMISTRY;GENETICS;GASTROENTEROLOGY;RADIOLOGY;IMMUNOLOGY;CARDIOLOGY;ONCOLOGY;ENDOCRINOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;PSYCHIATRY;ANESTHESIA;ENVIRONMENTAL HEALTH;PALEONTOLOGY;PEDIATRICS;OPTICS;ALGORITHM;CELL BIOLOGY;FAMILY MEDICINE;MOLECULAR BIOLOGY;PHYSICAL THERAPY","74;42;34;25;21;20;20;19;15;12;10;10;9;9;7;7;7;7;6;5;5;5;5;5","GENE;LYMPHOMA;OXIDATIVE STRESS;CANCER;MAGNETIC RESONANCE IMAGING;CHEMOTHERAPY;DISEASE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);HEART FAILURE;LUNG;ALTERNATIVE MEDICINE;CLINICAL TRIAL;MYOCARDIAL INFARCTION;POPULATION;PREGNANCY;RANDOMIZED CONTROLLED TRIAL;REGIMEN;ANTIBODY;ENZYME;IMMUNOHISTOCHEMISTRY;PROSPECTIVE COHORT STUDY;RECEPTOR;RETROSPECTIVE COHORT STUDY;TRANSPLANTATION","30;10;10;9;9;8;8;8;7;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4","RETT SYNDROME;MUTATION;PHENOTYPE;CLINICAL ENDPOINT;RITUXIMAB;VIRAL LOAD;CARDIOMYOPATHY;COINFECTION;CYCLOPHOSPHAMIDE;EJECTION FRACTION;GENOTYPE;POLYUNSATURATED FATTY ACID;SALVAGE THERAPY;TOLERABILITY;TRANSCRANIAL MAGNETIC STIMULATION;ACUTE CORONARY SYNDROME;ADALIMUMAB;BLOOD UREA NITROGEN;BONE MINERAL;CD30;CD34;CHEMOKINE;CHROMOSOME;EX VIVO;FOLLICULAR LYMPHOMA;GLUTATHIONE;INTRACEREBRAL HEMORRHAGE;LUNG FUNCTION;MANTLE CELL LYMPHOMA;MARAVIROC;MOTOR CORTEX;MUTANT;NATRIURETIC PEPTIDE;NEURORADIOLOGY;NEUTROPENIA;PERCUTANEOUS CORONARY INTERVENTION;PHASES OF CLINICAL RESEARCH;PLACEBO;RETINOBLASTOMA;STREPTOCOCCUS PNEUMONIAE;VASCULAR ENDOTHELIAL GROWTH FACTOR;VIRULENCE;WHITE MATTER","9;7;7;6;5;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MECP2;ANTIRETROVIRAL THERAPY;BENDAMUSTINE;MISSENSE MUTATION;FLUDARABINE;BRENTUXIMAB VEDOTIN;CHEMOKINE RECEPTOR;DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;EXOME SEQUENCING;GENE MUTATION;PNEUMOCOCCAL INFECTIONS;SINGLE-NUCLEOTIDE POLYMORPHISM;ALIEN;ANAPHYLACTIC REACTIONS;ANEUPLOIDY;ARTERY DISSECTION;BACTERIAL CAPSULE;BASDAI;BREAKPOINT;BREAST SURGERY;BUSULFAN;CAGA;CALSEQUESTRIN;CARDIAC RESYNCHRONIZATION THERAPY;CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME;CD38;CHEMOIMMUNOTHERAPY;COGNITIVE DECLINE;CONCURRENT VALIDITY;CORNEAL COLLAGEN CROSS-LINKING;CRITICAL LIMB ISCHEMIA;DIFFUSING CAPACITY;DISKECTOMY;DNA FRAGMENTATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;FRAMESHIFT MUTATION;GENE SIGNATURE;GERMLINE MUTATION;GP41;HAPLOINSUFFICIENCY;HPV INFECTION;IMMUNOGLOBULIN M;LDL RECEPTOR;LEUKAPHERESIS;LYMPHOBLASTIC LYMPHOMA;METATHESIS;MICRODELETION SYNDROME;MODIFIED RANKIN SCALE;NEUROSYPHILIS;OSWESTRY DISABILITY INDEX;PANNING (AUDIO);PEPTIDE LIBRARY;PNEUMOCOCCAL DISEASE;PRENATAL DIAGNOSIS;PRIMARY MOTOR CORTEX;PROSTATE CARCINOMA;PROSTATECTOMY;PROTEIN PHOSPHORYLATION;PYOGENIC LIVER ABSCESS;RIBAVIRIN;RIGHT CORONARY ARTERY;SANGER SEQUENCING;SILENT PERIOD;SPECKLE TRACKING ECHOCARDIOGRAPHY;STEROL REGULATORY ELEMENT-BINDING PROTEIN;STREPTOCOCCUS MITIS;SUPERIOR OBLIQUE MUSCLE;TOTAL BODY IRRADIATION;V600E;VEMURAFENIB;VIRULENCE FACTOR","5;4;4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;MIDDLE AGED;RETT SYNDROME;AGED;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ITALY;AGED, 80 AND OVER;METHYL-CPG-BINDING PROTEIN 2;MUTATION;YOUNG ADULT;BIOMARKERS;MULTIPLE SCLEROSIS;STROKE;INFLAMMATION","77;68;55;46;40;35;35;23;18;17;14;14;13;13;13;13;12;11;11;10","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;LYMPHOID NEOPLASMS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GLIOMAS;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;OCULAR CANCER RESEARCH AND TREATMENT;ORGAN TRANSPLANTATION AND REJECTION;RHEUMATOID ARTHRITIS;ACUTE MYELOID LEUKEMIA;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;ANALYSIS OF SYNTHETIC FOOD COLORANTS IN FOOD PRODUCTS;ANTIBIOTIC RESISTANCE IN AQUATIC ENVIRONMENTS AND WASTEWATER;BIOLOGICAL BASIS AND CLINICAL MANAGEMENT OF SYPHILIS;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH","13;6;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","RETT SYNDROME;CLINICAL ENDPOINT;MECP2;REGIMEN;BENDAMUSTINE;PERFUSION IMAGING;ADOPTIVE CELL TRANSFER;ANTIRETROVIRAL THERAPY;CORTICAL EXCITABILITY;HISTOPATHOLOGY;INTRAOCULAR CHEMOTHERAPY;PATHOGENESIS;RETINOBLASTOMA;SALVAGE THERAPY;STROKE (ENGINE);TOLERABILITY;TRANSCRANIAL DIRECT CURRENT STIMULATION;TRANSCRANIAL MAGNETIC STIMULATION;TREATMENT;AGING","10;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2","RETT SYNDROME;OXIDATIVE STRESS;HEART FAILURE;RANDOMIZED TRIAL;STEM CELL;TYPICAL RETT;AETHERA TRIAL;AUTOLOGOUS STEM;BRAIN DAMAGE;BRENTUXIMAB VEDOTIN;CELL TRANSPLANT;COMPARATIVE STUDY;CT PERFUSION;ELDERLY PATIENTS;FATTY ACID;GUSTA STUDY;HODGKIN LYMPHOMA;INTELLECTUAL DISABILITY;MULTICENTER EXPERIENCE;MULTICENTRE PROSPECTIVE;MULTIPLE SCLEROSIS;PATIENTS UNDERGOING;PHASE STUDY;POLYUNSATURATED FATTY;RENAL FUNCTION;SIENA UNIVERSITY;UNIVERSITY HOSPITAL;ABSCESS CAUSED;ACCELERATED CROSS-LINKING;ACCURACY STUDY","12;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","RTT PATIENTS;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;BLOOD OUTFLOW;CEREBRAL VENOUS;HIV DNA;SIGNAL-INTENSITY VOIDS;VENOUS BLOOD;OXIDATIVE STRESS;CONTINUOUS INFUSION;HEALTHY CONTROLS;RETT SYNDROME;SYNDROME RTT;BRAIN DAMAGE;DISK HERNIATIONS;NEURODEVELOPMENTAL DISORDER;OS MARKERS;SIGNIFICANT DIFFERENCE;SITTING POSITIONS;GELIFIED ETHANOL;GENE ENCODING;HIV RNA;INCREASED RISK;PLUNC PROTEINS;RADIOPAQUE GELIFIED;CAPSULE-SWITCHING MUTANT;CONFIDENCE INTERVAL;IDMMMLMINMMLMIMMLMOMMLMOMMLMN FONTSTYLEITALICMMLMNMMLMATHSPOTS;LIPID PEROXIDATION;LOG COPIES;LYMPHOBLASTIC LYMPHOMA","13;12;9;9;9;9;9;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4",33,0.26,5.31,4,11.75,1.5,1,4,2.25,0,1,4,1,0,4,0,1,1,2,3.5,8,0,0,69,69,2,0,0,2,0,0,0,0,0,0,0,0,2,0,0,0,5,2.82,4.5,0,2,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DE FELICE CLAUDIO;HAYEK JOUSSEF;NUTI FRANCESCA;PAPINI ANNA MARIA;REAL-FERNANDEZ FELICIANA;ROVERO PAOLO;SABATINO GIUSEPPINA;SANTUCCI ANNALISA;SPREAFICO ADRIANO;TIBERI CATERINA","1;1;1;1;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;NUTI FRANCESCA;PAPINI ANNA MARIA;REAL-FERNANDEZ FELICIANA;ROVERO PAOLO;SABATINO GIUSEPPINA;TIBERI CATERINA;UNIV SIENA","2;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","4;1;1","CARDIOVASCULAR;HEART DISEASE;RARE DISEASES","1;1;1","5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1","A61K31/519;A61K38/14;A61P3/00;C07K9/00","1;1;1;1","A61K31/519;A61P3/00;C07K9/001","1;1;1",12,6,319.67,5.13,5,0.42,55.83,2,0,5,0,1,0,0,4,0,9,3,0,0,0,0,0,0,11,0,1,11,0,0,1,0,0,0,0,0,0,"United States;Japan","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","12;8;7;4;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;ORPHAN DRUG;TRANSPLANTATION;AGING;ASSISTIVE TECHNOLOGY;BIOENGINEERING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;GENETICS;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;ACUTE RESPIRATORY DISTRESS SYNDROME;ARTHRITIS;AUTOIMMUNE DISEASE;COMPARATIVE EFFECTIVENESS RESEARCH","12;9;9;9;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;RESPIRATORY","6;2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;5.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES","8;3;2;1;1","LEUKEMIA / LEUKAEMIA;COLON AND RECTAL CANCER;LUNG CANCER;BLOOD CANCER;BREAST CANCER;KIDNEY CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;PROSTATE CANCER","3;2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","9;3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,"PUBLIC LIBRARY OF SCIENCE","15","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;42 HEALTH SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3107 MICROBIOLOGY;36 CREATIVE ARTS AND WRITING;3601 ART HISTORY, THEORY AND CRITICISM;4206 PUBLIC HEALTH;49 MATHEMATICAL SCIENCES","17;9;5;3;2;2;2;1;1;1;1;1;1","INFECTIOUS DISEASES;BRAIN DISORDERS;CLINICAL RESEARCH;RARE DISEASES;BIOTECHNOLOGY;HIV/AIDS;AGING;BIOMEDICAL IMAGING;CANCER;GENETICS;HUMAN GENOME;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;PREVENTION","4;3;3;3;2;2;1;1;1;1;1;1;1;1;1","INFECTION;NEUROLOGICAL;GENERIC HEALTH RELEVANCE","5;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","4;3;1;1;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","2;2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","4;2;1","KAPOSI'S SARCOMA;NON-HODGKIN'S LYMPHOMA","2;1",NA,NA
"AOU_SENESE",2015,153,14.4052287581699,2.62745098039216,0.30718954248366,0.313725490196078,0.313725490196078,1.62753036437247,1.175,1.37142857142857,1.2,0.542483660130719,3,71,39,17,11,0.46,0.25,0.11,0.07,38.07,1.02138958773103,4.98666666666666,0.42483660130719,0.915032679738562,0.433,0.377,0.405,0.422,"ALESSANDRA RENIERI;JOUSSEF HAYEK;NICOLA NANTE;PAOLO GALLUZZI;CLAUDIO DE FELICE;SONIA DE FRANCESCO;ALFONSO CERASE;LUIGI MECCARIELLO;ANGELO MICHELE CARELLA;ALESSANDRO GOZZETTI;GABRIELE MESSINA;THEODORA HADJISTILIANOU;SÍMONE ROSSI;ALESSANDRA PECORELLI;RANUCCIO NUTI;SILVIA LEONCINI;MARIA ANTONIETTA MENCARELLI;FRANCESCA MARI;FRANCESCA ARIANI;ALBERTO BOSI","12;9;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5","NICOLA NANTE;ALFONSO CERASE;LUIGI MECCARIELLO;PIETRO SARTORELLI;MARIE AIMEE GLORIA MUNEZERO;B CARANGELO;JOUSSEF HAYEK;CLAUDIO DE FELICE;RANUCCIO NUTI;ALESSANDRA RENIERI;SÍMONE ROSSI;PIETRO MANZI;PREDRAG GRUBOR;GABRIELE MESSINA;THEODORA HADJISTILIANOU;MARCO MANDALÀ;PAOLO GALLUZZI;SONIA DE FRANCESCO;SILVIA BRIANI;IRENE GRAZZINI","1.18;1.03;1.01;1;1;1;0.97;0.91;0.81;0.78;0.76;0.73;0.7;0.69;0.68;0.68;0.62;0.6;0.58;0.57","ALESSANDRA RENIERI;JOUSSEF HAYEK;NICOLA NANTE;PAOLO GALLUZZI;CLAUDIO DE FELICE;SONIA DE FRANCESCO;ALFONSO CERASE;LUIGI MECCARIELLO;ANGELO MICHELE CARELLA;ALESSANDRO GOZZETTI;THEODORA HADJISTILIANOU;SÍMONE ROSSI;ALESSANDRA PECORELLI;RANUCCIO NUTI;SILVIA LEONCINI;MARIA ANTONIETTA MENCARELLI;FRANCESCA MARI;FRANCESCA ARIANI;EMANUELE CENCINI;MONICA BOCCHIA","12;9;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4","NICOLA NANTE;ALFONSO CERASE;LUIGI MECCARIELLO;PIETRO SARTORELLI;MARIE AIMEE GLORIA MUNEZERO;B CARANGELO;JOUSSEF HAYEK;CLAUDIO DE FELICE;RANUCCIO NUTI;ALESSANDRA RENIERI;SÍMONE ROSSI;PIETRO MANZI;THEODORA HADJISTILIANOU;MARCO MANDALÀ;PAOLO GALLUZZI;SONIA DE FRANCESCO;SILVIA BRIANI;IRENE GRAZZINI;CLELIA MIRACCO;ALBERTO PALAZZUOLI","1.18;1.03;1.01;1;1;1;0.97;0.91;0.81;0.78;0.76;0.73;0.68;0.68;0.62;0.6;0.58;0.57;0.56;0.56","MARCO MANDALÀ;ALEXANDRE BISDORFF;DAVID E. NEWMAN‐TOKER;FRANCO TRABALZINI;JOEL A. GOEBEL;JOHN P. CAREY;JOSÉ A. LÓPEZ‐ESCÁMEZ;MAMORU SUZUKI;MICHAEL STRUPP;MÅNS MAGNUSSON;WON-HO CHUNG;ANGELO MICHELE CARELLA;JAN WALEWSKI;ANNA SUREDA;CRAIG H. MOSKOWITZ;DIRK HUEBNER;DZHELIL OSMANOV;EDWARD AGURA;EMILY K. LARSEN;JERZY HOŁOWIECKI","1233;1227;1227;1227;1227;1227;1227;1227;1227;1227;1227;869;715;713;713;713;713;713;713;713","MARCO MANDALÀ;FRANCO TRABALZINI;ANGELO MICHELE CARELLA;ALESSANDRA RENIERI;MARIA ANTONIETTA MENCARELLI;FRANCO LAGHI‐PASINI;JOUSSEF HAYEK;FURIO PACINI;CARLA VINDIGNI;FRANCESCA MARI;ALFONSO FAUSTO;FRANCESCA ARIANI;DANIELE MARRELLI;FELICE PETRAGLIA;GIUSEPPE MAROTTA;MIRELLA BRUTTINI;SÍMONE ROSSI;CLAUDIO DE FELICE;ALESSANDRA PECORELLI;PATRIZIA CARRARELLI","1233;1227;714;432;305;227;225;222;192;189;178;176;170;158;155;155;155;153;141;136","ALESSANDRA RENIERI;JOUSSEF HAYEK;CLAUDIO DE FELICE;LUIGI MECCARIELLO;PAOLO GALLUZZI;ALESSANDRO GOZZETTI;ALFONSO CERASE;MARIA ANTONIETTA MENCARELLI;MONICA BOCCHIA;SÍMONE ROSSI;ALBERTO FABBRI;ALESSANDRA PECORELLI;ANGELO MICHELE CARELLA;EMANUELE CENCINI;MARCO MANDALÀ;PIETRO MANZI;SILVIA LEONCINI;ALBERTO PALAZZUOLI;SANDRA BRACCO;ROBERTO PETRIOLI","9;8;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;BUSINESS;MATERIALS SCIENCE;POLITICAL SCIENCE;GEOLOGY;PHILOSOPHY;ECONOMICS;SOCIOLOGY","133;49;19;16;14;13;9;8;3;3;3;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;ONCOLOGY;BIOCHEMISTRY;RADIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;CARDIOLOGY;NEUROSCIENCE;PSYCHIATRY;PEDIATRICS;ENDOCRINOLOGY;CANCER RESEARCH;CELL BIOLOGY;ANATOMY;ENVIRONMENTAL HEALTH;OPTICS;AUDIOLOGY;MECHANICAL ENGINEERING;PHYSICAL MEDICINE AND REHABILITATION;UROLOGY","84;39;31;27;25;21;18;17;17;14;14;13;12;11;10;8;7;7;7;6;6;6;6","GENE;CANCER;CHEMOTHERAPY;LYMPHOMA;CLINICAL TRIAL;ANTIBODY;MULTIPLE MYELOMA;TRANSPLANTATION;ADVERSE EFFECT;RETROSPECTIVE COHORT STUDY;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;RANDOMIZED CONTROLLED TRIAL;REGIMEN;ALTERNATIVE MEDICINE;CONFIDENCE INTERVAL;DISEASE;POPULATION;STEM CELL;STROKE (ENGINE)","35;18;16;13;11;10;8;8;7;7;6;6;6;6;5;5;5;5;5;5","CLINICAL ENDPOINT;PHENOTYPE;RETT SYNDROME;MUTATION;CYCLOPHOSPHAMIDE;AUTOLOGOUS STEM-CELL TRANSPLANTATION;BREAST CANCER;RETINOBLASTOMA;RITUXIMAB;NEUTROPENIA;PHASES OF CLINICAL RESEARCH;PLACEBO;TOLERABILITY;AUTOANTIBODY;BORTEZOMIB;DNA SEQUENCING;GENOTYPE;HAZARD RATIO;INTERSTITIAL LUNG DISEASE;LENALIDOMIDE;NEURORADIOLOGY;OPHTHALMIC ARTERY;PROGRESSION-FREE SURVIVAL;PROSTATE CANCER;SEROLOGY;TRANSCRANIAL DIRECT-CURRENT STIMULATION","10;10;9;7;6;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","MECP2;ANDROGEN DEPRIVATION THERAPY;BRENTUXIMAB VEDOTIN;FLUDARABINE;VINCRISTINE;ENDOLYMPHATIC HYDROPS;GENETIC HETEROGENEITY;IPILIMUMAB;METASTATIC BREAST CANCER;MISSENSE MUTATION;NEUROTOLOGY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;ALPORT SYNDROME;ANTI-NUCLEAR ANTIBODY;ANTIRETROVIRAL THERAPY;ARTICULAR CARTILAGE;AZOOSPERMIA;BASILIXIMAB;BECN1;BENDAMUSTINE;BREAST RECONSTRUCTION;BUSULFAN;CALSEQUESTRIN;CHEMOIMMUNOTHERAPY;CIRCULATING TUMOR CELL;CLINICAL GLOBAL IMPRESSION;CONCENTRIC HYPERTROPHY;DIFFUSING CAPACITY;DISCOID LUPUS ERYTHEMATOSUS;DYSKERATOSIS CONGENITA;EMBOLIC STROKE;ENDOVASCULAR ANEURYSM REPAIR;ENTEROBACTERIACEAE;EPSTEIN–BARR VIRUS INFECTION;EXHALED NITRIC OXIDE;FEBRILE NEUTROPENIA;FELBAMATE;GENOTYPING;GERMLINE MUTATION;GLUTAMATERGIC;GLUTATHIONE PEROXIDASE;HEME OXYGENASE;HEPATITIS E;HEPATITIS E VIRUS;IIF;INTERFACE (MATTER);KLEBSIELLA PNEUMONIAE;LEFT ATRIAL ENLARGEMENT;LENVATINIB;LYMPHOPLASMACYTIC LYMPHOMA;MALE INFERTILITY;MARGINAL ZONE;MICROSATELLITE;MITOCHONDRIAL DISEASE;MONOCLONAL;MUTAGENESIS;N-LINKED GLYCOSYLATION;NILOTINIB;NIVOLUMAB;OFATUMUMAB;PENETRANCE;PEPTIDE VACCINE;PHARMACOGENETICS;PLACENTA;PRIMARY MOTOR CORTEX;PROBAND;PROSTATE DISEASE;PROSTATECTOMY;RADICAL HYSTERECTOMY;RADIOIMMUNOTHERAPY;RIBONUCLEOPROTEIN;RYANODINE RECEPTOR 2;SANGER SEQUENCING;SEMEN ANALYSIS;SEROPREVALENCE;SIGNET RING CELL;SOX9;SUPERFICIAL TEMPORAL ARTERY;SYNDESMOSIS;TERIPARATIDE;THYMIDYLATE SYNTHASE;TIMP1;TRASTUZUMAB;ULTRASOUND ELASTOGRAPHY;VARICOCELE;VEMURAFENIB;VIGABATRIN;VITREOUS HEMORRHAGE;X-INACTIVATION;X-LINKED RECESSIVE INHERITANCE;ZONISAMIDE","7;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;;MALE;ADULT;MIDDLE AGED;AGED;YOUNG ADULT;ITALY;RETT SYNDROME;RETINOBLASTOMA;RETROSPECTIVE STUDIES;ADOLESCENT;CHILD, PRESCHOOL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;BRAIN;RETINAL NEOPLASMS;BIOMARKERS, TUMOR;CHILD;TREATMENT OUTCOME","93;63;58;57;38;38;35;21;20;20;17;17;16;16;15;15;14;13;13;13","MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;OCULAR CANCER RESEARCH AND TREATMENT;LYMPHOID NEOPLASMS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;VIRAL-RELATED CANCERS IN IMMUNOCOMPROMISED PATIENTS;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GLIOMAS;GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE;IMPACT OF HEARING LOSS ON COGNITIVE FUNCTION;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER","12;8;6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","CLINICAL ENDPOINT;RETT SYNDROME;MECP2;REGIMEN;AUTOLOGOUS STEM-CELL TRANSPLANTATION;RETINOBLASTOMA;STROKE (ENGINE);BREAST CANCER;INTERNATIONAL MYELOMA WORKING GROUP;POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE;TOLERABILITY;BRENTUXIMAB VEDOTIN;CROSS-SECTIONAL STUDY;HEMATOLOGY;INTRAOCULAR CHEMOTHERAPY;LEFT VENTRICULAR FUNCTION;MANTLE CELL LYMPHOMA;METASTATIC PROSTATE CANCER;NEURORADIOLOGY;PROGRESSION-FREE SURVIVAL","10;9;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","RETROSPECTIVE STUDY;MULTIPLE MYELOMA;RETT SYNDROME;BREAST CANCER;AUTOLOGOUS STEM;BRENTUXIMAB VEDOTIN;DOUBLE-BLIND PLACEBO-CONTROLLED;ELDERLY PATIENTS;HODGKIN LYMPHOMA;LEFT VENTRICULAR;LYMPHOMA PATIENTS;MAGNETIC RESONANCE;MULTIPLE SCLEROSIS;PHASE TRIAL;RESONANCE IMAGING;STEM CELL;ACUTE HEART;ACUTE STROKE;AETHERA TRIAL;AUDITORY BRAINSTEM;B-CELL LYMPHOMA;CASTRATION-RESISTANT PROSTATE;CELL TRANSPLANT;CHRONIC LYMPHOCYTIC;COCHLEAR NERVE;COGNITIVE IMPAIRMENT;COMPUTED TOMOGRAPHY;CONTROLLED TUMOR;CURRENT STIMULATION;DIRECT CURRENT","6;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RETT SYNDROME;CROSSREF MEDLINE;BRENTUXIMAB VEDOTIN;CAS GOOGLE;MEDLINE CAS;ADVERSE EVENTS;PROGRESSION-FREE SURVIVAL;RESEARCH FUNDING;OXIDATIVE STRESS;ADVISORY COMMITTEES;BREAST CANCER;ENTITYS BOARD;DE FELICE;TSPP VACCINATION;BV ARM;RO- RO-;SERUM CT;SIENA ITALY;STEM-CELL TRANSPLANTATION;TOTAL DOSE;AUTOLOGOUS STEM-CELL;CONSECUTIVE DAYS;CONSULTANCY HONORARIA;DISEASE PROGRESSION;I- SIENA;INDEPENDENT REVIEW;MS PATIENTS;PATIENTS RECEIVED;PISA ITALY;PRIMARY ENDPOINT","44;21;18;16;16;12;12;12;11;9;9;9;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6",42,0.27,9.12,5,8,3,1,4.25,2.5,0,2,5,1,1,5,1,6,1.75,2,4,2.75,0,0,89.5,89.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,4.21,259.77,6.06,4,0.29,34.79,2,1,4,0,2,0,0,5,0,10,4,0,0,0,0,0,0,13,1,0,12,0,0,2,0,0,0,0,0,0,"United States;Italy;United Kingdom","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;3215 REPRODUCTIVE MEDICINE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","14;7;5;4;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;PATIENT SAFETY;BRAIN DISORDERS;EYE DISEASE AND DISORDERS OF VISION;IMMUNIZATION;INFECTIOUS DISEASES;PEDIATRIC;PREVENTION;VACCINE RELATED;AGING;BIOTECHNOLOGY;BREAST CANCER;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;HEMATOLOGY;HIV/AIDS;INFANT MORTALITY","12;10;7;6;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;EYE;INFECTION","6;2;2","6.1 PHARMACEUTICALS;3.4 VACCINES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES","11;1;1;1;1;1;1","LUNG CANCER;MELANOMA;BREAST CANCER;COLON AND RECTAL CANCER;ENDOMETRIAL CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;PROSTATE CANCER","2;2;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","7;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;1",NA,NA,"NEUROLOGICAL","1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOU_SENESE",2016,169,14.2011834319527,2.62130177514793,0.325443786982249,0.307692307692308,0.402366863905325,1.75098814229249,1.12244897959184,1.26829268292683,1.30769230769231,0.57396449704142,3,80,37,13,19,0.47,0.22,0.08,0.11,30.76,0.946876423431191,4.87445255474452,0.355029585798817,0.964497041420118,0.437,0.38,0.428,0.388,"LUIGI MECCARIELLO;ALESSANDRA RENIERI;PAOLO GALLUZZI;NICOLA NANTE;FRANCESCA MARI;CLAUDIO DE FELICE;GIUSEPPE BUONOCORE;SERAFINA PERRONE;MASSIMO FINESCHI;ANDREA DE LUCA;ELISA BELVISI;JOUSSEF HAYEK;ALESSIO CORTELAZZO;GABRIELE FALZARANO;ANTONIO MEDICI;SÍMONE ROSSI;SANDRA BRACCO;MONICA BOCCHIA;CARLOTTA BRACCIALI;SILVIA LEONCINI","9;9;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5","GIAN MARÍA ROSSOLINI;LUIGI MECCARIELLO;GIUSEPPE BUONOCORE;SERAFINA PERRONE;NICOLA NANTE;CARLO V. BELLIENI;DOMENICO IEMMA;SANDRA BRACCO;SÍMONE ROSSI;PAOLO GALLUZZI;GIANMARCO TROIANO;CLAUDIO DE FELICE;GABRIELE FALZARANO;ANTONIO MEDICI;EUGENIO BERTELLI;MARIA ANTONIETTA MAZZEI;ALESSANDRA RENIERI;ELISA BELVISI;ALESSIO CORTELAZZO;GABRIELE MESSINA","1.46;1.2;1.13;1.13;1.01;1;1;0.99;0.87;0.87;0.74;0.72;0.72;0.72;0.71;0.7;0.64;0.63;0.57;0.55","LUIGI MECCARIELLO;ALESSANDRA RENIERI;PAOLO GALLUZZI;FRANCESCA MARI;CLAUDIO DE FELICE;GIUSEPPE BUONOCORE;SERAFINA PERRONE;MASSIMO FINESCHI;ANDREA DE LUCA;ELISA BELVISI;JOUSSEF HAYEK;ALESSIO CORTELAZZO;SÍMONE ROSSI;SANDRA BRACCO;MONICA BOCCHIA;CARLOTTA BRACCIALI;SILVIA LEONCINI;GIAN MARÍA ROSSOLINI;ALESSANDRO GOZZETTI;FRANCESCA ARIANI","9;9;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5","GIAN MARÍA ROSSOLINI;LUIGI MECCARIELLO;GIUSEPPE BUONOCORE;SERAFINA PERRONE;CARLO V. BELLIENI;DOMENICO IEMMA;SANDRA BRACCO;SÍMONE ROSSI;PAOLO GALLUZZI;CLAUDIO DE FELICE;MARIA ANTONIETTA MAZZEI;ALESSANDRA RENIERI;ELISA BELVISI;ALESSIO CORTELAZZO;SERAFINO CARTA;PAOLO FERRATA;MATTIA FORTINA;FRANCESCA MARI;CARLOTTA BRACCIALI;FRANCESCO BAZZINI","1.46;1.2;1.13;1.13;1;1;0.99;0.87;0.87;0.72;0.7;0.64;0.63;0.57;0.55;0.55;0.55;0.54;0.52;0.52","CLAUS GARBE;GRANT A. MCARTHUR;ANNA MARIA DI GIACOMO;ANTONI RIBAS;BRIGITTE DRÉNO;CAROLINE DUTRIAUX;DANIEL O. KORALEK;DANIIL STROYAKOVSKIY;GABRIELLE LISZKAY;ILSUNG CHANG;ISABELLE ROONEY;JAMES LARKIN;JESSIE J. HSU;L. THOMAS;LEV DEMIDOV;LUIS DE LA CRUZ‐MERINO;MARIO MANDALÁ;MATTHEW WONGCHENKO;PAOLO A. ASCIERTO;VICTORIA ATKINSON","1127;1127;902;902;902;902;902;902;902;902;902;902;902;902;902;902;902;902;902;902","ANNA MARIA DI GIACOMO;ALBERTO FABBRI;ALESSANDRO GOZZETTI;BARBARA PAOLINI;CRISTINA CIUOLI;IRENE DEL CIONDOLO;ALESSANDRA RENIERI;FRANCESCO LAURIA;MICHELE MAIO;FRANCESCA MARI;FRANCESCA ARIANI;ALFONSO CERASE;ALESSANDRO IADANZA;ANDREA TIRONE;GIUSEPPINA COLASANTE;NICOLA ANTONIO PASCARELLI;SERGIO TRIPODI;EDOARDO G. GIANNINI;DAVID CIONCOLONI;JOUSSEF HAYEK","902;612;415;307;307;307;237;226;225;191;171;151;131;126;126;126;124;116;114;100","LUIGI MECCARIELLO;ALESSANDRA RENIERI;GIUSEPPE BUONOCORE;PAOLO GALLUZZI;ELISA BELVISI;MASSIMO FINESCHI;SERAFINA PERRONE;FRANCESCA MARI;MARIA ANTONIETTA MAZZEI;CARLOTTA BRACCIALI;FRANCESCA ARIANI;ALESSANDRO GOZZETTI;ANDREA DE LUCA;SANDRA BRACCO;ANTONINO SANTACROCE;FRANCESCO BAZZINI;ALBERTO FABBRI;ALESSANDRO IADANZA;ALESSIO CORTELAZZO;ALFONSO CERASE","9;8;7;7;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;BUSINESS;ART;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY;POLITICAL SCIENCE","157;53;20;17;17;13;12;8;3;3;3;3;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;CARDIOLOGY;BIOCHEMISTRY;ONCOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;RADIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;PHYSICAL THERAPY;ANATOMY;OPTICS;PEDIATRICS;ARTIFICIAL INTELLIGENCE;CANCER RESEARCH;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;NURSING;PALEONTOLOGY","101;54;33;31;23;22;19;17;14;14;11;11;11;10;9;8;8;7;7;7;7;7;7","GENE;CANCER;ADVERSE EFFECT;OXIDATIVE STRESS;PREGNANCY;POPULATION;ALTERNATIVE MEDICINE;CHEMOTHERAPY;CLINICAL TRIAL;DISEASE;RANDOMIZED CONTROLLED TRIAL;INFLAMMATION;RETROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;HEART FAILURE;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;REGIMEN;STROKE (ENGINE);VIRUS","23;18;13;12;11;10;9;9;9;9;9;7;7;6;6;6;6;6;6;6","CLINICAL ENDPOINT;MUTATION;TOLERABILITY;COLORECTAL CANCER;FETUS;GESTATIONAL AGE;PERCUTANEOUS CORONARY INTERVENTION;PHASES OF CLINICAL RESEARCH;RITUXIMAB;CYTARABINE;EJECTION FRACTION;IMATINIB;IMMUNOTHERAPY;LIPID PEROXIDATION;MANTLE CELL LYMPHOMA;NEUTROPENIA;PARKINSON'S DISEASE;PHENOTYPE;RETINOBLASTOMA;RETT SYNDROME;REVASCULARIZATION;TRANSCRANIAL MAGNETIC STIMULATION;VIRAL LOAD","7;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","EXOME SEQUENCING;RIBAVIRIN;ANTIRETROVIRAL THERAPY;NILOTINIB;ALPORT SYNDROME;AZOOSPERMIA;BENDAMUSTINE;BIORESORBABLE SCAFFOLD;BRONCHOPULMONARY DYSPLASIA;CARDIAC RESYNCHRONIZATION THERAPY;COMPARATIVE GENOMIC HYBRIDIZATION;DASATINIB;IMATINIB MESYLATE;KLEBSIELLA PNEUMONIAE;MECP2;MISSENSE MUTATION;MODIFIED RANKIN SCALE;NIVOLUMAB;PERIVENTRICULAR LEUKOMALACIA;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RETINOPATHY OF PREMATURITY;TARGET LESION;VEMURAFENIB","4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;MULTIPLE MYELOMA;ADOLESCENT;ANTINEOPLASTIC AGENTS;BRAIN NEOPLASMS;RETT SYNDROME;MUTATION;YOUNG ADULT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","97;71;71;70;46;43;37;25;23;23;17;15;14;13;13;13;13;12;12;11","MANAGEMENT OF VALVULAR HEART DISEASE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EFFICACY AND RESISTANCE IN CML TREATMENT;LYMPHOID NEOPLASMS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;OCULAR CANCER RESEARCH AND TREATMENT;CANCER IMMUNOTHERAPY;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GLIOMAS;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND TREATMENT OF RETINOPATHY OF PREMATURITY;HEPATITIS C INFECTION AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;IMPACT OF BURNOUT ON HEALTHCARE PROFESSIONALS AND STUDENTS;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER","5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","CLINICAL ENDPOINT;TREATMENT;REGIMEN;MANTLE CELL LYMPHOMA;STROKE (ENGINE);TOLERABILITY;INFARCTION TREATMENT;INTRAOCULAR CHEMOTHERAPY;PROSTHETIC VALVES EVALUATION;TRANSCATHETER AORTIC-VALVE REPLACEMENT;EXOME;HEMATOLOGY;INTERNATIONAL MYELOMA WORKING GROUP;RETINOBLASTOMA;RETT SYNDROME;RITONAVIR;RITUXIMAB;ALPORT SYNDROME;ANTIRETROVIRAL THERAPY;AUTOLOGOUS STEM-CELL TRANSPLANTATION","7;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2","CANCER PATIENTS;CHRONIC MYELOID;MYELOID LEUKEMIA;OXIDATIVE STRESS;PRELIMINARY RESULTS;ALPORT SYNDROME;CELL LYMPHOMA;EMERGENCY DEPARTMENT;EXOME SEQUENCING;HEART FAILURE;MANTLE CELL;MULTIPLE MYELOMA;PHASE TRIAL;SAFETY DATA;ACCESS PROGRAMME;ACUTE ISCHEMIC;ALTERED RECOVERY;ATRIAL FIBRILLATION;BALLOON-EXPANDABLE VALVE;BIORESORBABLE SCAFFOLD;CENTRAL NERVOUS;CHILDREN AGED;COLORECTAL CANCER;COMPUTED TOMOGRAPHY;CONTROLLED TRIAL;DECODE REGISTRY;ELDERLY PATIENTS;EXPANDED ACCESS;FINAL RESULTS;FONDAZIONE ITALIANA","5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ITALY HEMATOLOGY;HEMATOLOGY UNIT;ADVERSE EVENTS;CANCER PATIENTS;ATRIAL FIBRILLATION;HYALURONIC ACID;PINEAL GLAND;SERUM CHOLESTEROL;HR CI-;ITALY DEPARTMENT;MONTHS RANGE;ROME ITALY;ATAZANAVIRRITONAVIR LAMIVUDINE;CV EVENTS;ELDERLY PATIENTS;PATIENTS TREATED;TOTAL SERUM;CLINICAL PRACTICE;GASTROINTESTINAL TRACT;HEMATOLOGY UNIVERSITY;PATIENTS PTS;PRIMARY ENDPOINT;STRUCTURAL DAMAGE;CARBON DIOXIDE;CAROTID ARTERY;COMPLETE RESPONSE;EXTERNAL CAROTID;HIGHLY CO-MORBID;INTRA-ARTERIAL CHEMOTHERAPY;MAGNETIC RESONANCE","21;18;17;11;10;9;9;9;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5",46,0.27,9.71,9.75,1,1,1,1,1,0,2.5,10,0,0,9,1,1,1,3,6,4,0,0,79,79,3,0,0,3,0,0,0,0,0,0,0,0,2,0,1,5.5,5.5,2.48,1.33333333333333,1,1,2,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ARAQUE JOSÉ-ESTÉ;BOTTA MAURIZIO;BRAI ANNALAURA;DELLA VALLE ELENA;FAZI ROBERTA;MARTINEZ DE LA SIERRA MIGUEL-ANGEL;MARTINEZ JAVIER;MEYERHANS ANDREAS;PIANIGIANI ELISA;RAMELLI MASSIMILIANO","1;1;1;1;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIV SENESE;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;TISSUELAB S R L CON UNICO SOCIO","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;40 ENGINEERING","2;1;1;1;1",NA,NA,"5.1 PHARMACEUTICALS","1","A01N1/02;A61K31/41;A61K31/4192;A61K31/4245;A61K31/433;A61K31/4439;A61K31/4725;A61L27/36;A61P31/12;C07D249/04","1;1;1;1;1;1;1;1;1;1","C07D249/06;C07D257/04;C07D401/12;C07D405/12;A01N1/00;A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439","2;2;2;2;1;1;1;1;1;1",19,3.72,383.61,8.12,9,0.47,53.05,2,2,2,0,2,0,4,7,0,11,7,0,0,0,0,0,0,18,1,0,18,1,0,0,0,0,0,0,0,0,"United States;Japan","7;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","19;11;8;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;LUNG;AUTOIMMUNE DISEASE;ARTHRITIS;CARDIOVASCULAR;LUNG CANCER;LYMPHOMA;ORPHAN DRUG;PATIENT SAFETY;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;BIOENGINEERING;BREAST CANCER;CHILDHOOD LEUKEMIA;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH","17;12;9;7;5;5;3;2;2;2;2;2;2;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL;RESPIRATORY;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;INJURIES AND ACCIDENTS","7;2;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;6.4 SURGERY;7.3 MANAGEMENT AND DECISION MAKING","12;3;1;1;1","LEUKEMIA / LEUKAEMIA;LUNG CANCER;MELANOMA;BREAST CANCER;COLON AND RECTAL CANCER;KIDNEY CANCER;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","4;3;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","7;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"PUBLIC LIBRARY OF SCIENCE","10","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;40 ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3105 GENETICS;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;4018 NANOTECHNOLOGY;46 INFORMATION AND COMPUTING SCIENCES;51 PHYSICAL SCIENCES;5106 NUCLEAR AND PLASMA PHYSICS","4;3;2;2;2;1;1;1;1;1;1;1;1","HIV/AIDS","1","CONGENITAL;GENERIC HEALTH RELEVANCE;INFECTION;RESPIRATORY","3;1;1;1",NA,NA,"BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","4","LUNG CANCER","1",NA,NA
"AOU_SENESE",2017,190,12.3947368421053,2.55789473684211,0.378947368421053,0.352631578947368,0.457894736842105,1.79335793357934,1.53191489361702,1.45652173913043,1.5,0.536842105263158,0,84,48,22,24,0.44,0.25,0.12,0.13,17.47,0.592830132157392,5,0.289473684210526,0.921052631578947,0.43,0.334,0.372,0.33,"MONICA BOCCHIA;ALBERTO FABBRI;EMANUELE CENCINI;MARIA ANTONIETTA MAZZEI;MASSIMO FINESCHI;JOUSSEF HAYEK;FRANCESCO GENTILI;ALFONSO CERASE;FRANCESCO GIUSEPPE MAZZEI;DESIDERIO PASSÀLI;ALESSANDRO IADANZA;LAURA LIPPA;NICOLA NANTE;ANTONELLA FIORAVANTI;MICHELE MAIO;MAURO BACCI;ISABELLA MERCURIO;ANDREA DE LUCA;MARIA CARLA SPINOSI;ANTONIO FEDERICO","10;10;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5","LAURA LIPPA;FRANCESCO CACCIOLA;DESIDERIO PASSÀLI;MARIA CARLA SPINOSI;ANDREA FAGIOLINI;ALBERTO FABBRI;MAURIZIO ACAMPA;MONICA BOCCHIA;CARLO PIERLI;MASSIMO FINESCHI;ALFONSO CERASE;EMANUELE CENCINI;MARIA ANTONIETTA MAZZEI;NICOLA NANTE;ANTONELLA FIORAVANTI;MAURO BACCI;ISABELLA MERCURIO;GIUSEPPE MARTINI;PIETRO ENEA LAZZERINI;JOUSSEF HAYEK","2;1.75;1.15;1.12;1.04;1.01;0.97;0.95;0.94;0.92;0.91;0.88;0.87;0.86;0.85;0.83;0.83;0.82;0.79;0.78","MONICA BOCCHIA;ALBERTO FABBRI;EMANUELE CENCINI;MARIA ANTONIETTA MAZZEI;MASSIMO FINESCHI;JOUSSEF HAYEK;FRANCESCO GENTILI;ALFONSO CERASE;FRANCESCO GIUSEPPE MAZZEI;DESIDERIO PASSÀLI;ALESSANDRO IADANZA;LAURA LIPPA;ANTONELLA FIORAVANTI;MICHELE MAIO;ISABELLA MERCURIO;ANDREA DE LUCA;MARIA CARLA SPINOSI;ANTONIO FEDERICO;LUIGI PIRTOLI;CARLO PIERLI","10;10;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5","LAURA LIPPA;FRANCESCO CACCIOLA;DESIDERIO PASSÀLI;MARIA CARLA SPINOSI;ANDREA FAGIOLINI;ALBERTO FABBRI;MAURIZIO ACAMPA;MONICA BOCCHIA;CARLO PIERLI;MASSIMO FINESCHI;ALFONSO CERASE;EMANUELE CENCINI;MARIA ANTONIETTA MAZZEI;ANTONELLA FIORAVANTI;ISABELLA MERCURIO;GIUSEPPE MARTINI;JOUSSEF HAYEK;FRANCESCO GENTILI;LUCIA MONTI;SARA CHELESCHI","2;1.75;1.15;1.12;1.04;1.01;0.97;0.95;0.94;0.92;0.91;0.88;0.87;0.85;0.83;0.82;0.78;0.72;0.63;0.6","ALBERTO FABBRI;ANDRÉS J.M. FERRERI;MAURILIO PONZONI;ELISABETH SCHORB;GERALD ILLERHAUS;JEFFERY SMITH;KATE CWYNARSKI;KIM LINTON;ACHILLE AMBROSETTI;ALESSANDRA TUCCI;ALESSANDRO LEVIS;ALEXANDER RÖTH;BERND HERTENSTEIN;CHRISTOPHER P. FOX;CLAIRE HEMMAWAY;ELEONORA MINACAPELLI;ELISA JACOBSEN PULCZYNSKI;EMANUELE ZUCCA;F. ANGRILLI;FIORELLA ILARIUCCI","350;333;331;301;301;301;301;301;299;299;299;299;299;299;299;299;299;299;299;299","ALBERTO FABBRI;MONICA BOCCHIA;ANTONELLA FIORAVANTI;ROSSANA TASSI;MAURIZIO ACAMPA;FRANCESCA GUIDERI;JOUSSEF HAYEK;MARCO MANDALÀ;DANIELE NUTI;ALFONSO CERASE;NICOLA ANTONIO PASCARELLI;GIANNI LORENZINI;SARA CHELESCHI;DANIELA ROSSI;LUCIA GALLI;VINCENZO SORRENTINO;LUCIA MONTI;ELISA GUARINO;FRANCESCO DOTTA;D LENZI","347;295;229;200;177;159;129;119;116;115;115;110;92;90;90;90;79;77;77;76","ALBERTO FABBRI;MONICA BOCCHIA;EMANUELE CENCINI;JOUSSEF HAYEK;MASSIMO FINESCHI;ALESSANDRO IADANZA;ALFONSO CERASE;MAURIZIO ACAMPA;ANTONELLA FIORAVANTI;FRANCESCO GIUSEPPE MAZZEI;ISABELLA MERCURIO;MARIA ANTONIETTA MAZZEI;MARIA CARLA SPINOSI;LAURA LIPPA;ALESSIO CORTELAZZO;ANDREA DE LUCA;CARLO PIERLI;DESIDERIO PASSÀLI;FRANCESCO CACCIOLA;FRANCESCO GENTILI","9;9;8;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;BUSINESS;ECONOMICS;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;GEOGRAPHY;HISTORY","174;52;14;12;10;9;8;6;4;3;3;3;3;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;GENETICS;ONCOLOGY;RADIOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;PSYCHIATRY;IMMUNOLOGY;ENDOCRINOLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;ANATOMY;CANCER RESEARCH;PALEONTOLOGY;PHYSICAL THERAPY;ANESTHESIA;OPTICS;PHARMACOLOGY","123;62;41;31;28;28;23;21;20;16;15;14;12;11;10;10;10;10;9;7;7","GENE;CANCER;CHEMOTHERAPY;ALTERNATIVE MEDICINE;LYMPHOMA;REGIMEN;DISEASE;ADVERSE EFFECT;CLINICAL TRIAL;MYOCARDIAL INFARCTION;HEART FAILURE;LUNG;LUNG CANCER;POPULATION;RETROSPECTIVE COHORT STUDY;ATRIAL FIBRILLATION;RANDOMIZED CONTROLLED TRIAL;TRANSPLANTATION;MAGNETIC RESONANCE IMAGING;PATHOGENESIS;RADIATION THERAPY;STAGE (STRATIGRAPHY);STENOSIS;STROKE (ENGINE)","28;22;19;13;12;12;11;10;10;10;9;9;9;9;9;8;8;8;6;6;6;6;6;6","CLINICAL ENDPOINT;RITUXIMAB;METASTASIS;IMMUNOTHERAPY;OSTEOARTHRITIS;PHENOTYPE;AORTIC VALVE REPLACEMENT;CYCLOPHOSPHAMIDE;DIFFUSE LARGE B-CELL LYMPHOMA;EJECTION FRACTION;GENOTYPE;MICRORNA;PERCUTANEOUS CORONARY INTERVENTION;BEVACIZUMAB;INTERIM ANALYSIS;MUTATION;PLACEBO;RETT SYNDROME;BALNEOTHERAPY;BREAST CANCER;CONVENTIONAL PCI;ETOPOSIDE;GENE EXPRESSION;HAZARD RATIO;HEART TRANSPLANTATION;HEPATITIS C VIRUS;IMATINIB;ISCHEMIC STROKE;LIPID PEROXIDATION;NASAL SEPTUM;PROSTATE CANCER;TOLERABILITY;UNIVARIATE ANALYSIS;VALVE REPLACEMENT","9;9;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","NIVOLUMAB;MECP2;VINCRISTINE;ANDROGEN RECEPTOR;DASATINIB;INTERNATIONAL PROGNOSTIC INDEX;LYMPHATIC VESSEL;LYMPHEDEMA;LYMPHOVASCULAR INVASION;MICROSATELLITE;MONOCLONAL;PHARMACOGENETICS;SYNOVIAL FLUID;THIOTEPA;VISMODEGIB;AFLIBERCEPT;AGGRESSIVE LYMPHOMA;ALPORT SYNDROME;ANDROGEN DEPRIVATION THERAPY;ANTIANDROGEN;ANTIRETROVIRAL THERAPY;ANTISACCADE TASK;ARTHROPATHY;ARTICULAR CARTILAGE;ASYMMETRIC DIMETHYLARGININE;ATRIAL TACHYCARDIA;BIORESORBABLE SCAFFOLD;BREAKPOINT;CADASIL;CARDIAC RESYNCHRONIZATION THERAPY;CHA2DS2–VASC SCORE;CHEMOIMMUNOTHERAPY;CHIARI MALFORMATION;CIRCULATING TUMOR CELL;CONNECTIVE TISSUE DISEASE;DANIO;DKK1;DRUG-ELUTING STENT;DRY-POWDER INHALER;ELTROMBOPAG;ENHANCER;EXHALED NITRIC OXIDE;EXOME SEQUENCING;FORMOTEROL;FRACTIONAL FLOW RESERVE;FRAMESHIFT MUTATION;GENE EXPRESSION PROFILING;GENOTYPING;GERMLINE MUTATION;GESTATIONAL DIABETES;GLI1;GLOMERULAR BASEMENT MEMBRANE;GLYCATED HEMOGLOBIN;HBSAG;HEPACIVIRUS;HEREDITARY SPASTIC PARAPLEGIA;HYPOPHYSITIS;INTERGENIC REGION;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;IPILIMUMAB;ISOPROSTANES;KAEMPFEROL;KNEE PAIN;KRAS;LIVE DONOR;LRP5;LRP6;LUNG FIBROSIS;MACE;MALE INFERTILITY;MARGINAL ZONE;METHYLENE BLUE;MISSENSE MUTATION;MITOCHONDRIAL FUSION;MITOPHAGY;MODIFIED RANKIN SCALE;MULTILOCUS SEQUENCE TYPING;NILOTINIB;NULL ALLELE;OFATUMUMAB;OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT;PALIPERIDONE;PARKIN;PEMBROLIZUMAB;PENETRANCE;PHOSPHENE;PINOCEMBRIN;PODOCYTE;POLYCYSTIC OVARY;POSTURAL INSTABILITY;PREAMPLIFIER;PRETERM LABOR;PRIMARY MOTOR CORTEX;RANIBIZUMAB;REPRESSOR;REPRODUCTIVE TECHNOLOGY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RETINOPATHY OF PREMATURITY;RETURN OF SPONTANEOUS CIRCULATION;RUBELLA;SENTINEL LYMPH NODE;SINGLE-NUCLEOTIDE POLYMORPHISM;SMOOTHENED;SRC FAMILY KINASE;STREPTOCOCCUS PYOGENES;THROMBOPOIETIN;TITIN;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;WOMAC","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;TREATMENT OUTCOME;RETT SYNDROME;PROSPECTIVE STUDIES;HEART FAILURE;MAGNETIC RESONANCE IMAGING;BIOMARKERS;YOUNG ADULT;HIV INFECTIONS;RETROSPECTIVE STUDIES;STOMACH NEOPLASMS;STROKE","103;84;78;73;57;46;35;26;25;22;17;15;14;14;13;13;12;12;12;12","LYMPHOID NEOPLASMS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;MANAGEMENT OF VALVULAR HEART DISEASE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;ATRIAL FIBRILLATION;CANCER IMMUNOTHERAPY;ORGAN TRANSPLANTATION AND REJECTION;DIAGNOSIS AND TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;EFFICACY AND RESISTANCE IN CML TREATMENT;GASTRIC CANCER RESEARCH AND TREATMENT;OCULAR CANCER RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;THERAPEUTIC APPLICATIONS OF CLAY MINERALS IN HEALTH;ACCURACY OF CLINICAL CODING IN HEALTHCARE DATA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA","8;6;6;6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2","REGIMEN;CLINICAL ENDPOINT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;PATHOGENESIS;PROSTHETIC VALVES EVALUATION;STROKE (ENGINE);TREATMENT;CARDIAC IMAGING;MANTLE CELL LYMPHOMA;DISCONTINUATION;HEMATOLOGY;INTERIM ANALYSIS;RETT SYNDROME;BALNEOTHERAPY;CARDIOVASCULAR RISK ASSESSMENT;CORONARY STENTS;DRUG-ELUTING STENTS;EXPANDED ACCESS;GASTRIC CANCER;HEPATITIS C","12;10;8;6;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3","AORTIC VALVE;ATRIAL FIBRILLATION;TRANSCATHETER AORTIC;B-CELL LYMPHOMA;CANCER PATIENTS;CORONARY INTERVENTION;ISCHEMIC STROKE;PERCUTANEOUS CORONARY;RETT SYNDROME;VALVE REPLACEMENT;ACCESS PROGRAMME;CHRONIC MYELOID;CLINICAL PRACTICE;EXPANDED ACCESS;GASTRIC CANCER;HEART FAILURE;KNEE OSTEOARTHRITIS;LUNG CANCER;MAGNETIC RESONANCE;MYELOID LEUKEMIA;OXIDATIVE STRESS;PATIENTS TREATED;PATIENTS UNDERGOING;PHASE II;SINGLE CENTER;SURGICAL TREATMENT;TCT- IMPACT;WIN-TAVI REGISTRY;ALTERATION EFFICACY;APNEA SYNDROME","7;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","JOINT INSTABILITY;KNEE JOINT;CHADS-VASC SCORE;ADVERSE EVENTS;LUNG CANCER;PFIZER NOVARTIS;PRESTROKE CHADS-VASC;SAFETY PROFILE;SELF-REPORTED KNEE;AOR CI;B- CI-;EXPRESSION LEVELS;FODMAP DIET;LOW FODMAP;MEDIAN FOLLOW-UP;MSI-H NON-CRC;MUCOCILIARY CLEARANCE;NASAL SPRAY;TYPE DIABETES;EYELID MARGIN;ISCHEMIC STROKE;LOGISTIC REGRESSION;MSI-H CRC;PATIENTS PTS;ACEF II;ACUTE ISCHEMIC;ADVISORY BOARD;ATEZO BEV;ATRIAL FIBRILLATION;BF TURBUHALER","16;16;13;11;10;10;10;9;9;8;8;8;8;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6",39,0.21,4.45,5.5,2,1,0,2,3,0,1,6,0,0,5,1,1,1,2.25,4,2.75,0,0,72.5,72.5,4,0,2,2,0,1,0,0,0,0,0,0,3,1,1,1,4,4.12,1.4,0,2,3,0,0,3,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BOTTA MAURIZIO;BRAI ANNALAURA;TINTORI CRISTINA;ARAQUE JOSÉ-ESTÉ;DELLA VALLE ELENA;FAZI ROBERTA;MAGA GIOVANNI;MAIO MICHELE;MARTINEZ DE LA SIERRA MIGUEL-ANGEL;MARTINEZ JAVIER","3;3;3;1;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;AZIENDA OSPEDALIERA UNIV SENESE;CENTRO DI RIFERIMENTO ONCOLOGICO - ISTITUTO NAZIONALE TUMORI - AVIANO;TISSUELAB SRL CON UNICO SOCIO","3;2;1;1","34 CHEMICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;3402 INORGANIC CHEMISTRY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;40 ENGINEERING","3;2;1;1;1;1",NA,NA,"5.1 PHARMACEUTICALS","2","A61K31/41;A61K31/4192;A61K31/4245;A61K31/433;A61K31/18;A61K31/4196;A61K31/42;A61K31/497;A61K31/5377;A61K31/675","3;3;3;3;2;2;2;2;2;2","A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/496;A61K31/5377;A61K31/675;A61K31/7056;A61K45/06","3;3;3;3;3;3;3;3;3;3",18,4.89,454.33,7.32,11,0.61,85.61,0,0,3,1,8,0,1,5,0,14,4,0,0,0,0,0,0,18,0,0,18,0,0,0,0,0,0,0,0,0,"United States;Italy","8;3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;49 MATHEMATICAL SCIENCES;4901 APPLIED MATHEMATICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","17;7;6;3;3;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;LYMPHOMA;PATIENT SAFETY;ARTHRITIS;CARDIOVASCULAR;NEUROSCIENCES;ORPHAN DRUG;AGING;ALS;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CHRONIC PAIN;EYE DISEASE AND DISORDERS OF VISION;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","17;12;6;5;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;EYE;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;NEUROLOGICAL","3;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY","13;2;2;1;1;1","NON-HODGKIN'S LYMPHOMA;MELANOMA;LUNG CANCER","3;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","5",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","10;2","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;44 HUMAN SOCIETY;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY;3105 GENETICS;3107 MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;4403 DEMOGRAPHY;4409 SOCIAL WORK","7;5;4;3;3;2;2;1;1;1;1;1;1;1","RARE DISEASES;BRAIN DISORDERS;CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;GENETICS;HIV/AIDS;HUMAN GENOME;INFECTIOUS DISEASES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY","2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;MUSCULOSKELETAL","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS","2;1;1","BIOMEDICAL;CLINICAL;POPULATION & SOCIETY","1;1;1","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH;PUBLIC HEALTH","3;1;1","STOMACH CANCER","1","4 QUALITY EDUCATION","1"
"AOU_SENESE",2018,181,16.8342541436464,2.33701657458564,0.270718232044199,0.25414364640884,0.364640883977901,1.69879518072289,1.44117647058824,1.24324324324324,1.5,0.541436464088398,2,98,48,10,16,0.54,0.27,0.06,0.09,24.97,0.818363797627415,4.789592760181,0.430939226519337,0.950276243093923,0.44,0.444,0.399,0.44,"VALERIO ZACÀ;ROSSANA TASSI;GIUSEPPE MARTINI;ALESSANDRO IADANZA;MAURIZIO ACAMPA;MONICA BOCCHIA;MASSIMO FINESCHI;MAURO BIFFI;GABRIELE MESSINA;MARIA ANTONIETTA MAZZEI;FAUSTO CASTAGNETTI;THIERRY LEFÈVRE;PIETRO ENEA LAZZERINI;ELISABETTA ABRUZZESE;ÉLISA CINOTTI;PATRIZIA PRESBITERO;FRANCESCA GUIDERI;DANIELE MARRELLI;DIDIER TCHÉTCHÉ;GENNARO SARDELLA","12;11;11;10;9;8;8;8;7;7;6;6;6;6;6;6;6;6;6;6","VALERIO ZACÀ;GIUSEPPE MARTINI;MAURIZIO ACAMPA;PIETRO ENEA LAZZERINI;BARBARA PAOLINI;GABRIELE MESSINA;NICOLA NANTE;ROSSANA TASSI;ISABELLA MERCURIO;GIANMARCO TROIANO;FABIO FERRETTI;MAURO BACCI;MARIA ANTONIETTA MAZZEI;CHIARA MEZZEDIMI;ALESSANDRO IADANZA;ÉLISA CINOTTI;MARIA CARLA SPINOSI;MAURO BIFFI;D LENZI;RANUCCIO NUTI","1.84;1.4;1.36;1.24;1.14;0.93;0.83;0.82;0.81;0.81;0.77;0.67;0.65;0.65;0.65;0.63;0.62;0.6;0.6;0.6","VALERIO ZACÀ;ROSSANA TASSI;GIUSEPPE MARTINI;ALESSANDRO IADANZA;MAURIZIO ACAMPA;MONICA BOCCHIA;MASSIMO FINESCHI;MARIA ANTONIETTA MAZZEI;ÉLISA CINOTTI;FRANCESCA GUIDERI;DANIELE MARRELLI;ISABELLA MERCURIO;ANDREA DE LUCA;ALBERTO FABBRI;CARLA VINDIGNI;ALESSANDRA RENIERI;D LENZI;ALFONSO CERASE;RANUCCIO NUTI;ALESSANDRO GOZZETTI","12;11;11;10;9;8;8;7;6;6;6;5;5;5;5;5;5;4;4;4","VALERIO ZACÀ;GIUSEPPE MARTINI;MAURIZIO ACAMPA;BARBARA PAOLINI;ROSSANA TASSI;ISABELLA MERCURIO;FABIO FERRETTI;MARIA ANTONIETTA MAZZEI;CHIARA MEZZEDIMI;ALESSANDRO IADANZA;ÉLISA CINOTTI;MARIA CARLA SPINOSI;D LENZI;RANUCCIO NUTI;FRANCESCA GUIDERI;ANDREA DE LUCA;MASSIMO FINESCHI;ALFONSO CERASE;DANIELE MARRELLI;A TINTURINI","1.84;1.4;1.36;1.14;0.82;0.81;0.77;0.65;0.65;0.65;0.63;0.62;0.6;0.6;0.59;0.59;0.58;0.57;0.55;0.51","THOMAS POWLES;ALAIN RAVAUD;ALPA THOBHANI;BERNARD ESCUDIER;BRIAN I. RINI;CHRISTINA SCHIFF;CRISTINA SUÁREZ;DANIEL S. CHEN;DAVID F. MCDERMOTT;DOROTHEE NICKLES;ELISABETH PIAULT‐LOUIS;GREGG FINE;JAMES A. REEVES;JIAHENG QIU;JOHN D. HAINSWORTH;LAWRENCE FONG;MAHRUKH HUSENI;MARIO SZNOL;MARTIN GORE;MICHAEL B. ATKINS","1042;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036;1036","RICCARDO DANIELLI;ALESSANDRA RENIERI;ALESSANDRO IADANZA;ROSSANA TASSI;GUIDO GAROSI;FRANCESCA MARI;MAURIZIO ACAMPA;ALESSANDRO GOZZETTI;MASSIMO FINESCHI;AURORA CURRÒ;ALBERTO PALAZZUOLI;FRANCESCA GUIDERI;GIUSEPPE MARTINI;MONICA BOCCHIA;ANDREA DE LUCA;ÉLISA CINOTTI;PIETRO RUBEGNI;MARIA ANTONIETTA MAZZEI;ANNA SICURANZA;DONATELLA RASPADORI","1036;452;284;229;220;211;192;183;183;173;156;146;142;138;130;119;108;107;106;106","VALERIO ZACÀ;ALESSANDRO IADANZA;ROSSANA TASSI;MAURIZIO ACAMPA;MONICA BOCCHIA;GIUSEPPE MARTINI;MASSIMO FINESCHI;ÉLISA CINOTTI;ALBERTO FABBRI;D LENZI;ISABELLA MERCURIO;PIETRO RUBEGNI;ALESSANDRA RENIERI;FRANCESCA GUIDERI;MARIA ANTONIETTA MAZZEI;A TINTURINI;ALESSANDRO GOZZETTI;CARLA VINDIGNI;EMANUELE CENCINI;FABIO FERRETTI","12;10;9;8;8;8;7;6;5;5;5;5;5;5;5;4;4;4;4;4","MEDICINE;BIOLOGY;ENGINEERING;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;MATHEMATICS;ECONOMICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY;PHILOSOPHY;ART;BUSINESS","174;48;22;15;15;12;10;8;7;7;5;4;2;2;2;2;1;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;ENVIRONMENTAL HEALTH;GENETICS;PATHOLOGY;RADIOLOGY;ONCOLOGY;MECHANICAL ENGINEERING;GASTROENTEROLOGY;PSYCHIATRY;BIOCHEMISTRY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;NURSING;ANESTHESIA;NUCLEAR MEDICINE;PEDIATRICS;CELL BIOLOGY;DERMATOLOGY","119;44;39;29;29;29;24;23;19;18;18;17;17;14;11;10;9;9;8;7;7","GENE;CANCER;STROKE (ENGINE);POPULATION;ATRIAL FIBRILLATION;CONFIDENCE INTERVAL;ALTERNATIVE MEDICINE;CLINICAL TRIAL;MYOCARDIAL INFARCTION;ADVERSE EFFECT;CHEMOTHERAPY;DISEASE;RANDOMIZED CONTROLLED TRIAL;COHORT;LYMPHOMA;PROSPECTIVE COHORT STUDY;HEART FAILURE;MYELOID LEUKEMIA;STENOSIS;AORTIC VALVE;CORONARY ARTERY DISEASE;HEALTH CARE;VIRUS","27;17;17;16;12;12;11;11;11;10;10;10;10;9;8;8;7;7;7;6;6;6;6","CLINICAL ENDPOINT;MUTATION;PHENOTYPE;HAZARD RATIO;RITUXIMAB;BREAST CANCER;EJECTION FRACTION;IMATINIB;ALLELE;AORTIC VALVE STENOSIS;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CONVENTIONAL PCI;DIFFUSE LARGE B-CELL LYMPHOMA;GENE EXPRESSION;HEPATITIS C VIRUS;MULTICENTER STUDY;PERCUTANEOUS CORONARY INTERVENTION;PHASES OF CLINICAL RESEARCH;RETT SYNDROME;UNIVARIATE ANALYSIS","9;8;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","NILOTINIB;ANTIRETROVIRAL THERAPY;ATRIAL TACHYCARDIA;BENDAMUSTINE;COMPOUND HETEROZYGOSITY;DASATINIB;IMATINIB MESYLATE;MECP2;NEOADJUVANT THERAPY;RIBAVIRIN;AORTIC VALVULOPLASTY;CARDIAC RESYNCHRONIZATION THERAPY;CD38;DNA METHYLATION;ENDOVASCULAR ANEURYSM REPAIR;EXOME SEQUENCING;INTERNATIONAL PROGNOSTIC INDEX;LEUKOARAIOSIS;MICROSATELLITE;MODIFIED RANKIN SCALE;NIVOLUMAB;RNA SPLICING;SANGER SEQUENCING;VEMURAFENIB","4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;;MALE;AGED;MIDDLE AGED;AGED, 80 AND OVER;ITALY;ADULT;AORTIC VALVE STENOSIS;TREATMENT OUTCOME;STROKE;AORTIC VALVE;PROSPECTIVE STUDIES;TRANSCATHETER AORTIC VALVE REPLACEMENT;RETROSPECTIVE STUDIES;HEART FAILURE;TIME FACTORS;RISK FACTORS;ATRIAL FIBRILLATION","102;84;78;67;48;47;40;40;34;31;28;25;23;23;23;20;19;19;18;17","MANAGEMENT OF VALVULAR HEART DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EFFICACY AND RESISTANCE IN CML TREATMENT;ATRIAL FIBRILLATION;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;HEPATITIS C INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MELANOMA;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;ACCURACY OF CLINICAL CODING IN HEALTHCARE DATA;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF VOICE DISORDERS;GASTRIC CANCER RESEARCH AND TREATMENT;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS","9;7;7;7;6;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2","STROKE (ENGINE);CLINICAL ENDPOINT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;PROSTHETIC VALVES EVALUATION;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;ATRIAL FIBRILLATION;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CARDIAC RESYNCHRONIZATION THERAPY;DISCONTINUATION;HEPATITIS C;INFARCTION TREATMENT;INFLAMMATION;MELANOMA;METASTATIC GASTRIC CANCER;RETT SYNDROME;SURGICAL AORTIC-VALVE REPLACEMENT;TREATMENT;UNIVARIATE ANALYSIS;UPGRADE","16;9;9;8;6;6;4;4;4;4;4;4;4;4;4;4;4;4;4;4","AORTIC VALVE;TRANSCATHETER AORTIC;ATRIAL FIBRILLATION;PATIENTS UNDERGOING;CHRONIC MYELOID;GASTRIC CANCER;HEART FAILURE;MULTICENTER STUDY;MYELOID LEUKEMIA;PHASE II;COHORT STUDY;CONFOCAL MICROSCOPY;DECODE REGISTRY;PRELIMINARY RESULTS;RETT SYNDROME;STEM CELL;VALVE IMPLANTATION;ACUTE ISCHEMIC;ANTITACHYCARDIA PACING;ATRIAL ANTITACHYCARDIA;ATRIAL TACHYARRHYTHMIAS;CORONARY INTERVENTION;CRYPTOGENIC STROKE;FONDAZIONE ITALIANA;HEALTHCARE-ASSOCIATED INFECTIONS;II TRIAL;ISCHAEMIC STROKE;ISCHEMIC STROKE;ITALIANA LINFOMI;LEUKEMIA PATIENTS","7;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","ALPORT SYNDROME;PUBMED SCOPUS;CROSSREF PUBMED;BASEMENT MEMBRANE;ATRIAL FIBRILLATION;RENAL DISEASE;HR CI;THIN BASEMENT;NEPHROL -CROSSREF;AUTOSOMAL RECESSIVE;COLLAGEN IV;SPEAKERS BUREAU;HETEROZYGOUS MUTATIONS;CONFIDENCE INTERVAL;IV Α;MEMBRANE NEPHROPATHY;PATIENTS TREATED;SOC NEPHROL;CONSULTANCY HONORARIA;FEMALE SUBJECTS;RECESSIVE ALPORT;ADVISORY COMMITTEES;AUTOSOMAL DOMINANT;FOCAL SEGMENTAL;ENTITYS BOARD;RESEARCH FUNDING;X-LINKED ALPORT;BRISTOL-MYERS SQUIBB;ELTS SCORE;INT -ABSTRACT","93;42;32;28;22;20;19;19;18;17;17;17;15;14;14;14;14;14;13;13;13;12;12;12;11;11;11;10;10;10",50,0.28,8.73,6,1.25,2,0,5,6.25,0,1,7,0,0,6.5,0,0,1,3,7,6,0,0,57.75,57.75,2,2,0,1,1,0,0,0,0,0,0,0,3,0,1,3,6,5.67,1,0,0,4,1,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BOTTA MAURIZIO;BRAI ANNALAURA;TINTORI CRISTINA;MAGA GIOVANNI;ANDREAS MEYERHANS;ANNALAURA BRAI;ARAQUE JOSE-ESTE;CRISTINA TINTORI;FAZI ROBERTA;JAVIER MARTINEZ","3;3;3;2;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;AZIENDA OSPEDALIERA UNIV SENESE;AZIENDA OSPEDALIERA UNIVERSITARIA SENRESE","2;1;1","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;48 LAW AND LEGAL STUDIES;32 BIOMEDICAL AND CLINICAL SCIENCES;3402 INORGANIC CHEMISTRY;4806 PRIVATE LAW AND CIVIL OBLIGATIONS","5;2;2;1;1;1",NA,NA,"5.1 PHARMACEUTICALS","4","A61K31/4192;A61K31/4245;A61K31/433;A61K31/41;A61K31/42;A61K31/5377;A61K31/675;A61K31/7056;A61K31/18;A61K31/4196","4;4;4;3;3;3;3;3;2;2","A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/496;A61K31/5377;A61K31/675;A61K31/7056;A61K45/06","4;4;4;4;4;4;4;4;4;4",19,4.35,370.65,8.56,13,0.68,69.74,2,0,3,0,9,0,2,3,0,15,2,0,0,0,0,0,0,18,0,1,17,2,0,0,0,0,0,0,0,0,"United States;France;Italy;Japan;United Kingdom","8;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","19;8;7;2;2;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AGING;ARTHRITIS;AUTOIMMUNE DISEASE;PEDIATRIC;RARE DISEASES;AUTISM;BIOTECHNOLOGY;BRAIN DISORDERS;HEMATOLOGY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUNG;MENTAL HEALTH;BREAST CANCER;CHILDHOOD LEUKEMIA;CHRONIC PAIN;COLO-RECTAL CANCER;DIGESTIVE DISEASES","17;15;9;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1","CANCER;MUSCULOSKELETAL;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;RESPIRATORY","9;3;2;2;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","15;3;2;1;1","MELANOMA;LUNG CANCER;MYELOMA;BLADDER CANCER;BREAST CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER","3;2;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;3.3 CHEMOPREVENTION;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","9;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;MENDELEY DATA","4;4;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3008 HORTICULTURAL PRODUCTION;3215 REPRODUCTIVE MEDICINE;44 HUMAN SOCIETY;47 LANGUAGE, COMMUNICATION AND CULTURE;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;4403 DEMOGRAPHY","12;5;3;2;2;2;2;2;1;1;1;1;1","CARDIOVASCULAR;CANCER;GENETICS","3;1;1","CANCER","1","6.1 PHARMACEUTICALS","3","CLINICAL;POPULATION & SOCIETY;BIOMEDICAL","4;2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","4;3;2","MELANOMA;NOT SITE-SPECIFIC CANCER","1;1",NA,NA
"AOU_SENESE",2019,179,18.2122905027933,2.62011173184358,0.273743016759777,0.245810055865922,0.284916201117318,1.71428571428571,1.19512195121951,1.25714285714286,1.24390243902439,0.508379888268156,1,76,45,14,20,0.42,0.25,0.08,0.11,18.03,0.741604768849591,5.21524201853759,0.385474860335196,0.983240223463687,0.45,0.4,0.417,0.444,"ALESSANDRA RENIERI;MONICA BOCCHIA;ALBERTO FABBRI;MICHELE MAIO;JOUSSEF HAYEK;VALERIO ZACÀ;ANTONELLA FIORAVANTI;FRANCESCA RE;ELISA FRULLANTI;BARBARA ROSSETTI;SARA GALIMBERTI;STEFANO LUMINARI;MONICA TANI;ANDREA DE LUCA;ANNA MARIA PINTO;EMANUELE CENCINI;GUIDO FRANCINI;FRANCESCO MERLI;ANNA SICURANZA;MICHELE SPINA","14;10;10;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6","ANTONELLA FIORAVANTI;ALESSANDRA RENIERI;JOUSSEF HAYEK;ANNA COLUCCIA;FABIO FERRETTI;ANDREA POZZA;ALBERTO FABBRI;MONICA BOCCHIA;ALESSANDRA PECORELLI;GIUSEPPE VALACCHI;VALERIA CORDONE;FERNANDA AMICARELLI;SARA TENTI;LUCA GRIMALDI;GUIDO FRANCINI;NICOLA MONDANELLI;MARIA ANTONIETTA MAZZEI;MICHELE MAIO;ELISA FRULLANTI;SARA CHELESCHI","1.66;0.98;0.96;0.72;0.72;0.72;0.68;0.64;0.62;0.62;0.62;0.62;0.6;0.55;0.54;0.53;0.52;0.5;0.5;0.49","ALESSANDRA RENIERI;MONICA BOCCHIA;ALBERTO FABBRI;MICHELE MAIO;JOUSSEF HAYEK;VALERIO ZACÀ;ANTONELLA FIORAVANTI;BARBARA ROSSETTI;ANDREA DE LUCA;ANNA MARIA PINTO;EMANUELE CENCINI;GUIDO FRANCINI;ANNA SICURANZA;ANNA COLUCCIA;MARIA ANTONIETTA MENCARELLI;ALESSANDRO IADANZA;MARGHERITA BALDASSARRI;SARA TENTI;FABIO FERRETTI;ANDREA POZZA","14;10;10;8;8;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5","ANTONELLA FIORAVANTI;ALESSANDRA RENIERI;JOUSSEF HAYEK;ANNA COLUCCIA;FABIO FERRETTI;ANDREA POZZA;ALBERTO FABBRI;MONICA BOCCHIA;SARA TENTI;LUCA GRIMALDI;GUIDO FRANCINI;NICOLA MONDANELLI;MARIA ANTONIETTA MAZZEI;MICHELE MAIO;SARA CHELESCHI;ALFONSO CERASE;EMANUELE CENCINI;GIUSEPPE NISI;CESARE BRANDI;CRISTIANA BELLAN","1.66;0.98;0.96;0.72;0.72;0.72;0.68;0.64;0.6;0.55;0.54;0.53;0.52;0.5;0.49;0.49;0.46;0.46;0.46;0.46","ALESSANDRA RENIERI;GIUSEPPE BIONDI‐ZOCCAI;ENRICO ROMAGNOLI;CARLO TRANI;CORRADO TAMBURINO;FRANCESCO BURZOTTA;ALBERTO BOI;ALESSANDRO DI GIORGIO;ALESSIO LA MANNA;ELOISA ARBUSTINI;FERNÁNDO ALFONSO;FILIPPO CREA;FRANCESCO PRATI;FRANCESCO VERSACI;FRANCO FABBIOCCHI;GIAMPAOLO NICCOLI;GIANNI RUSCICA;GIUSEPPE CALLIGARIS;LAURA GATTO;MARIO ALBERTUCCI","394;359;351;327;327;327;296;296;296;296;296;296;296;296;296;296;296;296;296;296","ALESSANDRA RENIERI;MASSIMO FINESCHI;ANTONELLA FIORAVANTI;SARA TENTI;ROSSANA TASSI;MONICA BOCCHIA;SARA CHELESCHI;ALESSANDRO IADANZA;VALERIO ZACÀ;JOUSSEF HAYEK;INES GALLO;AURORA CURRÒ;SANDRA BRACCO;ALFONSO FAUSTO;BARBARA ROSSETTI;EMANUELE CENCINI;FRANCESCA GUIDERI;MAURIZIO ACAMPA;FRANCESCA MARI;ANNA SICURANZA","329;296;182;182;168;166;161;125;105;104;103;97;96;95;92;90;89;89;88;85","ALESSANDRA RENIERI;ALBERTO FABBRI;JOUSSEF HAYEK;BARBARA ROSSETTI;VALERIO ZACÀ;MICHELE MAIO;MONICA BOCCHIA;ANDREA DE LUCA;ANTONELLA FIORAVANTI;ANNA SICURANZA;EMANUELE CENCINI;ALESSANDRO IADANZA;MARIA ANTONIETTA MENCARELLI;ROSSANA TASSI;SANDRA BRACCO;SARA TENTI;SERAFINA VALENTE;ANNA MARIA PINTO;MARGHERITA BALDASSARRI;ALESSANDRO GOZZETTI","12;10;7;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;PSYCHOLOGY;MATHEMATICS;ECONOMICS;BUSINESS;SOCIOLOGY;PHILOSOPHY;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY;HISTORY;POLITICAL SCIENCE","166;62;14;14;13;12;9;8;7;4;3;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;GENETICS;CARDIOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;PATHOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;RADIOLOGY;PALEONTOLOGY;ENDOCRINOLOGY;PSYCHIATRY;CANCER RESEARCH;MECHANICAL ENGINEERING;CELL BIOLOGY;VIROLOGY;BIOINFORMATICS;ECONOMIC GROWTH;INTENSIVE CARE MEDICINE;NEUROSCIENCE;NURSING;OPTICS;PEDIATRICS","124;47;30;29;28;25;23;23;19;17;17;14;13;12;11;11;10;8;7;6;6;6;6;6;6","GENE;CANCER;POPULATION;CLINICAL TRIAL;CONFIDENCE INTERVAL;ADVERSE EFFECT;CHEMOTHERAPY;COHORT;DISEASE;LYMPHOMA;HEART FAILURE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);PROSPECTIVE COHORT STUDY;REGIMEN;RETROSPECTIVE COHORT STUDY;RECEPTOR;STROKE (ENGINE);CONCOMITANT;DISCONTINUATION;LOGISTIC REGRESSION;MAGNETIC RESONANCE IMAGING;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;TRANSPLANTATION","31;22;17;14;14;13;13;13;12;11;10;10;10;10;10;9;9;8;7;7;7;7;7;7","CLINICAL ENDPOINT;PHENOTYPE;VIRAL LOAD;BREAST CANCER;RETT SYNDROME;CYCLOPHOSPHAMIDE;IMMUNOTHERAPY;RITUXIMAB;DIFFUSE LARGE B-CELL LYMPHOMA;HAZARD RATIO;MUTATION;EJECTION FRACTION;GLOMERULONEPHRITIS;IDIOPATHIC PULMONARY FIBROSIS;NEURODEVELOPMENTAL DISORDER;PHASES OF CLINICAL RESEARCH;POLYUNSATURATED FATTY ACID;CHRONIC LYMPHOCYTIC LEUKEMIA;COLORECTAL CANCER;CYTARABINE;DACARBAZINE;IMATINIB;KIDNEY TRANSPLANTATION;LENALIDOMIDE;LUNG FUNCTION;PROTEINURIA;REIMBURSEMENT;SALVAGE THERAPY;SUPEROXIDE DISMUTASE;THROMBOLYSIS;TOLERABILITY","11;9;9;8;7;6;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ANTIRETROVIRAL THERAPY;MECP2;ALPORT SYNDROME;DIFFUSING CAPACITY;DOCOSAHEXAENOIC ACID;EXOME SEQUENCING;FLUDARABINE;IMATINIB MESYLATE;LAMIVUDINE;PODOCYTE;REVERSE TRANSCRIPTASE;VINCRISTINE;ADIPOKINE;ANTHRACYCLINE;CARDIAC RESYNCHRONIZATION THERAPY;CHEMOIMMUNOTHERAPY;DASATINIB;EICOSAPENTAENOIC ACID;GERMLINE MUTATION;GLOMERULAR BASEMENT MEMBRANE;IBRUTINIB;IDARUBICIN;INTERNATIONAL PROGNOSTIC INDEX;KARYOTYPE;MAMMOGRAPHY;MODIFIED RANKIN SCALE;NILOTINIB;PEMBROLIZUMAB;POLY ADP RIBOSE POLYMERASE;PRENATAL DIAGNOSIS;PROBAND","8;5;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;TREATMENT OUTCOME;STROKE;RETROSPECTIVE STUDIES;BRAIN ISCHEMIA;HIV INFECTIONS;RISK FACTORS;PROSPECTIVE STUDIES;TRANSCATHETER AORTIC VALVE REPLACEMENT;CARDIOVASCULAR DISEASES;TIME FACTORS;NEPHRITIS, HEREDITARY","94;84;73;67;50;41;39;28;26;26;19;17;16;15;15;14;14;13;13;12","LYMPHOID NEOPLASMS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;CANCER IMMUNOTHERAPY;EFFICACY AND RESISTANCE IN CML TREATMENT;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;MANAGEMENT OF VALVULAR HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;ACUTE MYELOID LEUKEMIA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;MOLECULAR MECHANISMS OF CARDIAC ARRHYTHMIAS;POSTTRAUMATIC STRESS DISORDER AND HUMAN RESILIENCE;ATRIAL FIBRILLATION;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;ECONOMIC BURDEN OF CANCER TREATMENT;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES","10;8;6;5;5;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2","CLINICAL ENDPOINT;REGIMEN;STROKE (ENGINE);CONCOMITANT;DISCONTINUATION;RETT SYNDROME;ANTIRETROVIRAL THERAPY;ECHOCARDIOGRAPHY;HIV;MANTLE CELL LYMPHOMA;MECP2;PROSTHETIC VALVES EVALUATION;TRANSCATHETER AORTIC-VALVE REPLACEMENT;DOLUTEGRAVIR;INFARCTION TREATMENT;NEURODEVELOPMENTAL DISORDER;TREATMENT OUTCOMES;ALPORT SYNDROME;BIOMARKERS FOR IMMUNOTHERAPY;CARDIAC IMAGING","11;10;9;8;7;7;6;6;5;5;5;5;5;4;4;4;4;3;3;3","PHASE II;FONDAZIONE ITALIANA;ITALIANA LINFOMI;AORTIC VALVE;CHRONIC MYELOID;RETT SYNDROME;TRANSCATHETER AORTIC;HEART FAILURE;HOMOLOGOUS RECOMBINATION;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;VALVE IMPLANTATION;VENTRICULAR FIBRILLATION;ACUTE HEART;ADVANCED CANCER;ALPORT SYNDROME;ANTIRETROVIRAL THERAPY;BCELL LYMPHOMA;ELDERLY PATIENTS;HODGKIN LYMPHOMA;II STUDY;ITALIAN MULTICENTER;ITALIAN PATIENTS;LEUKAEMIA PATIENTS;LINE THERAPY;MYELOID LEUKAEMIA;PATIENTS PTS;PATIENTS TREATED;PULMONARY FIBROSIS;RISK FACTORS","8;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ADVISORY CONSULTANCY;SPEAKERS BUREAU;ADVISORY COMMITTEES;ENTITYS BOARD;PUBMED SCOPUS;ACCOMMODATION EXPENSES;TRAVEL ACCOMMODATION;CROSSREF PUBMED;EXPECT NMDDE;ADVERSE EVENTS;ALDE NOVO;COMMITTEES SPEAKERS;HR CI;CONSULTANCY MEMBERSHIP;CD LSCS;GRANT FUNDING;MEDIAN AGE;OXIDATIVE STRESS;RESEARCH GRANT;VASCULAR SURGEONS;LECTURE FEE;PATIENTS TREATED;AUTISM SPECTRUM;DE NOVO;FLT-ITD MUTATION;FUNDING INSTITUTION;SIGNIFICANT DIFFERENCES;BUREAU EXPERT;CLINICAL TRIAL;CONFIDENCE INTERVAL","54;48;47;47;34;29;29;19;18;14;14;14;14;13;12;12;12;12;12;12;11;11;10;10;10;10;10;9;9;9",58,0.32,9.2,10.75,1,1.5,0,2,2,1,0,12.5,1,1,10.25,0,1,2,4,8,4,0,0,43.75,43.75,3,0,2,1,1,0,0,0,0,0,0,0,4,0,0,0,4.75,4.06,1.25,0,1,4,0,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BOTTA MAURIZIO;BRAI ANNALAURA;TINTORI CRISTINA;ARAQUE JOSÉ ESTÉ;FAZI ROBERTA;MAGA GIOVANNI;MAGA GLOVANNI;MANDALA' MARCO;MARTINEZ DE LA SIERRA MIGUEL ANGEL;MARTINEZ JAVIER","3;3;2;1;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;AZIENDA OSPEDALIERA UNIVERSITARIA SENRESE;UNIVERSITA DEGLI STUDI DI SIENA","3;1;1","34 CHEMICAL SCIENCES;3402 INORGANIC CHEMISTRY;40 ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4003 BIOMEDICAL ENGINEERING","5;2;2;1;1;1",NA,NA,"5.1 PHARMACEUTICALS","3","A61K31/18;A61K31/4192;A61K31/4196;A61K31/42;A61K31/4245;A61K31/433;A61K31/5377;A61K31/675;A61K31/7056;A61K31/41","2;2;2;2;2;2;2;2;2;1","A61K31/18;A61K31/41;A61K31/4192;A61K31/4196;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/4725;A61K31/496","2;2;2;2;2;2;2;2;2;2",19,5.06,319.94,7.72,8,0.42,66.74,0,1,8,0,6,0,0,4,0,14,3,0,0,0,0,0,0,17,2,0,16,2,0,1,0,0,0,0,0,0,"United States;Japan","5;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3207 MEDICAL MICROBIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;4204 MIDWIFERY","19;10;6;2;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;LYMPHOMA;ORPHAN DRUG;AUTOIMMUNE DISEASE;BRAIN DISORDERS;LUNG;NEUROSCIENCES;PATIENT SAFETY;PREVENTION;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BRAIN CANCER;CARDIOVASCULAR;COMPLEMENTARY AND INTEGRATIVE HEALTH;CONTRACEPTION/REPRODUCTION;DEPRESSION","15;12;11;7;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1","CANCER;MENTAL HEALTH;RESPIRATORY;CARDIOVASCULAR;INFECTION;NEUROLOGICAL;SKIN","8;2;2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES","15;3;2;1","NON-HODGKIN'S LYMPHOMA;SKIN CANCER;MELANOMA;BLADDER CANCER;HODGKIN'S DISEASE;LIVER CANCER;NOT SITE-SPECIFIC CANCER","3;3;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","9;1",2,55073832,399085.74,5.5,71.5,16.5,1,143,66514.2898550725,2.69115103521397,"AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;ACADEMIC MEDICAL CENTER;ACADEMY OF FINLAND;ACIBADEM UNIVERSITY;AGENCE NATIONALE DE LA RECHERCHE;AGENZIA PER LA PROMOZIONE DELLA RICERCA EUROPEA;AIX-MARSEILLE UNIVERSITY;ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;AUSTRIAN INSTITUTE OF TECHNOLOGY;AZIENDA OSPEDALIERA UNIVERSITARIA PISANA;AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE;BAMBINO GESÙ CHILDREN'S HOSPITAL;BARCELONA SUPERCOMPUTING CENTER;BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE - ERIC;BIOGEM;CANADIAN INSTITUTES OF HEALTH RESEARCH;CENTER FOR ADVANCED STUDIES RESEARCH AND DEVELOPMENT IN SARDINIA;CENTER OF MEDICAL GENETICS AND PRIMARY HEALTH CARE;CENTRE FOR GENOMIC REGULATION;CENTRE LÉON BÉRARD","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ITALIAN ASSOCIATION FOR CANCER RESEARCH","1;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","1;1;1","COFUND-EJP - COFUND (EUROPEAN JOINT PROGRAMME) (FUNDING SCHEME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME)","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1;1;1;1","BRAIN DISORDERS;CANCER;CLINICAL RESEARCH;GENETICS;RARE DISEASES;VACCINE RELATED","1;1;1;1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1","MELANOMA","1","1.4 CANCER PROGRESSION AND METASTASIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A01 CLINICAL MEDICINE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE","1;1",NA,NA,16,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;FRONTIERS;KARGER PUBLISHERS","7;6;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4905 STATISTICS;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3213 PAEDIATRICS;38 ECONOMICS;3801 APPLIED ECONOMICS;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;4407 POLICY AND ADMINISTRATION;4904 PURE MATHEMATICS","17;9;6;2;2;1;1;1;1;1;1;1;1;1","GENETICS;CANCER;HUMAN GENOME;BIOTECHNOLOGY;CLINICAL RESEARCH;PEDIATRIC;IMMUNIZATION;INFANT MORTALITY;PATIENT SAFETY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;PREVENTION;VACCINE RELATED","7;6;6;5;2;2;1;1;1;1;1;1;1","CANCER;INFECTION;MUSCULOSKELETAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","6;1;1;1","6.1 PHARMACEUTICALS;3.4 VACCINES","3;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH;PUBLIC HEALTH","9;1;1","MELANOMA","6","3 GOOD HEALTH AND WELL BEING","1"
"AOU_SENESE",2020,266,16.8045112781955,2.88721804511278,0.278195488721804,0.278195488721804,0.409774436090226,2.16101694915254,1.37735849056604,1.76190476190476,1.47945205479452,0.635338345864662,2,107,69,31,19,0.4,0.26,0.12,0.07,16.08,0.637940572661946,5.50299401197604,0.342105263157895,0.966165413533835,0.468,0.435,0.475,0.456,"ALESSANDRA RENIERI;MONICA BOCCHIA;MARIA ANTONIETTA MAZZEI;SERAFINA VALENTE;ROSSANA TASSI;CHIARA FALLERINI;BRUNO FREDIANI;ELISA FRULLANTI;ÉLISA CINOTTI;PIETRO RUBEGNI;ALESSANDRO IADANZA;MARIA GRAZIA CUSI;MANUEL CAPPELLARI;ELENA BARGAGLI;FABIO FERRETTI;ANNA SICURANZA;ANDREA ZINI;ANNARITA GILIBERTI;ANNA MARIA PINTO;MARGHERITA BALDASSARRI","26;18;16;15;13;12;11;11;11;11;9;9;9;9;9;9;8;8;8;8","ALESSANDRA RENIERI;PIETRO RUBEGNI;ÉLISA CINOTTI;MONICA BOCCHIA;ANTONELLA FIORAVANTI;SERAFINA VALENTE;MARIA ANTONIETTA MAZZEI;MARIA GRAZIA CUSI;FABIO FERRETTI;STEFANO MANCINI;ANNA COLUCCIA;ANDREA POZZA;GIACOMO GUALTIERI;FILOMENA RUSSO;ALESSANDRO GOZZETTI;BRUNO FREDIANI;AMATO SANTORO;CLAUDIA GANDOLFO;CHIARA FALLERINI;EMANUELE CENCINI","2.06;1.69;1.61;1.54;1.5;1.4;1.31;1.16;1.09;1;1;1;0.98;0.91;0.91;0.89;0.8;0.8;0.77;0.76","ALESSANDRA RENIERI;MONICA BOCCHIA;MARIA ANTONIETTA MAZZEI;SERAFINA VALENTE;ROSSANA TASSI;CHIARA FALLERINI;BRUNO FREDIANI;ÉLISA CINOTTI;PIETRO RUBEGNI;ALESSANDRO IADANZA;MARIA GRAZIA CUSI;ELENA BARGAGLI;ANNA SICURANZA;ANNARITA GILIBERTI;ANNA MARIA PINTO;MARGHERITA BALDASSARRI;ALBERTO FABBRI;EMANUELE CENCINI;ROSSELLA TITA;PIERSANTE SESTINI","26;18;16;15;13;12;11;11;11;9;9;9;9;8;8;8;8;8;8;7","ALESSANDRA RENIERI;PIETRO RUBEGNI;ÉLISA CINOTTI;MONICA BOCCHIA;ANTONELLA FIORAVANTI;SERAFINA VALENTE;MARIA ANTONIETTA MAZZEI;MARIA GRAZIA CUSI;STEFANO MANCINI;GIACOMO GUALTIERI;FILOMENA RUSSO;ALESSANDRO GOZZETTI;BRUNO FREDIANI;AMATO SANTORO;CLAUDIA GANDOLFO;CHIARA FALLERINI;EMANUELE CENCINI;LUCA PROVVIDENZIALE;SALVATORE GROSSO;ELENA BARGAGLI","2.06;1.69;1.61;1.54;1.5;1.4;1.31;1.16;1;0.98;0.91;0.91;0.89;0.8;0.8;0.77;0.76;0.74;0.73;0.69","MARIA ANTONIETTA MAZZEI;MONICA BOCCHIA;MAURO KRAMPERA;CARLO VISCO;LUCA ARCAINI;MARIA CHIARA TISI;ANNA CANDONI;ANNAROSA CUCCARO;FELICETTO FERRARA;PATRIZIA ZAPPASODI;FRANCESCO PASSAMONTI;LORENZA BERTÙ;PAOLO GROSSI;SARA GALIMBERTI;ROBERTO M. LEMOLI;CARLO GAMBACORTI‐PASSERINI;CARMEN FAVA;LUIGI RIGACCI;PIERO GALIENI;ADRIANO VENDITTI","753;652;624;590;590;590;566;555;552;552;517;517;517;517;515;504;504;503;502;501","MONICA BOCCHIA;MARIA ANTONIETTA MAZZEI;ALESSANDRA RENIERI;ROSSELLA TITA;ALESSANDRO IADANZA;MIRELLA BRUTTINI;SARA AMITRANO;FRANCESCA FAVA;ANDREA TOMMASI;ROSSANA TASSI;SANDRA BRACCO;SERAFINA VALENTE;ALBERTO FABBRI;DAVID BENNETT;PAOLO CAMELI;PIERSANTE SESTINI;BRUNO FREDIANI;FRANCESCA MARI;MARIA GRAZIA CUSI;PALMINO SACCO","646;430;379;330;322;307;306;302;285;196;171;171;163;162;159;148;120;117;115;113","ALESSANDRA RENIERI;MARIA ANTONIETTA MAZZEI;SERAFINA VALENTE;MONICA BOCCHIA;PIETRO RUBEGNI;ROSSANA TASSI;ANNA SICURANZA;MARIA GRAZIA CUSI;ÉLISA CINOTTI;ALESSANDRO IADANZA;ALBERTO FABBRI;ANNA MARIA PINTO;EMANUELE CENCINI;ROSSELLA TITA;BRUNO FREDIANI;SANDRA BRACCO;ALESSANDRO GOZZETTI;DONATO CASELLA;LUCA VOLTERRANI;MARIA ANTONIETTA MENCARELLI","25;17;17;14;13;12;9;9;9;9;8;8;8;8;7;6;6;6;6;6","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE;BUSINESS;PHILOSOPHY;HISTORY;SOCIOLOGY;ENVIRONMENTAL SCIENCE;ART;GEOLOGY","246;79;25;23;23;20;20;11;10;8;7;5;4;3;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;CARDIOLOGY;GASTROENTEROLOGY;ONCOLOGY;IMMUNOLOGY;RADIOLOGY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;PSYCHIATRY;VIROLOGY;MECHANICAL ENGINEERING;DERMATOLOGY;OPTICS;PEDIATRICS;CANCER RESEARCH;EMERGENCY MEDICINE","181;77;59;44;42;31;31;30;27;25;25;22;22;19;18;16;15;14;13;13","GENE;DISEASE;CANCER;COHORT;POPULATION;OUTBREAK;CHEMOTHERAPY;HEALTH CARE;STROKE (ENGINE);LYMPHOMA;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);PNEUMONIA;RETROSPECTIVE COHORT STUDY;HEART FAILURE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);MYOCARDIAL INFARCTION;RECEPTOR;LUNG;NEUROLOGY;VIRUS","50;48;38;21;20;17;15;13;13;12;11;11;11;11;10;10;10;10;9;9;9","INFECTIOUS DISEASE (MEDICAL SPECIALTY);PHENOTYPE;2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;MUTATION;RETT SYNDROME;IMMUNOTHERAPY;CLINICAL ENDPOINT;HAZARD RATIO;NEURORADIOLOGY;VIRAL LOAD;CHRONIC LYMPHOCYTIC LEUKEMIA;COLORECTAL CANCER;ISCHEMIC STROKE;EJECTION FRACTION;FETUS;GENOTYPE;LIQUID BIOPSY;TELEMEDICINE;CATHETER ABLATION;DIFFUSE LARGE B-CELL LYMPHOMA;DNA SEQUENCING;RITUXIMAB;SALVAGE THERAPY;SOMATIC CELL;THROMBOLYSIS","29;15;12;12;9;9;8;7;7;7;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);ANTIRETROVIRAL THERAPY;EXOME SEQUENCING;MECP2;PRENATAL DIAGNOSIS;BREAST RECONSTRUCTION;DARATUMUMAB;FLUDARABINE;IBRUTINIB;KRAS;MASTECTOMY;MISSENSE MUTATION;MODIFIED RANKIN SCALE;NIVOLUMAB;VENETOCLAX;ALPORT SYNDROME;CAS9;CHEMOIMMUNOTHERAPY;COLONOSCOPY;COMPOUND HETEROZYGOSITY;DNA METHYLATION;FRAMESHIFT MUTATION;GENOME EDITING;GERMLINE MUTATION;GROUND-GLASS OPACITY;IDARUBICIN;IGHV@;INDUCED PLURIPOTENT STEM CELL;IPILIMUMAB;KARYOTYPE;LAMIVUDINE;LYMPHEDEMA;MAMMOGRAPHY;NILOTINIB;PENETRANCE;RIBAVIRIN;SINGLE-NUCLEOTIDE POLYMORPHISM;TELEHEALTH;TROPOMYOSIN RECEPTOR KINASE A;TUMOR-INFILTRATING LYMPHOCYTES","29;6;5;5;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;COVID-19;AGED, 80 AND OVER;STROKE;CORONAVIRUS INFECTIONS;AORTIC VALVE STENOSIS;RETT SYNDROME;SARS-COV-2;BRAIN ISCHEMIA;ADOLESCENT;ENDOVASCULAR PROCEDURES","154;110;65;65;43;39;33;29;28;23;22;20;19;17;16;16;16;15;14;14","MANAGEMENT OF VALVULAR HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;CORONAVIRUS DISEASE 2019;CANCER IMMUNOTHERAPY;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;LYMPHOID NEOPLASMS;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;EFFICACY AND RESISTANCE IN CML TREATMENT;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;ATOPIC DERMATITIS AND SKIN MICROBIOME;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;GLIOMAS","10;9;7;7;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3","PANDEMIC;STROKE (ENGINE);2019-20 CORONAVIRUS OUTBREAK;PROSTHETIC VALVES EVALUATION;RETT SYNDROME;TRANSCATHETER AORTIC-VALVE REPLACEMENT;HIV;INFARCTION TREATMENT;CLINICAL ENDPOINT;NEURORADIOLOGY;DISCONTINUATION;ECHOCARDIOGRAPHY;ISOLATION (MICROBIOLOGY);REGIMEN;ANTIRETROVIRAL THERAPY;CATHETER ABLATION;CORONAVIRUS;LIQUID BIOPSY;MECP2;REFRACTORY (PLANETARY SCIENCE)","13;13;11;9;9;9;8;8;7;7;6;6;6;6;5;5;5;5;5;5","AORTIC VALVE;HEART FAILURE;TRANSCATHETER AORTIC;ANMCO POSITION;ISCHEMIC STROKE;POSITION PAPER;RETT SYNDROME;VALVE IMPLANTATION;ACUTE ISCHEMIC;CHRONIC MYELOID;COHORT STUDY;COVID- PANDEMIC;LEUKEMIA PATIENTS;MYELOID LEUKEMIA;PATIENTS TREATED;RISK FACTORS;ATOPIC DERMATITIS;B-CELL LYMPHOMA;CATHETER ABLATION;CELL-FREE DNA;CLINICAL PRACTICE;CONFOCAL MICROSCOPY;COVID- PNEUMONIA;GASTROINTESTINAL BLEEDING;GROWTH FACTOR;ITALIAN EXPERIENCE;LIQUID BIOPSY;LOWER GASTROINTESTINAL;MACHINE LEARNING;MULTICENTER STUDY","7;7;7;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ALLE SCOTTE;MARIA ALLE;SCOTTE HOSPITAL;MEDICAL SURGICAL;NEUROLOGICAL SCIENCE;SIENA ITALYSEARCH;PATIENTS TREATED;DERMATOLOGY UNIT;SIENA SIENA;UNIT DEPARTMENT;HOSPITAL SIENA;DERMATOLOGY SECTION;HOSPITAL UNIVERSITY;RETT SYNDROME;SCIENCE DERMATOLOGY;SECTION UNIVERSITY;ADVISORY COMMITTEES;ENTITYS BOARD;COVID- PATIENTS;HR P-;MEDIAN AGE;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;ODDS RATIO;RESEARCH FUNDING;SIENA ITALY;SPEAKERS BUREAU;SPINAL CORD;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMNMMLMNMMLMATH;CHEST CT;GA VERSUS","32;32;31;30;30;24;23;20;16;16;15;14;14;14;14;14;13;13;12;12;12;12;12;12;12;12;12;12;11;11",84,0.32,8.76,8.25,1,1,0,3,0,1,1,10,1.75,1,8.25,1,0,2,5,6,6,0,0,55,55,6,0,1,4,1,1,0,0,0,0,0,0,4,1,2,1.66666666666667,5,4.58,1.85714285714286,1,4,5,0,0,2,1,0,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CONTICELLO SILVESTRO;CROCI SUSANNA;DAGA SERGIO;DONATI FRANCESCO;LOPERGOLO DIEGO;MELONI ILARIA;PINTO ANNA MARIA;RENIERI ALESSANDRA;ARAQUE JOSE-ESTE;BOTTA MAURIZIO","2;2;2;2;2;2;2;2;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;AZIENDA OSPEDALIERA UNIV SENESE AOUS;ST PER LO STUDIO LA PREVENZIONE E LA RETE ONCOLOGICA ISPRO;UNIV DEGLI STUDI DI SIENA;TISSUELAB SRL CON UNICO SOCIO;UNIVERSITA DEGLI STUDI DI SIENA","4;3;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;40 ENGINEERING;31 BIOLOGICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3402 INORGANIC CHEMISTRY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4003 BIOMEDICAL ENGINEERING","3;3;2;1;1;1;1;1","BIOTECHNOLOGY;GENE THERAPY;GENETICS;HUMAN GENOME","1;1;1;1","5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","2;1","A61K31/4192;A61K31/5377;A01N1/00;A61K31/41;A61K31/4196;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/496","2;2;1;1;1;1;1;1;1;1","A61K48/00;C12N15/102;C12N15/63;C12N15/86;C12N15/902;C12N2310/20;C12N2750/14143;C12N9/22;A01N1/00;A61B17/122","2;2;2;2;2;2;2;2;1;1",18,3.5,563.17,5.79,8,0.44,55.44,1,1,2,0,7,0,0,7,0,11,7,0,0,0,0,0,0,18,0,0,18,0,0,0,0,0,0,0,0,0,"Italy;United States","7;4","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;31 BIOLOGICAL SCIENCES;3105 GENETICS;3203 DENTISTRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","17;8;7;5;3;3;2;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;PATIENT SAFETY;RARE DISEASES;GENETICS;INFECTIOUS DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;LUNG CANCER;PNEUMONIA;PNEUMONIA & INFLUENZA;BIOMEDICAL IMAGING;BRAIN DISORDERS;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;MENTAL HEALTH;PREVENTION;ACUTE RESPIRATORY DISTRESS SYNDROME","16;8;7;7;6;6;4;4;3;3;3;3;2;2;2;2;2;2;2;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;CARDIOVASCULAR;MENTAL HEALTH;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;RESPIRATORY","8;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES","12;2;2;2;1;1;1","LUNG CANCER;MELANOMA;BLOOD CANCER;BREAST CANCER;COLON AND RECTAL CANCER;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;MYELOMA;NON-HODGKIN'S LYMPHOMA;ORAL CAVITY AND LIP CANCER;PANCREATIC CANCER;PHARYNGEAL CANCER;RESPIRATORY SYSTEM","3;3;1;1;1;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","7;2",1,198119,49529.75,4,4,3,1,0,78896.7273550725,3.3714959912453,"ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;BAMBINO GESÙ CHILDREN'S HOSPITAL;UNIVERSITY MEDICAL CENTER GRONINGEN","1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","3RD HEALTH PROGRAMME (PROGRAMME)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH","1",NA,NA,NA,NA,NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,13,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;SCIELO JOURNALS;SPRINGER NATURE","8;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;40 ENGINEERING;42 HEALTH SCIENCES;3215 REPRODUCTIVE MEDICINE;34 CHEMICAL SCIENCES;4016 MATERIALS ENGINEERING;41 ENVIRONMENTAL SCIENCES;4205 NURSING;46 INFORMATION AND COMPUTING SCIENCES","20;4;4;4;3;2;2;2;2;1;1;1;1;1;1","GENETICS;CANCER;CLINICAL RESEARCH;RARE DISEASES;BIOMEDICAL IMAGING;GENETIC TESTING;HEMATOLOGY;HUMAN GENOME;INFECTIOUS DISEASES;KIDNEY DISEASE;LYMPHOMA;OVARIAN CANCER;PATIENT SAFETY;PEDIATRIC;PREVENTION","4;3;3;3;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL","2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","4;1;1","CLINICAL;BIOMEDICAL","3;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","9;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER;RETINOBLASTOMA;SARCOMA","1;1;1;1;1","13 CLIMATE ACTION;7 AFFORDABLE AND CLEAN ENERGY","1;1"
"AOU_SENESE",2021,263,19.2319391634981,2.78707224334601,0.247148288973384,0.262357414448669,0.300380228136882,2.13702623906706,1.3,1.64285714285714,1.36206896551724,0.627376425855513,2,107,56,40,20,0.41,0.21,0.15,0.08,11.68,0.757462351426618,5.85835257890685,0.307984790874525,0.954372623574145,0.492,0.415,0.459,0.45,"MONICA BOCCHIA;ALESSANDRA RENIERI;BRUNO FREDIANI;ALBERTO FABBRI;SARA GALIMBERTI;FRANCESCA MARI;MARGHERITA BALDASSARRI;ELENA BARGAGLI;CHIARA FALLERINI;ELISA BENETTI;FRANCESCA FAVA;FRANCESCO MERLI;MIRIANA D’ALESSANDRO;PAOLO CAMELI;MASSIMILIANO FABBIANI;GUIDO GINI;VITTORIO RUGGERO ZILIOLI;LAURA BERGANTINI;LUCA CANTARINI;MARIA ANTONIETTA MAZZEI","21;21;17;15;14;13;13;13;13;12;12;12;11;11;11;11;11;11;11;11","ANTONELLA FIORAVANTI;MONICA BOCCHIA;BRUNO FREDIANI;PIETRO RUBEGNI;ÉLISA CINOTTI;ALESSANDRA RENIERI;SONIA DE FRANCESCO;SARA TENTI;SARA CHELESCHI;ELENA BARGAGLI;CLAUDIA GANDOLFO;ALESSANDRO GOZZETTI;MARIA ANTONIETTA MAZZEI;ALBERTO FABBRI;STEFANO GIANNOTTI;MARIA GRAZIA CUSI;DONATO CASELLA;LUCA CANTARINI;MIRIANA D’ALESSANDRO;LAURA BERGANTINI","2.03;1.65;1.4;1.38;1.33;1.25;1.24;1.14;1.06;1.04;0.99;0.92;0.92;0.89;0.87;0.87;0.86;0.81;0.81;0.81","MONICA BOCCHIA;ALESSANDRA RENIERI;BRUNO FREDIANI;ALBERTO FABBRI;FRANCESCA MARI;ELENA BARGAGLI;FRANCESCA FAVA;MIRIANA D’ALESSANDRO;PAOLO CAMELI;MASSIMILIANO FABBIANI;LAURA BERGANTINI;LUCA CANTARINI;MARIA ANTONIETTA MAZZEI;MIRELLA BRUTTINI;BARBARA ROSSETTI;SERAFINA VALENTE;ALESSANDRO IADANZA;EMANUELE CENCINI;MASSIMO FINESCHI;ALESSANDRO GOZZETTI","21;21;17;15;13;13;12;11;11;11;11;11;11;10;10;9;9;9;8;8","ANTONELLA FIORAVANTI;MONICA BOCCHIA;BRUNO FREDIANI;PIETRO RUBEGNI;ÉLISA CINOTTI;ALESSANDRA RENIERI;SONIA DE FRANCESCO;SARA TENTI;SARA CHELESCHI;ELENA BARGAGLI;CLAUDIA GANDOLFO;ALESSANDRO GOZZETTI;MARIA ANTONIETTA MAZZEI;ALBERTO FABBRI;STEFANO GIANNOTTI;MARIA GRAZIA CUSI;DONATO CASELLA;LUCA CANTARINI;MIRIANA D’ALESSANDRO;LAURA BERGANTINI","2.03;1.65;1.4;1.38;1.33;1.25;1.24;1.14;1.06;1.04;0.99;0.92;0.92;0.89;0.87;0.87;0.86;0.81;0.81;0.81","FRANCESCA FAVA;MARGHERITA BALDASSARRI;CHIARA FALLERINI;ELISA BENETTI;SIMONE FURINI;FRANCESCA MARI;ALESSANDRA RENIERI;MARIA ANTONIETTA MAZZEI;SARA AMITRANO;ANNARITA GILIBERTI;FEDERICO FRANCHI;MIRELLA BRUTTINI;PAOLO CAMELI;LAURA BERGANTINI;MIRIANA D’ALESSANDRO;SERGIO DAGA;FLORIANA VALENTINO;ILARIA MELONI;BRUNO FREDIANI;FRANCESCA MONTAGNANI","572;560;549;545;530;517;500;490;474;444;437;437;426;424;424;418;409;403;393;392","SARA AMITRANO;ALESSANDRA RENIERI;FRANCESCA FAVA;FRANCESCA MARI;ANNA MARIA PINTO;ROSSELLA TITA;MASSIMILIANO FABBIANI;FRANCESCA MONTAGNANI;MIRELLA BRUTTINI;BARBARA ROSSETTI;MARIA ANTONIETTA MENCARELLI;CATERINA LO RIZZO;MONICA BOCCHIA;GIACOMO ZANELLI;ALESSANDRA VERGORI;FRANCESCA ANDRETTA;MICHELE MAIO;ANDRÉA TOMMASI;FRANCESCA GATTI;MARIA ANTONIETTA MAZZEI","474;452;445;418;354;348;341;339;338;336;251;245;234;232;206;206;187;175;175;167","MONICA BOCCHIA;ALESSANDRA RENIERI;ALBERTO FABBRI;SERAFINA VALENTE;FRANCESCA MARI;MARIA ANTONIETTA MAZZEI;MASSIMILIANO FABBIANI;EMANUELE CENCINI;FRANCESCA FAVA;ALESSANDRO IADANZA;ANNA MARIA PINTO;SARA AMITRANO;BARBARA ROSSETTI;BRUNO FREDIANI;MIRELLA BRUTTINI;ALESSANDRO GOZZETTI;MARIA GRAZIA CUSI;ANTONELLA FIORAVANTI;MARIA ANTONIETTA MENCARELLI;PIETRO RUBEGNI","21;19;15;14;11;10;10;9;9;8;8;8;8;8;8;8;7;7;7;7","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;PSYCHOLOGY;MATHEMATICS;ECONOMICS;SOCIOLOGY;GEOLOGY;HISTORY;POLITICAL SCIENCE;BUSINESS;PHILOSOPHY;ART;GEOGRAPHY;MATERIALS SCIENCE","248;66;21;18;13;11;10;9;7;5;4;4;4;3;3;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;ONCOLOGY;GENETICS;GASTROENTEROLOGY;IMMUNOLOGY;VIROLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;CANCER RESEARCH;PALEONTOLOGY;PHYSICAL THERAPY;PSYCHIATRY;BIOINFORMATICS;ENDOCRINOLOGY;PEDIATRICS","191;64;51;39;39;37;34;32;29;25;24;21;18;15;14;14;13;12;11;11","DISEASE;GENE;CANCER;POPULATION;COHORT;OUTBREAK;CLINICAL TRIAL;LYMPHOMA;ADVERSE EFFECT;CONFIDENCE INTERVAL;HEART FAILURE;MYOCARDIAL INFARCTION;PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;ANTIBODY;CHEMOTHERAPY;LEUKEMIA;MELANOMA;DISCONTINUATION;INCIDENCE (GEOMETRY);LUNG;MYELOID LEUKEMIA;RANDOMIZED CONTROLLED TRIAL;STENOSIS;STROKE (ENGINE);TRANSPLANTATION","66;38;34;25;21;19;18;18;13;13;13;12;12;11;10;10;10;10;9;9;9;9;9;9;9;9","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;PHENOTYPE;BREAST CANCER;MUTATION;EJECTION FRACTION;HAZARD RATIO;IMMUNOTHERAPY;GENOTYPE;IMATINIB;OSTEOARTHRITIS;TOLERABILITY;CHRONIC LYMPHOCYTIC LEUKEMIA;DIFFUSE LARGE B-CELL LYMPHOMA;HEMATOPOIETIC STEM CELL TRANSPLANTATION;MIDDLE CEREBRAL ARTERY;PSORIATIC ARTHRITIS;THROMBOLYSIS;UNIVARIATE ANALYSIS;VIRAL LOAD","36;17;11;11;10;9;8;7;7;6;6;6;6;5;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;NILOTINIB;ANTIRETROVIRAL THERAPY;BRENTUXIMAB VEDOTIN;DASATINIB;NIVOLUMAB;SINGLE-NUCLEOTIDE POLYMORPHISM;ANTHRACYCLINE;CANAKINUMAB;CARDIAC RESYNCHRONIZATION THERAPY;GENETIC HETEROGENEITY;IMATINIB MESYLATE;MISSENSE MUTATION;MODIFIED RANKIN SCALE;RUXOLITINIB;VENETOCLAX;ADIPOKINE;BASDAI;BENDAMUSTINE;BLINATUMOMAB;BODY CONTOURING;BREAST RECONSTRUCTION;COPY-NUMBER VARIATION;ENTHESITIS;GASTRIC BYPASS;GIANT CELL ARTERITIS;HAPLOINSUFFICIENCY;HEPACIVIRUS;IBRUTINIB;IL-2 RECEPTOR;INTERNATIONAL PROGNOSTIC INDEX;MASTECTOMY;PEMBROLIZUMAB;RIBAVIRIN;SEROPREVALENCE;SPITZ NEVUS;TOLL-LIKE RECEPTOR","36;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;COVID-19;MALE;MIDDLE AGED;ITALY;ADULT;AGED;SARS-COV-2;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;STROKE;AGED, 80 AND OVER;SKIN NEOPLASMS;MELANOMA;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;PROGNOSIS;RISK FACTORS;HIV INFECTIONS","150;113;54;50;48;43;38;34;34;31;29;23;20;18;15;14;13;13;13;12","LYMPHOID NEOPLASMS;EFFICACY AND RESISTANCE IN CML TREATMENT;MANAGEMENT OF VALVULAR HEART DISEASE;CORONAVIRUS DISEASE 2019 RESEARCH;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;MELANOMA;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;HEPATITIS C INFECTION AND TREATMENT;RADIOMICS IN MEDICAL IMAGING ANALYSIS;ACUTE MYELOID LEUKEMIA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CLASSIFICATION AND TREATMENT OF CUTANEOUS LYMPHOMAS;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;HEALTH ECONOMICS AND QUALITY OF LIFE ASSESSMENT","14;8;8;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3","2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;CLINICAL ENDPOINT;DISCONTINUATION;STROKE (ENGINE);MANTLE CELL LYMPHOMA;MELANOMA;REFRACTORY (PLANETARY SCIENCE);REGIMEN;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CARDIOVASCULAR RISK ASSESSMENT;INFARCTION TREATMENT;INTERQUARTILE RANGE;PROSTHETIC VALVES EVALUATION;TOLERABILITY;CARDIAC IMAGING;CONCOMITANT;DERMOSCOPY;EXOME;UNIVARIATE ANALYSIS","15;12;11;9;9;8;8;8;8;8;6;6;6;6;6;5;5;5;5;5","FONDAZIONE ITALIANA;ITALIANA LINFOMI;POSITION PAPER;ANMCO POSITION;CHRONIC MYELOID;AORTIC VALVE;HEART FAILURE;MULTICENTER STUDY;MYELOID LEUKEMIA;CELL LYMPHOMA;COHORT STUDY;HODGKIN LYMPHOMA;LINFOMI FIL;CELL TRANSPLANTATION;CLINICAL PRACTICE;ELDERLY PROJECT;GASTRIC CANCER;ITALIAN SOCIETY;MANTLE CELL;METAL STENT;MULTIPLE MYELOMA;OBSERVATIONAL STUDY;RETT SYNDROME;SEVERE COVID-;TRANSCATHETER AORTIC;VALVE IMPLANTATION;VALVE REPLACEMENT;ANTIBODY RESPONSE;B-CELL LYMPHOMA;BREAST CANCER","11;11;11;9;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","ADVISORY COMMITTEES;ENTITYS BOARD;RESEARCH FUNDING;SPEAKERS BUREAU;CONSULTANCY HONORARIA;PUBMED SCOPUS;PERONEAL TUBERCLE;HR CI;AORTIC VALVE;PERONEUS LONGUS;HONORARIA RESEARCH;INSTITUTIONAL PRINCIPAL;PRINCIPAL INVESTIGATOR;HONORARIA MEMBERSHIP;MEDIAN AGE;LONGUS TENDON;TRANSCATHETER AORTIC;ADVISORY ROLE;NORMAL BMI;BRISTOL MYERS;JANSSEN CONSULTANCY;BLEEDING COMPLICATIONS;ABBVIE CONSULTANCY;BODY MASS;MASS INDEX;PATIENTS TREATED;PERSONAL ADVISORY;ABBVIE HONORARIA;ACCOMODATIONS EXPENSES;CROSSREF PUBMED","139;139;101;100;96;83;39;34;33;32;31;31;31;28;27;26;26;24;24;23;23;22;20;20;20;20;20;19;19;19",80,0.3,8.91,9,1,4,0,2.5,0,1,1,10.25,1.75,0,8,0,0,1,2.25,7,4,0,0,34.25,34.25,5,0,1,1,1,3,0,0,0,0,0,0,2,4,0,0,4.66666666666667,3.82,1.33333333333333,1,2,3,0,0,2,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BOTTA MAURIZIO;BRAI ANNALAURA;TINTORI CRISTINA;MAGA GIOVANNI;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;CONTICELLO SILVESTRO;CROCI SUSANNA;DAGA SERGIO;DONATI FRANCESCO;ESTE-ARAQUE JOSE","3;3;3;2;1;1;1;1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;UNIVERSITA DEGLI STUDI DI SIENA;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE AOUS","5;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;40 ENGINEERING;31 BIOLOGICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3402 INORGANIC CHEMISTRY;4003 BIOMEDICAL ENGINEERING","4;4;2;2;1;1;1;1","BIOTECHNOLOGY;GENE THERAPY;GENETICS;HUMAN GENOME","1;1;1;1","5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","3;1","A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/5377;A61K31/675;A61K31/7056;A61K31/18;A61K31/41;A61K31/4196","3;3;3;3;3;3;3;2;2;2","A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/496;A61K31/5377;A61K31/675;A61K31/7056;A61K45/06","3;3;3;3;3;3;3;3;3;3",21,4.19,1070.95,6.86,10,0.48,129.05,1,0,6,0,8,0,0,5,1,15,6,0,0,0,0,0,0,20,1,0,20,0,1,0,0,0,0,0,0,0,"Italy;United States;Brazil;Poland;Russia;Sweden;Thailand","10;4;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3207 MEDICAL MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","21;13;6;3;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;AUTOIMMUNE DISEASE;LUNG;CARDIOVASCULAR;DENTAL/ORAL AND CRANIOFACIAL DISEASE;GENETICS;HEART DISEASE;HEMATOLOGY;HIV/AIDS;INFECTIOUS DISEASES;PAIN RESEARCH;PATIENT SAFETY;PREVENTION;AGING;ANTIMICROBIAL RESISTANCE;ARTHRITIS;BEHAVIORAL AND SOCIAL SCIENCE","20;16;8;7;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;EYE;RESPIRATORY;STROKE","4;2;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;7.1 INDIVIDUAL CARE NEEDS","16;3;2;1;1","HEAD AND NECK CANCER;BREAST CANCER;EAR CANCER;LARYNGEAL CANCER;MELANOMA;MYELOMA;NASAL CAVITY AND PARANASAL SINUS CANCER;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER;SALIVARY GLAND CANCER","2;1;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","5;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;ZENODO;MENDELEY DATA","7;2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY","18;9;5;5;4;4;4;1;1;1","CANCER;BREAST CANCER;GENETIC TESTING;GENETICS;OVARIAN CANCER;RARE DISEASES;CLINICAL RESEARCH;LUNG;BIODEFENSE;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EMERGING INFECTIOUS DISEASES;IMMUNIZATION;INFECTIOUS DISEASES;LUNG CANCER;MENTAL HEALTH;PATIENT SAFETY;PNEUMONIA;PNEUMONIA & INFLUENZA","5;4;4;4;4;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION","4;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.4 VACCINES;6.4 SURGERY","5;1;1","BIOMEDICAL;CLINICAL","5;3","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","8;1","BREAST CANCER;OVARIAN CANCER;CERVICAL CANCER;LUNG CANCER;SKIN CANCER","4;4;2;1;1","3 GOOD HEALTH AND WELL BEING","1"
"AOU_SENESE",2022,280,19.8714285714286,2.59285714285714,0.260714285714286,0.257142857142857,0.360714285714286,1.87113402061856,1.25862068965517,1.41176470588235,1.24691358024691,0.710714285714286,0,104,50,34,21,0.37,0.18,0.12,0.07,6.48,0.725743299385957,5.37138830162086,0.364285714285714,0.960714285714286,0.444,0.448,0.503,0.45,"MONICA BOCCHIA;ALESSANDRA RENIERI;BRUNO FREDIANI;ALESSANDRO GOZZETTI;SERAFINA VALENTE;LUCA CANTARINI;FLORENZO IANNONE;SARA GALIMBERTI;GAAFAR RAGAB;GIUSEPPE LOPALCO;ANTONIO VITALE;PIERO RUSCITTI;ALBERTO BALISTRERI;EMANUELE CENCINI;ELENA BARGAGLI;EWA WIĘSIK–SZEWCZYK;ROSA MARIA RODRIGUES PEREIRA;FRANCESCO LA TORRE;DONATO RIGANTE;FRANCESCA DELLA CASA","31;17;13;13;13;13;12;10;10;10;10;10;10;10;10;10;10;10;10;10","MONICA BOCCHIA;MATTEO CAMELI;ALESSANDRO GOZZETTI;PIETRO RUBEGNI;OLINDO MASSARELLI;ALESSANDRA RENIERI;SERAFINA VALENTE;ÉLISA CINOTTI;ELENA BARGAGLI;MASSIMO FINESCHI;GUIDO GABRIELE;PAOLO GENNARO;GIANPAOLO FAINI;FLAVIA CASCINO;EUGÉNIO NERI;DILETTA MARIA PIERAZZI;PAOLO CAMELI;GABRIELE MESSINA;SARA GANGI;MIRIANA D’ALESSANDRO","2.16;1.33;1.27;1.21;1.2;1.15;1.14;1.05;1.03;0.94;0.92;0.92;0.92;0.92;0.92;0.92;0.78;0.73;0.72;0.68","MONICA BOCCHIA;ALESSANDRA RENIERI;BRUNO FREDIANI;ALESSANDRO GOZZETTI;SERAFINA VALENTE;LUCA CANTARINI;EMANUELE CENCINI;ELENA BARGAGLI;MATTEO CAMELI;MASSIMO FINESCHI;STEFANO GENTILESCHI;MIRIANA D’ALESSANDRO;PAOLO CAMELI;MASSIMILIANO FABBIANI;LAURA BERGANTINI;PIETRO RUBEGNI;DALILA CAVALLARO;SARA GANGI;FRANCESCA FAVA;ALESSANDRO IADANZA","31;17;13;13;13;13;10;10;10;9;9;8;8;8;8;8;7;7;7;7","MONICA BOCCHIA;MATTEO CAMELI;ALESSANDRO GOZZETTI;PIETRO RUBEGNI;OLINDO MASSARELLI;ALESSANDRA RENIERI;SERAFINA VALENTE;ÉLISA CINOTTI;ELENA BARGAGLI;MASSIMO FINESCHI;GUIDO GABRIELE;PAOLO GENNARO;FLAVIA CASCINO;EUGÉNIO NERI;DILETTA MARIA PIERAZZI;PAOLO CAMELI;SARA GANGI;MIRIANA D’ALESSANDRO;LAURA BERGANTINI;ROBERTO CUOMO","2.16;1.33;1.27;1.21;1.2;1.15;1.14;1.05;1.03;0.94;0.92;0.92;0.92;0.92;0.92;0.78;0.72;0.68;0.68;0.67","ALESSANDRA RENIERI;MONICA BOCCHIA;FRANCESCA FAVA;BRUNO FREDIANI;SIMONE FURINI;LUCA CANTARINI;ALBERTO BALISTRERI;ALESSANDRO GOZZETTI;ANTONIO VITALE;CARLA GAGGIANO;CLAUDIA FABIANI;DONATO RIGANTE;EWA WIĘSIK–SZEWCZYK;FRANCESCA DELLA CASA;FRANCESCO LA TORRE;GAAFAR RAGAB;GIUSEPPE LOPALCO;JURGEN SOTA;PIERO RUSCITTI;ROSA MARIA RODRIGUES PEREIRA","224;196;128;127;122;121;115;115;115;115;115;115;115;115;115;115;115;115;115;115","ALESSANDRA RENIERI;MONICA BOCCHIA;FRANCESCA FAVA;BRUNO FREDIANI;ALBERTO FABBRI;ALESSANDRO GOZZETTI;ALBERTO PALAZZUOLI;STEFANO GENTILESCHI;EMANUELE CENCINI;ANNA MARIA PINTO;MARIA ANTONIETTA MENCARELLI;ALESSANDRA FABBIANI;FRANCESCA MARI;RAFFAELE MACCHIARELLI;MASSIMILIANO FABBIANI;ROBERTO CUOMO;ANNA SICURANZA;ROSSANA TASSI;PIETRO RUBEGNI;ALESSANDRO IADANZA","224;172;123;119;112;92;84;80;77;75;72;68;65;63;59;47;46;46;45;44","MONICA BOCCHIA;ALESSANDRA RENIERI;ALESSANDRO GOZZETTI;BRUNO FREDIANI;EMANUELE CENCINI;MASSIMO FINESCHI;PIETRO RUBEGNI;SERAFINA VALENTE;STEFANO GENTILESCHI;MASSIMILIANO FABBIANI;ANTONELLA FIORAVANTI;ALESSANDRO IADANZA;ROSSANA TASSI;MARIA ANTONIETTA MENCARELLI;FRANCESCA FAVA;ÉLISA CINOTTI;ANNA SICURANZA;FRANCESCA MARI;ALBERTO FABBRI;ALESSANDRA FABBIANI","30;18;12;11;10;9;9;9;8;8;7;7;7;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;ENGINEERING;PHYSICS;MATHEMATICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;SOCIOLOGY;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOLOGY;HISTORY;ENVIRONMENTAL SCIENCE;GEOGRAPHY","272;84;20;18;17;14;13;13;8;7;6;5;4;4;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;IMMUNOLOGY;GENETICS;ONCOLOGY;PEDIATRICS;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;BIOCHEMISTRY;VIROLOGY;INTENSIVE CARE MEDICINE;FAMILY MEDICINE;MECHANICAL ENGINEERING;PSYCHIATRY;ANATOMY;PHARMACOLOGY;PHYSICAL THERAPY","202;82;56;44;44;42;28;24;23;22;21;19;16;15;14;13;13;12;12;12","DISEASE;GENE;COHORT;CANCER;POPULATION;ADVERSE EFFECT;HEART FAILURE;MYOCARDIAL INFARCTION;RETROSPECTIVE COHORT STUDY;ANTIBODY;CLINICAL TRIAL;CONFIDENCE INTERVAL;LUNG;CHEMOTHERAPY;IMMUNE SYSTEM;OBSERVATIONAL STUDY;LYMPHOMA;LEUKEMIA;MULTIPLE MYELOMA;ALTERNATIVE MEDICINE;REGIMEN;TRANSPLANTATION","52;32;29;28;21;20;18;18;18;17;16;15;15;14;14;14;13;12;12;11;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;EJECTION FRACTION;HAZARD RATIO;CD8;BREAST CANCER;PHENOTYPE;DISEASE REGISTRY;ELECTRONIC DATA CAPTURE;T CELL;VIRAL LOAD;B CELL;BRONCHOALVEOLAR LAVAGE;CHRONIC LYMPHOCYTIC LEUKEMIA;CUMULATIVE INCIDENCE;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;MUTATION;PSORIATIC ARTHRITIS;RITUXIMAB","21;12;11;10;9;8;8;7;6;6;6;5;5;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);ANTIRETROVIRAL THERAPY;EXOME SEQUENCING;RUXOLITINIB;NILOTINIB;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;AL AMYLOIDOSIS;ANTHRACYCLINE;AXILLA;BASDAI;BENDAMUSTINE;BREAST RECONSTRUCTION;CARFILZOMIB;CHEMOIMMUNOTHERAPY;DARATUMUMAB;DOCOSAHEXAENOIC ACID;ENTHESITIS;EXTRAVERSION AND INTROVERSION;FLUDARABINE;FRACTIONAL FLOW RESERVE;HERPESVIRIDAE;IBRUTINIB;INTERNATIONAL PROGNOSTIC INDEX;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;LOSS FUNCTION;MASTECTOMY;MEMORY B CELL;MISSENSE MUTATION;MONOCLONAL;PRENATAL DIAGNOSIS;RESPIRATORY DISTURBANCE INDEX;RIVAROXABAN;SECUKINUMAB;TIGIT;USTEKINUMAB;VENETOCLAX","21;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;RETROSPECTIVE STUDIES;COVID-19;MALE;TREATMENT OUTCOME;ADULT;AGED;ANTI-HIV AGENTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;HIV INFECTIONS;ITALY;MIDDLE AGED;SARS-COV-2;MULTIPLE MYELOMA;QUALITY OF LIFE;REGISTRIES;AORTIC VALVE STENOSIS;CORONARY ARTERY DISEASE","139;133;39;38;33;28;24;17;17;16;15;14;14;13;13;12;12;12;11;10","LYMPHOID NEOPLASMS;CORONAVIRUS DISEASE 2019 RESEARCH;MANAGEMENT OF VALVULAR HEART DISEASE;ACUTE MYELOID LEUKEMIA;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;CANCER IMMUNOTHERAPY;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;MICROSURGICAL RECONSTRUCTION TECHNIQUES;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF AMYLOIDOSIS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ATRIAL FIBRILLATION;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS","8;7;7;6;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3","CLINICAL ENDPOINT;REGIMEN;DISCONTINUATION;STROKE (ENGINE);ANTIRETROVIRAL THERAPY;CONCOMITANT;ECHOCARDIOGRAPHY;PANDEMIC;TRANSCATHETER AORTIC-VALVE REPLACEMENT;2019-20 CORONAVIRUS OUTBREAK;DISEASE REGISTRY;PROSTHETIC VALVES EVALUATION;CUMULATIVE INCIDENCE;ELECTRONIC DATA CAPTURE;INTERNATIONAL MYELOMA WORKING GROUP;ACUTE MYELOID LEUKEMIA;CARDIAC AMYLOIDOSIS;DIAGNOSIS;HIV;MINIMAL RESIDUAL DISEASE","12;11;10;9;7;7;7;7;7;6;6;6;5;5;5;4;4;4;4;4","AIDA INTERNATIONAL;HEART FAILURE;INTERNATIONAL REGISTRY;MULTIPLE MYELOMA;OBSERVATIONAL STUDY;AORTIC VALVE;MYELOID LEUKEMIA;FONDAZIONE ITALIANA;TRANSCATHETER AORTIC;ANMCO POSITION;COHORT STUDY;GASTRIC CANCER;ITALIANA LINFOMI;NEWLY DIAGNOSED;NK CELLS;POSITION PAPER;RETROSPECTIVE STUDY;ACUTE ISCHEMIC;ACUTE MYELOID;ARTERY DISEASE;ARTERY DISSECTION;AUTOINFLAMMATORY DISEASES;BCELL LYMPHOMA;BRONCHOALVEOLAR LAVAGE;CHRONIC MYELOID;CML PATIENTS;CML STUDY;COVID- PANDEMIC;COVID- SEVERITY;ENDOVASCULAR TREATMENT","8;8;8;7;7;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","PATIENTS TREATED;MEDIAN AGE;LEFT VENTRICULAR;INTERNATIONAL REGISTRY;MEDIAN TIME;MYELOID LEUKEMIA;HEART FAILURE;DBS TEST;MULTIPLE MYELOMA;CML PATIENTS;EJECTION FRACTION;NEWLY DIAGNOSED;VIEW LARGEDOWNLOAD;AIDA INTERNATIONAL;CLINICAL PRACTICE;HR CI;LEFT ATRIAL;PRIMARY ENDPOINT;SURVIVAL OS;ACUTE MYELOID;ADVERSE EVENTS;LEFT VENTRICLE;MEDIAN FOLLOW-UP;RETROSPECTIVE STUDY;RISK FACTORS;ALLIANCE AIDA;ATRIAL FIBRILLATION;CAPTURE REDCAP;DATA CAPTURE;DATA MANAGERS","24;23;22;16;16;15;14;13;13;12;12;12;12;11;11;11;11;11;11;10;10;10;10;10;10;9;9;9;9;9",97,0.35,6,7,1.5,2.5,0,11,0,1,1,10,1,0,7.25,1,1.5,1,7,6.25,3.25,0,0,17,17,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,3,0.41,2,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"MANDALA, MARKO;PRATTICHIZHO, DOMENIKO;ROSSI, SIMONE","1;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;UNIVERSITA DEGLI STUDI DI SIENA","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING","1;1;1",NA,NA,NA,NA,"A61F11/00;H04R25/00","1;1",NA,NA,27,3.04,394.88,7.85,13,0.48,67.67,1,4,2,1,8,0,1,9,1,19,7,0,0,0,0,0,0,26,1,0,25,1,1,0,0,0,0,0,0,0,"Italy;United States;Portugal","11;11;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3203 DENTISTRY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;40 ENGINEERING","26;11;9;5;3;3;3;3;2;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;PATIENT SAFETY;NEUROSCIENCES;BRAIN DISORDERS;BEHAVIORAL AND SOCIAL SCIENCE;CARDIOVASCULAR;LUNG;PREVENTION;BIOENGINEERING;LUNG CANCER;MENTAL HEALTH;ASSISTIVE TECHNOLOGY;BREAST CANCER;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DEPRESSION;HEART DISEASE;INFECTIOUS DISEASES","19;14;13;8;7;6;5;4;4;4;4;3;3;3;2;2;2;2;2;2","CANCER;CARDIOVASCULAR;MENTAL HEALTH;ORAL AND GASTROINTESTINAL;MUSCULOSKELETAL;NEUROLOGICAL;RESPIRATORY","11;4;3;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES","17;6;2;1;1;1;1","MELANOMA;LUNG CANCER;BREAST CANCER;BRAIN TUMOR;MYELOMA;PANCREATIC CANCER;RESPIRATORY SYSTEM","4;3;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","10;2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;FRONTIERS;KARGER PUBLISHERS","15;7;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;49 MATHEMATICAL SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;46 INFORMATION AND COMPUTING SCIENCES;50 PHILOSOPHY AND RELIGIOUS STUDIES;3213 PAEDIATRICS;3215 REPRODUCTIVE MEDICINE;37 EARTH SCIENCES;40 ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;42 HEALTH SCIENCES;4601 APPLIED COMPUTING;4903 NUMERICAL AND COMPUTATIONAL MATHEMATICS;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","27;8;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;IMMUNIZATION;VACCINE RELATED;GENETICS;CLINICAL RESEARCH;LUNG;ASTHMA;BIODEFENSE;BIOTECHNOLOGY;CARDIOVASCULAR;EMERGING INFECTIOUS DISEASES;GENETIC TESTING;HEART DISEASE;HEMATOLOGY;HUMAN GENOME;INFANT MORTALITY;PATIENT SAFETY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS","6;6;6;5;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;REPRODUCTIVE HEALTH AND CHILDBIRTH;RESPIRATORY","6;1;1;1;1;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS;3.4 VACCINES","7;2;2;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","7;2;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH","6;4;1","MELANOMA;LEUKEMIA / LEUKAEMIA","7;1","3 GOOD HEALTH AND WELL BEING","2"
"AOU_SENESE",2023,282,21.4929078014184,2.64893617021277,0.25531914893617,0.269503546099291,0.319148936170213,2.09243697478992,1.44,1.38181818181818,1.32352941176471,0.663120567375887,3,119,54,25,30,0.42,0.19,0.09,0.11,2.73,0.622152570145843,4.9242132305716,0.319148936170213,0.950354609929078,0.581,0.442,0.542,0.508,"MONICA BOCCHIA;MASSIMO BRECCIA;LUCA CANTARINI;MASSIMILIANO BONIFACIO;EMANUELE CENCINI;ELISABETTA ABRUZZESE;SARA GALIMBERTI;ELENA BARGAGLI;ALESSANDRA IURLO;BRUNO FREDIANI;MARIO TIRIBELLI;AMATO SANTORO;MIRIANA D’ALESSANDRO;PAOLO CAMELI;FABRIZIO PANE;CLAUDIA FABIANI;MONICA CRUGNOLA;ANTONIO VITALE;LAURA BERGANTINI;ALBERTO FABBRI","40;18;17;16;15;15;14;14;13;13;13;13;12;12;12;12;11;11;11;11","MONICA BOCCHIA;ALESSANDRO GOZZETTI;ELENA BARGAGLI;PIETRO RUBEGNI;PAOLO CAMELI;FILOMENA RUSSO;MIRIANA D’ALESSANDRO;LAURA LAZZERI;LAURA BERGANTINI;AMATO SANTORO;BIANCA MECACCI;ANTONIO MURSIA;GUIDO GABRIELE;FLAVIA CASCINO;EMANUELE CENCINI;PAOLO GENNARO;LUCA CANTARINI;CLAUDIA FABIANI;NICOLA MONDANELLI;ELISA TROIANO","2.08;1.71;1.49;1.26;1.19;1.19;1.15;1.13;1.08;1.08;1;1;0.94;0.94;0.92;0.9;0.87;0.84;0.83;0.83","MONICA BOCCHIA;LUCA CANTARINI;EMANUELE CENCINI;ELENA BARGAGLI;BRUNO FREDIANI;AMATO SANTORO;MIRIANA D’ALESSANDRO;PAOLO CAMELI;CLAUDIA FABIANI;ANTONIO VITALE;LAURA BERGANTINI;ALBERTO FABBRI;ROSSANA TASSI;PIETRO RUBEGNI;STEFANO GENTILESCHI;SANDRA BRACCO;FILOMENA RUSSO;SARA GANGI;MASSIMO FINESCHI;VALERIA CAGGIANO","40;17;15;14;13;13;12;12;12;11;11;11;11;10;9;9;8;8;8;8","MONICA BOCCHIA;ALESSANDRO GOZZETTI;ELENA BARGAGLI;PIETRO RUBEGNI;PAOLO CAMELI;FILOMENA RUSSO;MIRIANA D’ALESSANDRO;LAURA LAZZERI;LAURA BERGANTINI;AMATO SANTORO;BIANCA MECACCI;ANTONIO MURSIA;GUIDO GABRIELE;FLAVIA CASCINO;EMANUELE CENCINI;PAOLO GENNARO;LUCA CANTARINI;CLAUDIA FABIANI;NICOLA MONDANELLI;ELISA TROIANO","2.08;1.71;1.49;1.26;1.19;1.19;1.15;1.13;1.08;1.08;1;1;0.94;0.94;0.92;0.9;0.87;0.84;0.83;0.83","MONICA BOCCHIA;MASSIMO BRECCIA;BRUNO FREDIANI;ALESSANDRO IADANZA;ELISABETTA ABRUZZESE;LUCA CANTARINI;ITALO PORTO;MASSIMILIANO BONIFACIO;ALESSANDRA IURLO;DAIJIRO TOMII;MATTI ADAM;THOMAS PILGRIM;FRANCESCO BEDOGNI;AZEEM LATIB;CORRADO TAMBURINO;EBERHARD GRUBE;FRANCESCO BURZOTTA;FRANCESCO SAIA;GIULIANO COSTA;LARS SØNDERGAARD","135;84;71;66;66;65;63;63;61;59;59;59;56;53;53;53;53;53;53;53","MONICA BOCCHIA;ALESSANDRO IADANZA;BRUNO FREDIANI;ROSSANA TASSI;ALBERTO PALAZZUOLI;ANTONIO VITALE;LUCA CANTARINI;MASSIMO FINESCHI;EMANUELE CENCINI;VALERIA CAGGIANO;ALBERTO FABBRI;ANNA SICURANZA;CARLA GAGGIANO;DONATELLA RASPADORI;PAOLA PACELLI;AMATO SANTORO;MARZIA DEFINA;ALESSANDRA RENIERI;ALESSANDRO LEONE;JURGEN SOTA","135;66;43;43;41;41;41;38;33;28;27;26;26;26;26;25;25;24;24;22","MONICA BOCCHIA;EMANUELE CENCINI;AMATO SANTORO;ALBERTO FABBRI;ROSSANA TASSI;BRUNO FREDIANI;LUCA CANTARINI;ALESSANDRA RENIERI;ANTONIO VITALE;SANDRA BRACCO;CARLA GAGGIANO;ANNA SICURANZA;MARZIA DEFINA;PIETRO RUBEGNI;MASSIMO FINESCHI;FABRIZIO MEZZASALMA;SERAFINA VALENTE;VALERIA CAGGIANO;CLAUDIA FABIANI;LUCA LUZZI","40;15;13;11;11;11;11;9;9;9;8;8;8;8;8;7;7;7;7;6","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;GEOLOGY;SOCIOLOGY;MATERIALS SCIENCE;ART;HISTORY","273;51;27;24;21;13;12;12;10;8;5;4;4;3;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;CARDIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PEDIATRICS;GENETICS;RADIOLOGY;DERMATOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;MECHANICAL ENGINEERING;INTENSIVE CARE MEDICINE;NURSING;PSYCHIATRY;ENDOCRINOLOGY;OPTICS;CANCER RESEARCH;FAMILY MEDICINE","212;81;57;55;40;37;37;27;25;20;19;18;18;18;16;16;15;12;12;10;10","DISEASE;CHEMOTHERAPY;GENE;CANCER;COHORT;LEUKEMIA;HEART FAILURE;LYMPHOMA;MYELOID LEUKEMIA;POPULATION;BONE MARROW;RETROSPECTIVE COHORT STUDY;STROKE (ENGINE);LUNG;ANTIBODY;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;ADVERSE EFFECT;CLINICAL TRIAL;ALTERNATIVE MEDICINE;IMMUNE SYSTEM;PROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL","44;30;24;23;23;23;22;21;18;18;17;17;17;16;14;14;14;13;13;11;11;11;11;11","MINIMAL RESIDUAL DISEASE;EJECTION FRACTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);CHRONIC LYMPHOCYTIC LEUKEMIA;HAZARD RATIO;RITUXIMAB;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;IMATINIB;INTERSTITIAL LUNG DISEASE;MUTATION;AUTOANTIBODY;COLORECTAL CANCER;HEMATOPOIETIC STEM CELL TRANSPLANTATION;THROMBOLYSIS;CHEMOTHERAPY REGIMEN;CYTARABINE;DIFFUSE LARGE B-CELL LYMPHOMA;GENE EXPRESSION;GENOTYPE;ISCHEMIC STROKE;MYELODYSPLASTIC SYNDROMES;MYELOFIBROSIS;NEUTROPENIA;UNIVARIATE ANALYSIS","13;12;11;10;10;10;9;9;9;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);DASATINIB;NILOTINIB;VENETOCLAX;CARDIAC RESYNCHRONIZATION THERAPY;DNA METHYLATION;FLUDARABINE;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;MODIFIED RANKIN SCALE;RUXOLITINIB;SECUKINUMAB;VINCRISTINE;ACUTE LYMPHOCYTIC LEUKEMIA;ANTIRETROVIRAL THERAPY;FEBRILE NEUTROPENIA;IDARUBICIN;INTERNATIONAL PROGNOSTIC INDEX;MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM","11;7;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3",";HUMANS;RETROSPECTIVE STUDIES;STROKE;TREATMENT OUTCOME;BRAIN ISCHEMIA;MALE;AGED;FEMALE;ADULT;THROMBECTOMY;COVID-19;HEART FAILURE;ITALY;PROSPECTIVE STUDIES;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;STILL'S DISEASE, ADULT-ONSET;VITAMIN D DEFICIENCY;CHILD;ENDOVASCULAR PROCEDURES","147;132;32;32;26;24;22;20;19;18;15;14;14;13;13;11;11;11;10;10","EFFICACY AND RESISTANCE IN CML TREATMENT;LYMPHOID NEOPLASMS;ACUTE MYELOID LEUKEMIA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;MANAGEMENT OF VALVULAR HEART DISEASE;AUTISM SPECTRUM DISORDERS;CANCER IMMUNOTHERAPY;CORONAVIRUS DISEASE 2019 RESEARCH;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;CHOLESTEROL-LOWERING TREATMENT;CLINICAL CHARACTERISTICS AND MANAGEMENT OF SARCOIDOSIS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE","13;13;11;11;10;9;6;5;5;5;5;5;4;4;4;4;3;3;3;3","STROKE (ENGINE);MINIMAL RESIDUAL DISEASE;CLINICAL ENDPOINT;HEMATOLOGY;TREATMENT OUTCOMES;DISCONTINUATION;INFARCTION TREATMENT;TREATMENT;TREATMENT DISCONTINUATION;INTERQUARTILE RANGE;MANTLE CELL LYMPHOMA;REFRACTORY (PLANETARY SCIENCE);MYELOFIBROSIS;REGIMEN;VENETOCLAX;CARDIAC IMAGING;CHEMOTHERAPY REGIMEN;CONCOMITANT;ECHOCARDIOGRAPHY;IMATINIB MESYLATE","17;14;10;10;10;9;8;8;8;7;7;7;6;6;6;5;5;5;5;5","MYELOID LEUKEMIA;HEART FAILURE;CHRONIC MYELOID;AIDA NETWORK;ACUTE LYMPHOBLASTIC;ACUTE MYELOID;FONDAZIONE ITALIANA;ITALIANA LINFOMI;STILLS DISEASE;IMPLANTABLE DEFIBRILLATOR;LYMPHOBLASTIC LEUKEMIA;ANMCO POSITION;COLORECTAL CANCER;DEFIBRILLATOR ALGORITHM;ELDERLY PATIENTS;GIMEMA AML;INTERSTITIAL LUNG;LEUKEMIA PATIENTS;PATIENTS TREATED;POSITION PAPER;RESIDUAL DISEASE;STEM CELL;AORTIC VALVE;CAMPUS CML;CARDIAC RESYNCHRONIZATION;COHERENCE TOMOGRAPHY;DISEASE REGISTRY;INTERNATIONAL AIDA;IV THROMBOLYSIS;MECHANICAL THROMBECTOMY","15;12;10;8;7;7;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","MEDIAN AGE;MEDIAN FOLLOW-UP;MOLECULAR RESPONSE;PATIENTS TREATED;MYELOID LEUKEMIA;SURVIVAL OS;PATIENTS RECEIVED;HEART FAILURE;NEWLY DIAGNOSED;RESIDUAL DISEASE;STILLS DISEASE;BONE MARROW;FLOW CYTOMETRY;MEDIAN OS;PATIENTS AGED;STATISTICALLY SIGNIFICANT;COMPLETE REMISSION;MINIMAL RESIDUAL;STABLE IMPROVED;WORSENED STABLE;ADVERSE EVENTS;CML PATIENTS;ELDERLY PATIENTS;SIGNIFICANT DIFFERENCES;TREATED PATIENTS;CLINICAL FEATURES;MEDIAN TIME;MRD ANALYSIS;MRD NEGATIVITY;ACUTE MYELOID","36;32;27;25;23;23;21;17;17;17;17;16;16;16;16;16;15;15;15;15;14;14;14;14;14;13;13;13;13;12",81,0.29,7.25,8,1.25,1.5,0,2,0,0,1,8,0,0,8,0,1,1,2,6.5,4,0,0,7,7,4,0,0,1,1,3,0,0,0,0,0,0,1,2,2,0,7,4.69,1.4,0,2,3,0,0,2,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ARAQUE JOSÉ-ESTÉ;BOTTA MAURIZIO;BRAI ANNALAURA;FAZI ROBERTA;MARTINEZ DE LA SIERRA MIGUEL-ANGEL;MARTINEZ JAVIER;MEYERHANS ANDREAS;TINTORI CRISTINA;ANDREAS MEYERHANS;ANNALAURA BRAI","2;2;2;2;2;2;2;2;1;1","AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;UNIVERSITA DEGLI STUDI DI SIENA;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE AOUS","4;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;40 ENGINEERING;31 BIOLOGICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4003 BIOMEDICAL ENGINEERING","5;3;2;2;1;1;1;1","BIOTECHNOLOGY;GENE THERAPY;GENETICS;HUMAN GENOME","1;1;1;1","5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","3;1","A61K31/41;A61K31/4192;A61K31/4245;A61K31/433;A61K31/4439;A61K31/4725;A61P31/12;C07D249/04;C07D249/06;C07D257/04","3;3;3;3;3;3;3;3;3;3","A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4439;A61K31/496;A61K31/5377;A61K31/675;A61K31/7056;A61K45/06","2;2;2;2;2;2;2;2;2;2",10,3.1,1083,3.03,4,0.4,104.2,0,1,2,1,4,0,0,2,0,8,2,0,0,0,0,0,0,10,0,0,10,0,0,0,0,0,0,0,0,0,"United States;Denmark;Italy","5;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","9;4;4;3;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;CHRONIC PAIN;PAIN RESEARCH;RARE DISEASES;AGING;ALCOHOLISM, ALCOHOL USE AND HEALTH;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BREAST CANCER;CARDIOVASCULAR;DEPRESSION;FIBROMYALGIA;GENETICS;HEART DISEASE;LUNG;MENTAL HEALTH;MIND AND BODY;PATIENT SAFETY","10;8;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR","5;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","7;1","MELANOMA;CERVICAL CANCER","4;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,"FRONTIERS;AMERICAN ASSOCIATION FOR CANCER RESEARCH;FUTURE SCIENCE GROUP","9;6;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES","31;12;6;4;4;3;3;3;3;2;2","CLINICAL RESEARCH;GENETICS;AUTOIMMUNE DISEASE;CANCER;CONTRACEPTION/REPRODUCTION;GENETIC TESTING;HUMAN GENOME;INFERTILITY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;RARE DISEASES;CARDIOVASCULAR;HEART DISEASE;HEMATOLOGY;LYMPHOMA;TRANSPLANTATION","8;7;3;3;3;3;3;3;3;3;3;2;2;2;2;2","REPRODUCTIVE HEALTH AND CHILDBIRTH;CANCER;CARDIOVASCULAR","3;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","6;3;3","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","5;2;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","10;3","NOT SITE-SPECIFIC CANCER;MELANOMA;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","4;3;2;2",NA,NA
"AOU_SENESE",2024,196,24.515306122449,2.55102040816327,0.23469387755102,0.229591836734694,0.26530612244898,1.76056338028169,1.21052631578947,1.21621621621622,1.26829268292683,0.637755102040816,0,74,43,17,15,0.38,0.22,0.09,0.08,0.71,0.742053272075846,3.95283018867924,0.362244897959184,0.969387755102041,0.427,0.473,0.379,0.459,"LUCA CANTARINI;BRUNO FREDIANI;ANTONIO VITALE;CLAUDIA FABIANI;MARIA ANTONIETTA MAZZEI;ROSSANA TASSI;MANUEL CAPPELLARI;JURGEN SOTA;ALESSANDRO PEZZINI;CARLA GAGGIANO;VALERIA CAGGIANO;MONICA BOCCHIA;GAAFAR RAGAB;ANDREA ZINI;ANNA CAVALLINI;MASSIMO DEL SETTE;GIAN MARCO TOSI;PATRIZIA NENCINI;MARINA DIOMEDI;ÉLISA CINOTTI","15;14;12;12;11;11;10;10;10;10;9;8;8;8;8;8;8;8;8;8","ÉLISA CINOTTI;PIETRO RUBEGNI;AMATO SANTORO;ALBERTO PALAZZUOLI;SIMONE TADDEUCCI;LINDA TOGNETTI;MIRIANA D’ALESSANDRO;ELENA BARGAGLI;BRUNO FREDIANI;MARIA ANTONIETTA MAZZEI;SERAFINA VALENTE;PAOLO CAMELI;GUIDO GABRIELE;LUCA CANTARINI;NICOLA MONDANELLI;ELISA TROIANO;GIOVANNI BATTISTA COLASANTI;STEFANO GIANNOTTI;PAOLO GENNARO;FLAVIA CASCINO","0.92;0.87;0.85;0.73;0.68;0.66;0.65;0.63;0.63;0.6;0.57;0.55;0.5;0.48;0.48;0.48;0.48;0.48;0.48;0.48","LUCA CANTARINI;BRUNO FREDIANI;ANTONIO VITALE;CLAUDIA FABIANI;MARIA ANTONIETTA MAZZEI;ROSSANA TASSI;JURGEN SOTA;CARLA GAGGIANO;VALERIA CAGGIANO;MONICA BOCCHIA;GIAN MARCO TOSI;ÉLISA CINOTTI;STEFANO GENTILESCHI;MARIO TUMBARELLO;PAOLO CAMELI;ALBERTO BALISTRERI;ALBERTO PALAZZUOLI;ELENA BARGAGLI;SERAFINA VALENTE;AMATO SANTORO","15;14;12;12;11;11;10;10;9;8;8;8;8;8;7;7;7;7;7;7","ÉLISA CINOTTI;PIETRO RUBEGNI;AMATO SANTORO;ALBERTO PALAZZUOLI;SIMONE TADDEUCCI;LINDA TOGNETTI;MIRIANA D’ALESSANDRO;ELENA BARGAGLI;BRUNO FREDIANI;MARIA ANTONIETTA MAZZEI;SERAFINA VALENTE;PAOLO CAMELI;GUIDO GABRIELE;LUCA CANTARINI;NICOLA MONDANELLI;ELISA TROIANO;GIOVANNI BATTISTA COLASANTI;STEFANO GIANNOTTI;PAOLO GENNARO;FLAVIA CASCINO","0.92;0.87;0.85;0.73;0.68;0.66;0.65;0.63;0.63;0.6;0.57;0.55;0.5;0.48;0.48;0.48;0.48;0.48;0.48;0.48","ALESSANDRO PINI;GIOVANNI CAPPELLO;LAURA CRESTI;MARTINA NESTI;MARIA CONCETTA PASTORE;MARTA FOCARDI;MATTEO CAMELI;VERONICA LORENZ;MONICA BOCCHIA;ROBERTO CERAVOLO;ADA CUTOLO;ALAIDE CHIEFFO;ALESSANDRO NAVAZIO;ALESSANDRO VICENTINI;ALFONSO IORIO;AMATO SANTORO;ANDREA MONTALTO;ANDREA POZZI;ANDREA ROSSI;ANGELO AURICCHIO","19;17;17;16;14;14;14;14;11;11;8;8;8;8;8;8;8;8;8;8","ALESSANDRO PINI;VERONICA LORENZ;AMATO SANTORO;FEDERICO LANDRA;MARTINA NESTI;MONICA BOCCHIA;SERAFINA VALENTE;ALBERTO PALAZZUOLI;GIANFRANCO MONTESI;MARIO TUMBARELLO;ALESSANDRA RUFA;ALESSANDRO MALANDRINI;EMANUELE CENCINI;GIORGIA SIMONCELLI;MARIA ANTONIETTA MAZZEI;MASSIMILIANO FABBIANI;ALESSANDRA RENIERI;ANTONIO VITALE;DIEGO LOPERGOLO;FRANCESCA MONTAGNANI","17;14;8;8;8;8;8;7;7;7;5;5;5;5;5;5;4;4;4;4","ROSSANA TASSI;ANTONIO VITALE;BRUNO FREDIANI;CLAUDIA FABIANI;MONICA BOCCHIA;ÉLISA CINOTTI;ALBERTO PALAZZUOLI;LUCA CANTARINI;MARIA ANTONIETTA MAZZEI;MARIO TUMBARELLO;SERAFINA VALENTE;AMATO SANTORO;CARLA GAGGIANO;PIETRO RUBEGNI;VALERIA CAGGIANO;EMANUELE CENCINI;JURGEN SOTA;STEFANO GENTILESCHI;DIEGO LOPERGOLO;ELENA BARGAGLI","11;8;8;8;8;8;7;7;7;7;7;7;6;6;6;5;5;5;4;4","MEDICINE;BIOLOGY;ENGINEERING;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ECONOMICS;PSYCHOLOGY;MATHEMATICS;POLITICAL SCIENCE;GEOLOGY;HISTORY;PHILOSOPHY;ART;BUSINESS;MATERIALS SCIENCE;SOCIOLOGY","184;45;20;15;13;13;11;11;6;6;5;3;3;2;2;2;2","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;INTENSIVE CARE MEDICINE;DERMATOLOGY;GENETICS;ONCOLOGY;RADIOLOGY;BIOCHEMISTRY;IMMUNOLOGY;PEDIATRICS;MECHANICAL ENGINEERING;PSYCHIATRY;CANCER RESEARCH;COMPUTATIONAL BIOLOGY;NURSING;OPHTHALMOLOGY;PALEONTOLOGY;FAMILY MEDICINE;OPTICS","139;46;39;33;27;23;21;18;18;17;17;15;13;12;11;9;9;9;9;8;8","DISEASE;GENE;COHORT;RETROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;CANCER;HEART FAILURE;STROKE (ENGINE);CHEMOTHERAPY;MYOCARDIAL INFARCTION;ISCHEMIA;STENOSIS;ADVERSE EFFECT;CLINICAL TRIAL;LUNG;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);LYMPHOMA;OBSERVATIONAL STUDY;UVEITIS","23;23;17;15;14;13;13;13;11;10;9;9;8;8;8;7;7;7;7;7","EJECTION FRACTION;ISCHEMIC STROKE;HAZARD RATIO;MUTATION;CLINICAL ENDPOINT;GENOTYPE;IDIOPATHIC PULMONARY FIBROSIS;NEURORADIOLOGY;RITUXIMAB;VASCULITIS;ADALIMUMAB;ANTIBIOTIC RESISTANCE;BEHCET'S DISEASE;HISTONE;IMMUNOTHERAPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLIXIMAB;INTERSTITIAL LUNG DISEASE;INTRACEREBRAL HEMORRHAGE;MINOR STROKE;MULTICENTER STUDY;PULMONARY FIBROSIS;SEDIMENTATION;THROMBOLYSIS","9;7;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);SINGLE-NUCLEOTIDE POLYMORPHISM;CARDIAC RESYNCHRONIZATION THERAPY;DASATINIB;HISTONE DEACETYLASE;MEROPENEM;MISSENSE MUTATION;MODIFIED RANKIN SCALE;RETINAL VASCULITIS;SPECKLE TRACKING ECHOCARDIOGRAPHY;ACUTE LYMPHOCYTIC LEUKEMIA;ADAMTS13;ALPORT SYNDROME;ALTERNATIVE SPLICING;ANTIBACTERIAL PEPTIDE;ANTIRETROVIRAL THERAPY;ARID1A;AUTOTAXIN;AXIAL SPONDYLOARTHRITIS;BLINATUMOMAB;BODY CONTOURING;BRONCHOPULMONARY DYSPLASIA;BUSULFAN;CADASIL;CARFILZOMIB;CEFTAZIDIME;CETUXIMAB;CHRONOTROPIC;CLAUDICATION;CYBERKNIFE;DARATUMUMAB;EGFR INHIBITORS;EPISCLERITIS;EXOME SEQUENCING;EXTERNAL LIMITING MEMBRANE;FLUDARABINE;FRACTIONAL FLOW RESERVE;FRONTOTEMPORAL DEMENTIA;GASTRIC BYPASS;GENE EXPRESSION PROFILING;GENE SIGNATURE;GENITAL WARTS;GENOMICS;GRANULOMATOSIS WITH POLYANGIITIS;IMPELLA;INFLAMMATORY BOWEL DISEASES;INTERNATIONAL PROGNOSTIC INDEX;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;INTRA ARTICULAR;INTRAVENTRICULAR HEMORRHAGE;KLEBSIELLA PNEUMONIAE;KNEE ARTHRITIS;KRAS;LIMB-GIRDLE MUSCULAR DYSTROPHY;LURASIDONE;MACULAR HOLE;MALE INFERTILITY;MAMMOGRAPHY;MARGINAL ZONE;MECP2;MEPOLIZUMAB;METASTASECTOMY;MICROSCOPIC POLYANGIITIS;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NAB-PACLITAXEL;NILOTINIB;NON-SMALL CELL LUNG CANCER (NSCLC);OLIGOARTHRITIS;OSWESTRY DISABILITY INDEX;PANCREATIC DUCTAL ADENOCARCINOMA;PERIVENTRICULAR LEUKOMALACIA;PHOSPHOINOSITIDE 3-KINASE;POMALIDOMIDE;POPILLIA;RETINOPATHY OF PREMATURITY;RNA SPLICING;RUXOLITINIB;SECUKINUMAB;SOD1;STAT;STEREOTACTIC RADIOTHERAPY;STROKE VOLUME;SURFACTANT THERAPY;TERIPARATIDE;TRANSCRIPTOME;VARICOCELE;WHOLE GENOME SEQUENCING;XANTHOGRANULOMATOUS PYELONEPHRITIS","3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;PROSPECTIVE STUDIES;ADOLESCENT;TREATMENT OUTCOME;REGISTRIES;YOUNG ADULT;CHILD;PROGNOSIS;QUALITY OF LIFE;TIME FACTORS;ANTIBODIES, MONOCLONAL, HUMANIZED","135;60;38;35;29;24;20;19;12;10;10;9;9;8;7;6;5;5;5;4","EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT OF VALVULAR HEART DISEASE;LYMPHOID NEOPLASMS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;ATOPIC DERMATITIS AND SKIN MICROBIOME;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;ATRIAL FIBRILLATION;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;CUTANEOUS ADNEXAL NEOPLASMS AND RELATED SYNDROMES;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE","9;6;6;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","STROKE (ENGINE);INFARCTION TREATMENT;PROSTHETIC VALVES EVALUATION;CARDIAC IMAGING;CLINICAL ENDPOINT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;TREATMENT;CARDIAC RESYNCHRONIZATION THERAPY;ECHOCARDIOGRAPHY;ERYTHROCYTE SEDIMENTATION RATE;NEURORADIOLOGY;POSITION PAPER;REFRACTORY (PLANETARY SCIENCE);UVEITIS;ASSOCIATION (PSYCHOLOGY);CARDIOGENIC SHOCK;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL FEATURES;CLINICAL PRACTICE;HEART VALVE SURGERY","13;8;7;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3","AIDA NETWORK;COHORT STUDY;HEART FAILURE;ISCHEMIC STROKE;INTERNATIONAL AIDA;ITALIAN SOCIETY;EJECTION FRACTION;IDIOPATHIC PULMONARY;LEFT VENTRICULAR;LUNG CANCER;MULTICENTER STUDY;POSITION PAPER;PULMONARY FIBROSIS;RANDOMIZED CONTROLLED;REAL-LIFE STUDY;RETROSPECTIVE COHORT;VENTRICULAR EJECTION;ADULT PATIENTS;ANTIPLATELET TREATMENT;AORTIC VALVE;BEHÇETS DISEASE;CARDIOGENIC SHOCK;CLINICAL PRACTICE;CONTROLLED TRIAL;CORONARY ARTERY;DISEASE REGISTRY;DUAL ANTIPLATELET;ERYTHROCYTE SEDIMENTATION;MULTICENTRE STUDY;PATIENTS UNDERGOING","8;7;7;7;6;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","PATIENTS TREATED;ISCHEMIC STROKE;RETROSPECTIVE STUDY;BREAST CANCER;LUNG CANCER;PATIENTS UNDERGOING;CANCER PATIENTS;LOGISTIC REGRESSION;ML BLOCK;CLINICAL PRACTICE;FEMALE PATIENTS;HAZARD RATIO;HEALTHY CONTROLS;HEART FAILURE;PULMONARY FIBROSIS;RISK FACTORS;SIGNIFICANTLY LOWER;ACUTE EXACERBATION;CHORUS PROMONITOR;FUNCTIONAL OUTCOME;MEDIAN AGE;PATIENTS AFFECTED;RATIO CI;REPERFUSION THERAPIES;SIGNIFICANT DIFFERENCES;SOCIAL MEDIA;BOOLEAN FEATURES;CLINICAL TRIALS;COMPLETE OMENTECTOMY;DAY MORTALITY","14;11;11;10;9;9;8;8;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,7,422,0.79,0,0,32,0,0,0,0,1,0,0,1,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Netherlands;Switzerland","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES","2;2;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;HEMATOLOGY;LYMPHOMA;PATIENT SAFETY;PREVENTION;RARE DISEASES","2;2;2;1;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS;6.4 SURGERY;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","2;1;1","NON-HODGKIN'S LYMPHOMA;STOMACH CANCER","1;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"FRONTIERS;TAYLOR & FRANCIS GROUP","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1;1;1;1;1","BIOENGINEERING;CANCER;CLINICAL RESEARCH;GENETICS;HEMATOLOGY;LUNG;LYMPHOMA;RARE DISEASES","1;1;1;1;1;1;1;1","CANCER","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1;1","BIOMEDICAL","1","BASIC SCIENCE","1","LEUKEMIA / LEUKAEMIA","1",NA,NA
